{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 686676, "items": [{"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T02:19:43Z", "timestamp": 1574734783763}, "reference-count": 38, "publisher": "Wiley", "issue": "10", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"name": "Office of International Relations", "award": []}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Mass Spectrom."], "published-print": {"date-parts": [[2015, 10]]}, "DOI": "10.1002/jms.3635", "type": "journal-article", "created": {"date-parts": [[2015, 10, 12]], "date-time": "2015-10-12T21:16:49Z", "timestamp": 1444684609000}, "page": "1163-1174", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Low resolution and high resolution MS for studies on the metabolism and toxicological detection of the new psychoactive substance methoxypiperamide (MeOP)"], "prefix": "10.1002", "volume": "50", "author": [{"given": "Markus R.", "family": "Meyer", "sequence": "first", "affiliation": [{"name": "Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology; Saarland University; Homburg (Saar) Germany"}, {"name": "Division of Clinical Pharmacology, Department of Laboratory Medicine; Karolinska Institute; Stockholm Sweden"}]}, {"given": "Anna", "family": "Holderbaum", "sequence": "additional", "affiliation": [{"name": "Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology; Saarland University; Homburg (Saar) Germany"}]}, {"given": "Pierce", "family": "Kavanagh", "sequence": "additional", "affiliation": [{"name": "Department of Pharmacology and Therapeutics; Trinity Centre for Health and Sciences, St. James's Hospital; Dublin 8 Ireland"}]}, {"given": "Hans H.", "family": "Maurer", "sequence": "additional", "affiliation": [{"name": "Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology; Saarland University; Homburg (Saar) Germany"}]}], "member": "311", "published-online": {"date-parts": [[2015, 9, 9]]}, "reference": [{"key": "10.1002/jms.3635-BIB0001|jms3635-cit-0001", "unstructured": "EMCDDA-Europol 2013 Annual Report on the Implementation of Council Decision 2005/387/JHA http://www.emcdda.europa.eu/attachements.cfm/att_229598_EN_TDAN14001ENN.pdf 2014"}, {"key": "10.1002/jms.3635-BIB0002|jms3635-cit-0002", "author": "Prasad", "volume": "11", "first-page": "1144", "year": "1968", "journal-title": "J. Med. Chem.", "DOI": "10.1021/jm00312a009", "doi-asserted-by": "crossref"}, {"key": "10.1002/jms.3635-BIB0003|jms3635-cit-0003", "author": "Tekes", "volume": "39", "first-page": "203", "year": "1987", "journal-title": "Pol. J. Pharmacol. Pharm.", "DOI": "10.1111/j.2042-7158.1987.tb06249.x", "doi-asserted-by": "crossref"}, {"key": "10.1002/jms.3635-BIB0004|jms3635-cit-0004", "author": "Szucks", "volume": "39", "first-page": "185", "year": "1987", "journal-title": "Pol. J. Pharmacol. Pharm.", "DOI": "10.1111/j.2042-7158.1987.tb06246.x", "doi-asserted-by": "crossref"}, {"key": "10.1002/jms.3635-BIB0005|jms3635-cit-0005", "author": "Oberlander", "volume": "60", "first-page": "163", "year": "1979", "journal-title": "Eur. J. Pharmacol.", "DOI": "10.1016/0014-2999(79)90215-2", "doi-asserted-by": "crossref"}, {"key": "10.1002/jms.3635-BIB0006|jms3635-cit-0006", "author": "Magyar", "volume": "130", "first-page": "219", "year": "1986", "journal-title": "Eur. J. Pharmacol.", "DOI": "10.1016/0014-2999(86)90271-2", "doi-asserted-by": "crossref"}, {"key": "10.1002/jms.3635-BIB0007|jms3635-cit-0007", "unstructured": "Report on the risk assessment of BZP in the framework of the Council decision on new psychoactive substances http://www.emcdda.europa.eu/attachements.cfm/att_70975_EN_EMCDDA_risk_assessment_8 . pdf. Assessed August 25, 2014"}, {"key": "10.1002/jms.3635-BIB0008|jms3635-cit-0008", "author": "Gee", "volume": "48", "first-page": "230", "year": "2010", "journal-title": "Clin. Toxicol. (Phila.)", "DOI": "10.3109/15563651003592948", "doi-asserted-by": "crossref"}, {"key": "10.1002/jms.3635-BIB0009|jms3635-cit-0009", "author": "Wood", "volume": "369", "first-page": "1490", "year": "2007", "journal-title": "Lancet", "DOI": "10.1016/S0140-6736(07)60674-6", "doi-asserted-by": "crossref"}, {"key": "10.1002/jms.3635-BIB0010|jms3635-cit-0010", "author": "Thompson", "volume": "24", "first-page": "1299", "year": "2010", "journal-title": "J. Psychopharmacol.", "DOI": "10.1177/0269881109102608", "doi-asserted-by": "crossref"}, {"key": "10.1002/jms.3635-BIB0011|jms3635-cit-0011", "author": "Gee", "volume": "46", "first-page": "802", "year": "2008", "journal-title": "Clin. Toxicol. (Phila.)", "DOI": "10.1080/15563650802307602", "doi-asserted-by": "crossref"}, {"key": "10.1002/jms.3635-BIB0012|jms3635-cit-0012", "author": "Staack", "volume": "27", "first-page": "560", "year": "2003", "journal-title": "J. Anal. Toxicol.", "DOI": "10.1093/jat/27.8.560", "doi-asserted-by": "crossref"}, {"key": "10.1002/jms.3635-BIB0013|jms3635-cit-0013", "author": "Staack", "volume": "798", "first-page": "333", "year": "2003", "journal-title": "J. Chromatogr. B", "DOI": "10.1016/j.jchromb.2003.10.004", "doi-asserted-by": "crossref"}, {"key": "10.1002/jms.3635-BIB0014|jms3635-cit-0014", "author": "Power", "volume": "6", "first-page": "668", "year": "2014", "journal-title": "Drug Test. Anal.", "DOI": "10.1002/dta.1616", "doi-asserted-by": "crossref"}, {"key": "10.1002/jms.3635-BIB0015|jms3635-cit-0015", "author": "Maurer", "year": "2011", "edition": "4", "volume-title": "Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants and Their Metabolites"}, {"key": "10.1002/jms.3635-BIB0016|jms3635-cit-0016", "author": "Wissenbach", "volume": "400", "first-page": "3481", "year": "2011", "journal-title": "Anal. Bioanal. Chem.", "DOI": "10.1007/s00216-011-5032-1", "doi-asserted-by": "crossref"}, {"key": "10.1002/jms.3635-BIB0017|jms3635-cit-0017", "unstructured": "Bundesrepublik Deutschland 2013 http://www.gesetze-im-internet.de/bundesrecht/tierschg/gesamt.pdf"}, {"key": "10.1002/jms.3635-BIB0018|jms3635-cit-0018", "author": "Welter", "volume": "405", "first-page": "3125", "year": "2013", "journal-title": "Anal. Bioanal. Chem.", "DOI": "10.1007/s00216-013-6741-4", "doi-asserted-by": "crossref"}, {"key": "10.1002/jms.3635-BIB0019|jms3635-cit-0019", "author": "Meyer", "volume": "48", "first-page": "243", "year": "2013", "journal-title": "J. Mass Spectrom.", "DOI": "10.1002/jms.3142", "doi-asserted-by": "crossref"}, {"key": "10.1002/jms.3635-BIB0020|jms3635-cit-0020", "author": "Wink", "volume": "6", "first-page": "1038", "year": "2014", "journal-title": "Drug Test. Anal.", "DOI": "10.1002/dta.1621", "doi-asserted-by": "crossref"}, {"key": "10.1002/jms.3635-BIB0021|jms3635-cit-0021", "author": "Helfer", "year": "2015", "journal-title": "Drug Test. Anal."}, {"key": "10.1002/jms.3635-BIB0022|jms3635-cit-0022", "author": "Maurer", "year": "2011", "volume-title": "Mass Spectral Library of Drugs, Poisons, Pesticides, Pollutants and Their Metabolites"}, {"key": "10.1002/jms.3635-BIB0023|jms3635-cit-0023", "author": "Meyer", "volume": "56", "first-page": "575", "year": "2010", "journal-title": "Clin. Chem.", "DOI": "10.1373/clinchem.2009.135517", "doi-asserted-by": "crossref"}, {"key": "10.1002/jms.3635-BIB0024|jms3635-cit-0024", "author": "McLafferty", "year": "1993", "edition": "4", "volume-title": "Interpretation of Mass Spectra"}, {"key": "10.1002/jms.3635-BIB0025|jms3635-cit-0025", "author": "Smith", "year": "1999", "volume-title": "Understanding Mass Spectra - A Basic Approach"}, {"key": "10.1002/jms.3635-BIB0026|jms3635-cit-0026", "author": "Kovats", "volume": "41", "first-page": "1915", "year": "1958", "journal-title": "Helv. Chim. Acta", "DOI": "10.1002/hlca.19580410703", "doi-asserted-by": "crossref"}, {"key": "10.1002/jms.3635-BIB0027|jms3635-cit-0027", "author": "Abdel-Hay", "volume": "237", "first-page": "53", "year": "2014", "journal-title": "Forensic Sci. Int.", "DOI": "10.1016/j.forsciint.2014.01.010", "doi-asserted-by": "crossref"}, {"issue": "Suppl 2", "key": "10.1002/jms.3635-BIB0028|jms3635-cit-0028", "doi-asserted-by": "crossref", "first-page": "76", "DOI": "10.1159/000137914", "volume": "27", "author": "Gaillot", "year": "1983", "journal-title": "Pharmacology"}, {"key": "10.1002/jms.3635-BIB0029|jms3635-cit-0029", "author": "Porter", "volume": "3", "first-page": "189", "year": "1975", "journal-title": "Drug Metab. Dispos."}, {"key": "10.1002/jms.3635-BIB0030|jms3635-cit-0030", "author": "Jackson", "volume": "26", "first-page": "221", "year": "1996", "journal-title": "Xenobiotica", "DOI": "10.3109/00498259609046702", "doi-asserted-by": "crossref"}, {"key": "10.1002/jms.3635-BIB0031|jms3635-cit-0031", "author": "Breyer", "volume": "21", "first-page": "1419", "year": "1972", "journal-title": "Biochem. Pharmacol.", "DOI": "10.1016/0006-2952(72)90366-8", "doi-asserted-by": "crossref"}, {"key": "10.1002/jms.3635-BIB0032|jms3635-cit-0032", "author": "Staack", "volume": "773", "first-page": "35", "year": "2002", "journal-title": "J. Chromatogr. B", "DOI": "10.1016/S1570-0232(01)00619-5", "doi-asserted-by": "crossref"}, {"key": "10.1002/jms.3635-BIB0033|jms3635-cit-0033", "author": "Staack", "volume": "38", "first-page": "971", "year": "2003", "journal-title": "J. Mass Spectrom.", "DOI": "10.1002/jms.513", "doi-asserted-by": "crossref"}, {"key": "10.1002/jms.3635-BIB0034|jms3635-cit-0034", "author": "Staack", "volume": "34", "first-page": "179", "year": "2004", "journal-title": "Xenobiotica", "DOI": "10.1080/00498250310001644544", "doi-asserted-by": "crossref"}, {"key": "10.1002/jms.3635-BIB0035|jms3635-cit-0035", "author": "Staack", "volume": "39", "first-page": "255", "year": "2004", "journal-title": "J. Mass Spectrom.", "DOI": "10.1002/jms.556", "doi-asserted-by": "crossref"}, {"key": "10.1002/jms.3635-BIB0036|jms3635-cit-0036", "author": "Thornberry", "volume": "7", "first-page": "557", "year": "2007", "journal-title": "Curr. Top. Med. Chem.", "DOI": "10.2174/156802607780091028", "doi-asserted-by": "crossref"}, {"key": "10.1002/jms.3635-BIB0037|jms3635-cit-0037", "author": "Welter", "volume": "407", "first-page": "1371", "year": "2015", "journal-title": "Anal. Bioanal. Chem.", "DOI": "10.1007/s00216-014-8360-0", "doi-asserted-by": "crossref"}, {"key": "10.1002/jms.3635-BIB0038|jms3635-cit-0038", "author": "Sharma", "volume": "157", "first-page": "907", "year": "2009", "journal-title": "Br. J. Pharmacol.", "DOI": "10.1111/j.1476-5381.2009.00267.x", "doi-asserted-by": "crossref"}], "container-title": ["Journal of Mass Spectrometry"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjms.3635", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 23]], "date-time": "2017-06-23T21:06:18Z", "timestamp": 1498251978000}, "score": 100.78865, "subtitle": ["Metabolism of methoxypiperamide"], "issued": {"date-parts": [[2015, 9, 9]]}, "references-count": 38, "journal-issue": {"published-print": {"date-parts": [[2015, 10]]}, "issue": "10"}, "URL": "http://dx.doi.org/10.1002/jms.3635", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["1076-5174"], "issn-type": [{"value": "1076-5174", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T16:25:55Z", "timestamp": 1574526355015}, "reference-count": 29, "publisher": "Wiley", "issue": "1", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 973, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Mass Spectrom."], "published-print": {"date-parts": [[2013, 1]]}, "DOI": "10.1002/jms.3112", "type": "journal-article", "created": {"date-parts": [[2013, 1, 9]], "date-time": "2013-01-09T01:31:03Z", "timestamp": 1357695063000}, "page": "24-41", "source": "Crossref", "is-referenced-by-count": 22, "title": ["Studies on the metabolism and toxicological detection of glaucine, an isoquinoline alkaloid fromGlaucium flavum(Papaveraceae), in rat urine using GC-MS, LC-MSnand LC-high-resolution MSn"], "prefix": "10.1002", "volume": "48", "author": [{"given": "Golo M.J.", "family": "Meyer", "sequence": "first", "affiliation": [{"name": "Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology; Saarland University; D-66421; Homburg; Saar; Germany"}]}, {"given": "Markus R.", "family": "Meyer", "sequence": "additional", "affiliation": [{"name": "Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology; Saarland University; D-66421; Homburg; Saar; Germany"}]}, {"given": "Dirk K.", "family": "Wissenbach", "sequence": "additional", "affiliation": []}, {"given": "Hans H.", "family": "Maurer", "sequence": "additional", "affiliation": [{"name": "Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology; Saarland University; D-66421; Homburg; Saar; Germany"}]}], "member": "311", "published-online": {"date-parts": [[2013, 1, 7]]}, "reference": [{"key": "10.1002/jms.3112-BIB0001|jms3112-cit-0001", "doi-asserted-by": "crossref", "first-page": "493", "DOI": "10.1016/S0367-326X(03)00113-8", "article-title": "Antifungal activity of the methanolic extract and alkaloids of Glaucium oxylobum", "volume": "74", "author": "Morteza-Semnani", "year": "2003", "journal-title": "Fitoterapia"}, {"key": "10.1002/jms.3112-BIB0002|jms3112-cit-0002", "doi-asserted-by": "crossref", "first-page": "814", "DOI": "10.1021/np000270v", "article-title": "Geographic distribution of three alkaloid chemotypes of Croton lechleri", "volume": "65", "author": "Milanowski", "year": "2002", "journal-title": "J. Nat. Prod."}, {"key": "10.1002/jms.3112-BIB0003|jms3112-cit-0003", "author": "Xu", "volume": "29", "first-page": "399", "year": "2004", "journal-title": "Zhongguo Zhong Yao Za Zhi"}, {"key": "10.1002/jms.3112-BIB0004|jms3112-cit-0004", "doi-asserted-by": "crossref", "first-page": "1033", "DOI": "10.1080/14786410902904418", "article-title": "Alkaloids from Glaucium flavum from Sardinia", "volume": "24", "author": "Petitto", "year": "2010", "journal-title": "Nat. Prod. Res."}, {"key": "10.1002/jms.3112-BIB0005|jms3112-cit-0005", "doi-asserted-by": "crossref", "first-page": "953", "DOI": "10.1016/0031-9422(88)84134-7", "article-title": "Minor Alkaloids of Glaucium flavum", "volume": "27", "author": "Daskalova", "year": "1987", "journal-title": "Phytochem"}, {"key": "10.1002/jms.3112-BIB0006|jms3112-cit-0006", "doi-asserted-by": "crossref", "first-page": "1641", "DOI": "10.1038/sj.bjp.0702702", "article-title": "Bronchodilator and anti-inflammatory activities of glaucine: In vitro studies in human airway smooth muscle and polymorphonuclear leukocytes", "volume": "127", "author": "Cortijo", "year": "1999", "journal-title": "Br. J. Pharmacol."}, {"key": "10.1002/jms.3112-BIB0007|jms3112-cit-0007", "doi-asserted-by": "crossref", "first-page": "3699", "DOI": "10.1016/j.bmc.2005.03.022", "article-title": "Structure-affinity relationships of halogenated predicentrine and glaucine derivatives at D1 and D2 dopaminergic receptors: halogenation and D1 receptor selectivity", "volume": "13", "author": "Asencio", "year": "2005", "journal-title": "Bioorg. Med. Chem."}, {"key": "10.1002/jms.3112-BIB0008|jms3112-cit-0008", "doi-asserted-by": "crossref", "first-page": "171", "DOI": "10.1021/jm060959i", "article-title": "Advances in development of dopaminergic aporphinoids", "volume": "50", "author": "Zhang", "year": "2007", "journal-title": "J. Med. Chem."}, {"key": "10.1002/jms.3112-BIB0009|jms3112-cit-0009", "doi-asserted-by": "crossref", "first-page": "553", "DOI": "10.1007/s00228-007-0451-9", "article-title": "Detection of the pharmaceutical agent glaucine as a recreational drug", "volume": "64", "author": "Dargan", "year": "2008", "journal-title": "Eur. J. Clin. Pharmacol."}, {"key": "10.1002/jms.3112-BIB0010|jms3112-cit-0010", "doi-asserted-by": "crossref", "first-page": "167", "DOI": "10.1007/BF03161195", "article-title": "Cardiovascular toxicity associated with recreational use of diphenylprolinol (diphenyl-2-pyrrolidinemethanol [D2PM])", "volume": "4", "author": "Lidder", "year": "2008", "journal-title": "J. Med. Toxicol."}, {"key": "10.1002/jms.3112-BIB0011|jms3112-cit-0011", "first-page": "401", "article-title": "Glaucine as a non-declared active component of \u201cLegal Highs\u201d", "volume": "84", "author": "Geppert", "year": "2010", "journal-title": "Problems Forensic Sci."}, {"key": "10.1002/jms.3112-BIB0012|jms3112-cit-0012", "doi-asserted-by": "crossref", "first-page": "92", "DOI": "10.1016/j.forsciint.2010.06.030", "article-title": "\u201cLegal highs\u201d on the net-Evaluation of UK-based Websites, products and product information", "volume": "206", "author": "Schmidt", "year": "2011", "journal-title": "Forensic Sci. Int."}, {"key": "10.1002/jms.3112-BIB0013|jms3112-cit-0013", "author": "Maurer", "year": "2011", "volume-title": "Mass Spectral Library of Drugs, Poisons, Pesticides"}, {"key": "10.1002/jms.3112-BIB0014|jms3112-cit-0014", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1007/s00216-010-4398-9", "article-title": "Development of the first metabolite-based LC-MSn urine drug screening procedure - exemplified for antidepressants", "volume": "400", "author": "Wissenbach", "year": "2011", "journal-title": "Anal. Bioanal. Chem."}, {"key": "10.1002/jms.3112-BIB0015|jms3112-cit-0015", "doi-asserted-by": "crossref", "first-page": "3481", "DOI": "10.1007/s00216-011-5032-1", "article-title": "Drugs of abuse screening in urine as part of a metabolite-based LC-MS(n) screening concept", "volume": "400", "author": "Wissenbach", "year": "2011", "journal-title": "Anal. Bioanal. Chem."}, {"key": "10.1002/jms.3112-BIB0016|jms3112-cit-0016", "doi-asserted-by": "crossref", "first-page": "468", "DOI": "10.2174/138920010791526042", "article-title": "Metabolism of designer drugs of abuse: An updated review [review]", "volume": "11", "author": "Meyer", "year": "2010", "journal-title": "Curr. Drug Metab."}, {"key": "10.1002/jms.3112-BIB0017|jms3112-cit-0017", "doi-asserted-by": "crossref", "first-page": "1225", "DOI": "10.1007/s00216-010-3636-5", "article-title": "Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry", "volume": "397", "author": "Meyer", "year": "2010", "journal-title": "Anal. Bioanal. Chem."}, {"key": "10.1002/jms.3112-BIB0018|jms3112-cit-0018", "doi-asserted-by": "crossref", "first-page": "1426", "DOI": "10.1002/jms.1859", "article-title": "Studies on the metabolism of the alpha-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat urine and human liver microsomes using GC-MS and LC-high-resolution-MS and its detectability in urine by GC-MS", "volume": "45", "author": "Meyer", "year": "2010", "journal-title": "J. Mass Spectrom."}, {"key": "10.1002/jms.3112-BIB0019|jms3112-cit-0019", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1002/jms.2960", "article-title": "New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine", "volume": "47", "author": "Meyer", "year": "2012", "journal-title": "J. Mass Spectrom."}, {"key": "10.1002/jms.3112-BIB0020|jms3112-cit-0020", "doi-asserted-by": "crossref", "first-page": "1249", "DOI": "10.1002/jms.1607", "article-title": "Studies on the metabolism of mitragynine, the main alkaloid of the herbal drug Kratom, in rat and human urine using liquid chromatography-linear ion trap mass spectrometry", "volume": "44", "author": "Philipp", "year": "2009", "journal-title": "J. Mass Spectrom."}, {"key": "10.1002/jms.3112-BIB0021|jms3112-cit-0021", "author": "Maurer", "year": "2011", "volume-title": "Mass Spectral and GC Data of Drugs, Poisons, Pesticides"}, {"key": "10.1002/jms.3112-BIB0022|jms3112-cit-0022", "doi-asserted-by": "crossref", "first-page": "1837", "DOI": "10.1007/s00216-008-1917-z", "article-title": "Metabolism and toxicological detection of the designer drug 4-chloro-2,5-dimethoxyamphetamine in rat urine using gas chromatography-mass spectrometry", "volume": "390", "author": "Ewald", "year": "2008", "journal-title": "Anal. Bioanal. Chem."}, {"key": "10.1002/jms.3112-BIB0023|jms3112-cit-0023", "doi-asserted-by": "crossref", "first-page": "349", "DOI": "10.1002/(SICI)1097-0231(20000315)14:5<349::AID-RCM873>3.0.CO;2-P", "article-title": "A library of atmospheric pressure ionization daughter ion mass spectra based on wideband excitation in an ion trap mass spectrometer", "volume": "14", "author": "Baumann", "year": "2000", "journal-title": "Rapid Commun. Mass Spectrom."}, {"key": "10.1002/jms.3112-BIB0024|jms3112-cit-0024", "doi-asserted-by": "crossref", "first-page": "523", "DOI": "10.1002/rcm.1343", "article-title": "H.E. de, J. Quetin-Leclercq. Key fragmentation patterns of aporphine alkaloids by electrospray ionization with multistage mass spectrometry", "volume": "18", "author": "Stevigny", "year": "2004", "journal-title": "Rapid Commun. Mass Spectrom."}, {"key": "10.1002/jms.3112-BIB0025|jms3112-cit-0025", "first-page": "331", "article-title": "The Methylation of Boldine with Diazomethane", "volume": "38", "author": "Asencio", "year": "1993", "journal-title": "Bol. Soc. Chil. Quim."}, {"key": "10.1002/jms.3112-BIB0026|jms3112-cit-0026", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1016/S0021-9673(00)00919-5", "article-title": "Direct characterization of isoquinoline alkaloids in a crude plant extract by ion-pair liquid chromatography-electrospray ionization tandem mass spectrometry: example of Eschscholtzia californica", "volume": "904", "author": "Fabre", "year": "2000", "journal-title": "J. Chromatogr. A"}, {"key": "10.1002/jms.3112-BIB0027|jms3112-cit-0027", "doi-asserted-by": "crossref", "first-page": "1024", "DOI": "10.1002/jms.1234", "article-title": "Even-electron ions: a systematic study of the neutral species lost in the dissociation of quasi-molecular ions", "volume": "42", "author": "Levsen", "year": "2007", "journal-title": "J. Mass Spectrom."}, {"key": "10.1002/jms.3112-BIB0028|jms3112-cit-0028", "doi-asserted-by": "crossref", "first-page": "1344", "DOI": "10.1002/jms.1848", "article-title": "Phase I and II metabolites of speciogynine, a diastereomer of the main Kratom alkaloid mitragynine, identified in rat and human urine by liquid chromatography coupled to low and high resolution linear ion trap mass spectrometry", "volume": "45", "author": "Philipp", "year": "2010", "journal-title": "J. Mass Spectrom."}, {"key": "10.1002/jms.3112-BIB0029|jms3112-cit-0029", "doi-asserted-by": "crossref", "first-page": "907", "DOI": "10.1111/j.1476-5381.2009.00267.x", "article-title": "To scale or not to scale: the principles of dose extrapolation", "volume": "157", "author": "Sharma", "year": "2009", "journal-title": "Br. J. Pharmacol."}], "container-title": ["Journal of Mass Spectrometry"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjms.3112", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 21]], "date-time": "2017-06-21T05:21:39Z", "timestamp": 1498022499000}, "score": 47.688267, "subtitle": ["Metabolism of glaucine"], "issued": {"date-parts": [[2013, 1]]}, "references-count": 29, "journal-issue": {"published-print": {"date-parts": [[2013, 1]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1002/jms.3112", "relation": {"cites": []}, "ISSN": ["1076-5174"], "issn-type": [{"value": "1076-5174", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T18:05:49Z", "timestamp": 1574791549091}, "reference-count": 57, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2016, 7, 1]], "date-time": "2016-07-01T00:00:00Z", "timestamp": 1467331200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Analytica Chimica Acta"], "published-print": {"date-parts": [[2016, 7]]}, "DOI": "10.1016/j.aca.2016.04.046", "type": "journal-article", "created": {"date-parts": [[2016, 4, 30]], "date-time": "2016-04-30T15:12:05Z", "timestamp": 1462029125000}, "page": "13-20", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 38, "title": ["Review: LC coupled to low- and high-resolution mass spectrometry for new psychoactive substance screening in biological matrices \u2013 Where do we stand today?"], "prefix": "10.1016", "volume": "927", "author": [{"given": "Markus R.", "family": "Meyer", "sequence": "first", "affiliation": []}, {"given": "Hans H.", "family": "Maurer", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Analytica Chimica Acta"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0003267016305190?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0003267016305190?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 10, 28]], "date-time": "2019-10-28T02:56:36Z", "timestamp": 1572231396000}, "score": 45.437878, "issued": {"date-parts": [[2016, 7]]}, "references-count": 57, "alternative-id": ["S0003267016305190"], "URL": "http://dx.doi.org/10.1016/j.aca.2016.04.046", "ISSN": ["0003-2670"], "issn-type": [{"value": "0003-2670", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Review: LC coupled to low- and high-resolution mass spectrometry for new psychoactive substance screening in biological matrices \u2013 Where do we stand today?", "name": "articletitle", "label": "Article Title"}, {"value": "Analytica Chimica Acta", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.aca.2016.04.046", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "\u00a9 2016 Elsevier B.V. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T20:35:24Z", "timestamp": 1574454924663}, "reference-count": 26, "publisher": "Wiley", "issue": "2", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1308, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Mass. Spectrom."], "published-print": {"date-parts": [[2012, 2]]}, "DOI": "10.1002/jms.2960", "type": "journal-article", "created": {"date-parts": [[2012, 2, 23]], "date-time": "2012-02-23T05:42:57Z", "timestamp": 1329975777000}, "page": "253-262", "source": "Crossref", "is-referenced-by-count": 66, "title": ["New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine"], "prefix": "10.1002", "volume": "47", "author": [{"given": "Markus R.", "family": "Meyer", "sequence": "first", "affiliation": [{"name": "Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology; Saarland University; D-66421; Homburg (Saar); Germany"}]}, {"given": "Christian", "family": "Vollmar", "sequence": "additional", "affiliation": [{"name": "Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology; Saarland University; D-66421; Homburg (Saar); Germany"}]}, {"given": "Andrea E.", "family": "Schwaninger", "sequence": "additional", "affiliation": [{"name": "Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology; Saarland University; D-66421; Homburg (Saar); Germany"}]}, {"given": "Ehud Udi", "family": "Wolf", "sequence": "additional", "affiliation": [{"name": "Analytical Lab; Division of Identification and Forensic Sciences (DIFS) Israel Police HQ; Jerusalem; 91906; Israel"}]}, {"given": "Hans H.", "family": "Maurer", "sequence": "additional", "affiliation": [{"name": "Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology; Saarland University; D-66421; Homburg (Saar); Germany"}]}], "member": "311", "published-online": {"date-parts": [[2012, 2, 20]]}, "reference": [{"key": "10.1002/jms.2960-BIB2960-bib-0001|jms2960-cit-0001", "doi-asserted-by": "crossref", "first-page": "604", "DOI": "10.1007/s00508-009-1259-7", "article-title": "Khat - a controversial plant", "volume": "121", "author": "Balint", "year": "2009", "journal-title": "Wien. Klin. Wochenschr."}, {"key": "10.1002/jms.2960-BIB2960-bib-0002|jms2960-cit-0002", "doi-asserted-by": "crossref", "first-page": "457", "DOI": "10.1007/s00210-002-0532-3", "article-title": "Inhibition of transport function and desipramine binding at the human noradrenaline transporter by N-ethylmaleimide and protection by substrate analogs", "volume": "365", "author": "Foley", "year": "2002", "journal-title": "Naunyn Schmiedebergs Arch. Pharmacol."}, {"key": "10.1002/jms.2960-BIB2960-bib-0003|jms2960-cit-0003", "doi-asserted-by": "crossref", "first-page": "252", "DOI": "10.1002/ddr.10297", "article-title": "Novel aminopropiophenones as potential antidepressants", "volume": "60", "author": "Foley", "year": "2003", "journal-title": "Drug Dev. Res."}, {"key": "10.1002/jms.2960-BIB2960-bib-0004|jms2960-cit-0004", "doi-asserted-by": "crossref", "first-page": "593", "DOI": "10.1007/s00213-010-2070-x", "article-title": "Mephedrone (4-methylmethcathinone; 'meow meow'): chemical, pharmacological and clinical issues", "volume": "214", "author": "Schifano", "year": "2011", "journal-title": "Psychopharmacology (Berl)"}, {"key": "10.1002/jms.2960-BIB2960-bib-0005|jms2960-cit-0005", "unstructured": "AnonymousLand der Traeume Forum http://www.land-der-traeume.de/forum.php?t\u2009=\u200927073&PHPSESSID\u2009=\u2009aaa914fd406db6f4232137148dad7d52) 2011"}, {"key": "10.1002/jms.2960-BIB2960-bib-0006|jms2960-cit-0006", "doi-asserted-by": "crossref", "first-page": "1991", "DOI": "10.1111/j.1360-0443.2011.03502.x", "article-title": "Mephedrone: use, subjective effects and health risks", "volume": "106", "author": "Winstock", "year": "2011", "journal-title": "Addiction"}, {"key": "10.1002/jms.2960-BIB2960-bib-0007|jms2960-cit-0007", "first-page": "84", "article-title": "Badesalz f\u00fcr die Nase - Fluormethcathinon neu auf dem Drogenmarkt", "volume": "77", "author": "Westpfahl", "year": "2010", "journal-title": "Toxichem. Krimtech."}, {"key": "10.1002/jms.2960-BIB2960-bib-0008|jms2960-cit-0008", "doi-asserted-by": "crossref", "first-page": "10", "DOI": "10.1016/j.forsciint.2008.11.013", "article-title": "Fluoromethcathinone, a new substance of abuse", "volume": "185", "author": "Archer", "year": "2009", "journal-title": "Forensic Sci. Int."}, {"key": "10.1002/jms.2960-BIB2960-bib-0009|jms2960-cit-0009", "author": "Pawlik", "year": "2011", "article-title": "Studies on the phase I metabolism of the new designer drug 3-fluoromethcathinone using rabbit liver slices", "journal-title": "Int. J. Legal Med."}, {"key": "10.1002/jms.2960-BIB2960-bib-0010|jms2960-cit-0010", "author": "Maurer", "year": "2011", "volume-title": "Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants and their Metabolites"}, {"key": "10.1002/jms.2960-BIB2960-bib-0011|jms2960-cit-0011", "doi-asserted-by": "crossref", "first-page": "1310", "DOI": "10.1515/CCLM.2004.250", "article-title": "Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control [review]", "volume": "42", "author": "Maurer", "year": "2004", "journal-title": "Clin. Chem. Lab. Med."}, {"key": "10.1002/jms.2960-BIB2960-bib-0012|jms2960-cit-0012", "doi-asserted-by": "crossref", "first-page": "1837", "DOI": "10.1007/s00216-008-1917-z", "article-title": "Metabolism and toxicological detection of the designer drug 4-chloro-2,5-dimethoxyamphetamine in rat urine using gas chromatography-mass spectrometry", "volume": "390", "author": "Ewald", "year": "2008", "journal-title": "Anal. Bioanal. Chem."}, {"key": "10.1002/jms.2960-BIB2960-bib-0013|jms2960-cit-0013", "doi-asserted-by": "crossref", "first-page": "1167", "DOI": "10.1080/004982598238877", "article-title": "In vitro assessment of human cytochrome P450", "volume": "28", "author": "Clarke", "year": "1998", "journal-title": "Xenobiotica"}, {"key": "10.1002/jms.2960-BIB2960-bib-0014|jms2960-cit-0014", "doi-asserted-by": "crossref", "first-page": "121", "DOI": "10.1016/S0163-7258(99)00028-5", "article-title": "The use of heterologously expressed drug metabolizing enzymes-state of the art and prospects for the future", "volume": "84", "author": "Crespi", "year": "1999", "journal-title": "Pharmacol. Ther."}, {"key": "10.1002/jms.2960-BIB2960-bib-0015|jms2960-cit-0015", "first-page": "1493", "article-title": "Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches", "volume": "28", "author": "Venkatakrishnan", "year": "2000", "journal-title": "Drug Metab. Dispos."}, {"key": "10.1002/jms.2960-BIB2960-bib-0016|jms2960-cit-0016", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.2174/138920006776359266", "article-title": "The impact of in vitro binding on in vitro-in vivo extrapolations, projections of metabolic clearance and clinical drug-drug interactions", "volume": "7", "author": "Grime", "year": "2006", "journal-title": "Curr. Drug Metab."}, {"key": "10.1002/jms.2960-BIB2960-bib-0017|jms2960-cit-0017", "doi-asserted-by": "crossref", "first-page": "575", "DOI": "10.1373/clinchem.2009.135517", "article-title": "Automated mass spectral deconvolution and identification system for GC-MS screening for drugs, poisons, and metabolites in urine", "volume": "56", "author": "Meyer", "year": "2010", "journal-title": "Clin. Chem."}, {"key": "10.1002/jms.2960-BIB2960-bib-0018|jms2960-cit-0018", "author": "Maurer", "year": "2011", "volume-title": "Mass Spectral Library of Drugs, Poisons, Pesticides, Pollutants and their Metabolites"}, {"key": "10.1002/jms.2960-BIB2960-bib-0019|jms2960-cit-0019", "doi-asserted-by": "crossref", "first-page": "32", "DOI": "10.1016/j.forsciint.2006.07.024", "article-title": "Mass spectral and NMR spectral data of two new designer drugs with an alpha-aminophenone structure: 4'-Methyl-alpha-pyrrolidinohexanophenone and 4'-methyl-alpha-pyrrolidinobutyrophenone", "volume": "169", "author": "Westphal", "year": "2007", "journal-title": "Forensic Sci. Int."}, {"key": "10.1002/jms.2960-BIB2960-bib-0020|jms2960-cit-0020", "author": "McLafferty", "year": "1993", "volume-title": "Interpretation of Mass Spectra"}, {"key": "10.1002/jms.2960-BIB2960-bib-0021|jms2960-cit-0021", "author": "Smith", "year": "1999", "volume-title": "Understanding Mass Spectra - A Basic Approach"}, {"key": "10.1002/jms.2960-BIB2960-bib-0022|jms2960-cit-0022", "author": "de-Zeeuw", "year": "1992", "volume-title": "Gas Chromatographic Retention Indices of Toxicologically Relevant Substances and their Metabolites (Report of the DFG commission for clinical toxicological analysis, special issue of the TIAFT bulletin)"}, {"key": "10.1002/jms.2960-BIB2960-bib-0023|jms2960-cit-0023", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.1016/j.forsciint.2004.05.003", "article-title": "Isomeric fluoro-methoxy-phenylalkylamines: a new series of controlled-substance analogues (designer drugs)", "volume": "148", "author": "Rosner", "year": "2005", "journal-title": "Forensic Sci. Int."}, {"key": "10.1002/jms.2960-BIB2960-bib-0024|jms2960-cit-0024", "doi-asserted-by": "crossref", "first-page": "3481", "DOI": "10.1007/s00216-011-5032-1", "article-title": "Drugs of abuse screening in urine as part of a metabolite-based LC-MS(n) screening concept", "volume": "400", "author": "Wissenbach", "year": "2011", "journal-title": "Anal. Bioanal. Chem."}, {"key": "10.1002/jms.2960-BIB2960-bib-0025|jms2960-cit-0025", "doi-asserted-by": "crossref", "first-page": "2345", "DOI": "10.1124/dmd.108.021543", "article-title": "The role of human hepatic cytochrome P450 isozymes in the metabolism of racemic 3,4-methylenedioxy-methamphetamine and its enantiomers", "volume": "36", "author": "Meyer", "year": "2008", "journal-title": "Drug Metab. Dispos."}, {"key": "10.1002/jms.2960-BIB2960-bib-0026|jms2960-cit-0026", "doi-asserted-by": "crossref", "first-page": "1725", "DOI": "10.1016/j.bcp.2009.03.001", "article-title": "Stereoselective differences in the cytochrome P450-dependent dealkylation and demethylenation of N-methyl-benzodioxolyl-butanamine (MBDB, Eden) enantiomers", "volume": "77", "author": "Meyer", "year": "2009", "journal-title": "Biochem. Pharmacol."}], "container-title": ["Journal of Mass Spectrometry"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjms.2960", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/jms.2960", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 2]], "date-time": "2018-08-02T00:13:27Z", "timestamp": 1533168807000}, "score": 44.92138, "subtitle": ["Metabolism of 3-BMC and 3-FMC and their toxicological detection"], "issued": {"date-parts": [[2012, 2]]}, "references-count": 26, "journal-issue": {"published-print": {"date-parts": [[2012, 2]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1002/jms.2960", "relation": {"cites": []}, "ISSN": ["1076-5174"], "issn-type": [{"value": "1076-5174", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T21:45:24Z", "timestamp": 1575495924037}, "reference-count": 30, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2014, 9, 1]], "date-time": "2014-09-01T00:00:00Z", "timestamp": 1409529600000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"name": "European Union's Seventh Framework Programme", "award": ["317205"]}], "content-domain": {"domain": ["elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Science of The Total Environment"], "published-print": {"date-parts": [[2014, 9]]}, "DOI": "10.1016/j.scitotenv.2014.06.016", "type": "journal-article", "created": {"date-parts": [[2014, 6, 28]], "date-time": "2014-06-28T10:47:42Z", "timestamp": 1403952462000}, "page": "588-595", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 20, "title": ["Studies on the microbial biotransformation of the novel psychoactive substance methylenedioxypyrovalerone (MDPV) in wastewater by means of liquid chromatography-high resolution mass spectrometry/mass spectrometry"], "prefix": "10.1016", "volume": "493", "author": [{"given": "Marie", "family": "Mardal", "sequence": "first", "affiliation": []}, {"given": "Markus R.", "family": "Meyer", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Science of The Total Environment"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0048969714008596?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0048969714008596?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 3]], "date-time": "2018-10-03T01:51:54Z", "timestamp": 1538531514000}, "score": 44.065025, "issued": {"date-parts": [[2014, 9]]}, "references-count": 30, "alternative-id": ["S0048969714008596"], "URL": "http://dx.doi.org/10.1016/j.scitotenv.2014.06.016", "ISSN": ["0048-9697"], "issn-type": [{"value": "0048-9697", "type": "print"}], "subject": ["Environmental Engineering", "Waste Management and Disposal", "Pollution", "Environmental Chemistry"], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Studies on the microbial biotransformation of the novel psychoactive substance methylenedioxypyrovalerone (MDPV) in wastewater by means of liquid chromatography-high resolution mass spectrometry/mass spectrometry", "name": "articletitle", "label": "Article Title"}, {"value": "Science of The Total Environment", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.scitotenv.2014.06.016", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2014 Elsevier B.V. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T19:38:18Z", "timestamp": 1575229098453}, "reference-count": 14, "publisher": "Future Science Ltd", "issue": "10", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Bioanalysis"], "published-print": {"date-parts": [[2013, 5]]}, "DOI": "10.4155/bio.13.70", "type": "journal-article", "created": {"date-parts": [[2013, 5, 30]], "date-time": "2013-05-30T15:52:11Z", "timestamp": 1369929131000}, "page": "1161-1163", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Do we need high-resolution MS in forensic and clinical toxicology?"], "prefix": "10.4155", "volume": "5", "author": [{"given": "Markus R", "family": "Meyer", "sequence": "first", "affiliation": []}], "member": "2641", "reference": [{"key": "ref-1", "DOI": "10.1007/s00216-012-5807-z", "doi-asserted-by": "publisher"}, {"key": "ref-2", "DOI": "10.1002/jms.3126", "doi-asserted-by": "publisher"}, {"key": "ref-3", "DOI": "10.1016/j.jasms.2009.03.002", "doi-asserted-by": "publisher"}, {"key": "ref-4", "DOI": "10.4155/bio.13.3", "doi-asserted-by": "publisher"}, {"key": "ref-5", "DOI": "10.1002/jms.3170", "doi-asserted-by": "publisher"}, {"key": "ref-6", "DOI": "10.1007/s00216-012-5726-z", "doi-asserted-by": "publisher"}, {"key": "ref-7", "DOI": "10.1007/s00216-011-4859-9", "doi-asserted-by": "publisher"}, {"key": "ref-8", "DOI": "10.1093/jat/bks071", "doi-asserted-by": "publisher"}, {"key": "ref-9", "DOI": "10.1016/j.forsciint.2011.10.004", "doi-asserted-by": "publisher"}, {"key": "ref-10", "DOI": "10.1002/rcm.6439", "doi-asserted-by": "publisher"}, {"key": "ref-11", "DOI": "10.1016/j.chroma.2012.10.054", "doi-asserted-by": "publisher"}, {"key": "ref-12", "DOI": "10.3109/15563650.2012.713108", "doi-asserted-by": "publisher"}, {"key": "ref-13", "DOI": "10.1002/rcm.3901", "doi-asserted-by": "publisher"}, {"key": "ref-14", "DOI": "10.1016/j.clinbiochem.2010.08.008", "doi-asserted-by": "publisher"}], "container-title": ["Bioanalysis"], "language": "en", "link": [{"URL": "http://www.future-science.com/doi/pdf/10.4155/bio.13.70", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T09:52:38Z", "timestamp": 1574243558000}, "score": 43.652966, "issued": {"date-parts": [[2013, 5]]}, "references-count": 14, "journal-issue": {"published-print": {"date-parts": [[2013, 5]]}, "issue": "10"}, "alternative-id": ["10.4155/bio.13.70"], "URL": "http://dx.doi.org/10.4155/bio.13.70", "relation": {"cites": []}, "ISSN": ["1757-6180", "1757-6199"], "issn-type": [{"value": "1757-6180", "type": "print"}, {"value": "1757-6199", "type": "electronic"}], "subject": ["General Pharmacology, Toxicology and Pharmaceutics", "Analytical Chemistry", "Clinical Biochemistry", "Medical Laboratory Technology", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T01:07:42Z", "timestamp": 1574816862535}, "reference-count": 47, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2017, 7, 31]], "date-time": "2017-07-31T00:00:00Z", "timestamp": 1501459200000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Anal Bioanal Chem"], "published-print": {"date-parts": [[2018, 1]]}, "DOI": "10.1007/s00216-017-0526-0", "type": "journal-article", "created": {"date-parts": [[2017, 7, 31]], "date-time": "2017-07-31T08:44:54Z", "timestamp": 1501490694000}, "page": "897-912", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 13, "title": ["LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening power with further MS techniques"], "prefix": "10.1007", "volume": "410", "author": [{"given": "Achim T.", "family": "Caspar", "sequence": "first", "affiliation": []}, {"given": "Folker", "family": "Westphal", "sequence": "additional", "affiliation": []}, {"given": "Markus R.", "family": "Meyer", "sequence": "additional", "affiliation": []}, {"given": "Hans H.", "family": "Maurer", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2017, 7, 31]]}, "reference": [{"key": "526_CR1", "unstructured": "European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2015) New psychoactive substances in Europe. An update from the EU Early Warning System. \nhttp://www.emcdda.europa.eu/attachements.cfm/att_235958_EN_TD0415135ENN.pdf"}, {"key": "526_CR2", "unstructured": "United Nations Office on Drugs and Crime (UNODC) (2014) World drug report 2014. \nhttp://www.unodc.org/documents/data-and-analysis/WDR2014/World_Drug_Report_2014_web.pdf"}, {"key": "526_CR3", "unstructured": "United Nations Office on Drugs and Crime (UNODC) (2015) World drug report 2015. \nhttps://www.unodc.org/documents/wdr2015/World_Drug_Report_2015.pdf"}, {"key": "526_CR4", "unstructured": "United Nations Office on Drugs and Crime (UNODC) (2016) World drug report 2016. \nhttps://www.unodc.org/doc/wdr2016/WORLD_DRUG_REPORT_2016_web.pdf"}, {"key": "526_CR5", "doi-asserted-by": "crossref", "first-page": "6697", "DOI": "10.1007/s00216-015-8828-6", "volume": "407", "author": "AT Caspar", "year": "2015", "unstructured": "Caspar AT, Helfer AG, Michely JA, Auwaerter V, Brandt SD, Meyer MR, et al. Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MSn, and LC-HR-MS/MS. Anal Bioanal Chem. 2015;407:6697\u2013719.", "journal-title": "Anal Bioanal Chem"}, {"key": "526_CR6", "doi-asserted-by": "crossref", "first-page": "158", "DOI": "10.1016/j.jpba.2016.11.040", "volume": "134", "author": "AT Caspar", "year": "2017", "unstructured": "Caspar AT, Brandt SD, Stoever AE, Meyer MR, Maurer HH. Metabolic fate and detectability of the new psychoactive substances 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25B-NBOMe) and 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe) in human and rat urine by GC-MS, LC-MSn, and LC-HR-MS/MS approaches. J Pharm Biomed Anal. 2017;134:158\u201369.", "journal-title": "J Pharm Biomed Anal"}, {"key": "526_CR7", "doi-asserted-by": "crossref", "first-page": "680", "DOI": "10.1002/dta.2044", "volume": "9", "author": "A Wohlfarth", "year": "2017", "unstructured": "Wohlfarth A, Roman M, Andersson M, Kugelberg FC, Diao X, Carlier J, et al. 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry. Drug Test Anal. 2017;9:680\u201398.", "journal-title": "Drug Test Anal"}, {"key": "526_CR8", "doi-asserted-by": "crossref", "first-page": "129", "DOI": "10.1016/j.psym.2014.11.002", "volume": "56", "author": "J Suzuki", "year": "2015", "unstructured": "Suzuki J, Dekker MA, Valenti ES, Arbelo Cruz FA, Correa AM, Poklis JL, et al. Toxicities associated with NBOMe ingestion\u2014a novel class of potent hallucinogens: a review of the literature. Psychosomatics. 2015;56:129\u201339.", "journal-title": "Psychosomatics"}, {"key": "526_CR9", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1016/j.forsciint.2012.08.027", "volume": "227", "author": "D Zuba", "year": "2013", "unstructured": "Zuba D, Sekula K, Buczek A. 25C-NBOMe\u2014new potent hallucinogenic substance identified on the drug market. Forensic Sci Int. 2013;227:7\u201314.", "journal-title": "Forensic Sci Int"}, {"key": "526_CR10", "doi-asserted-by": "crossref", "first-page": "1794", "DOI": "10.1002/bmc.2999", "volume": "27", "author": "JL Poklis", "year": "2013", "unstructured": "Poklis JL, Charles J, Wolf CE, Poklis A. High-performance liquid chromatography tandem mass spectrometry method for the determination of 2CC-NBOMe and 25I-NBOMe in human serum. Biomed Chromatogr. 2013;27:1794\u2013800.", "journal-title": "Biomed Chromatogr"}, {"key": "526_CR11", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1093/jat/bku005", "volume": "38", "author": "JL Poklis", "year": "2014", "unstructured": "Poklis JL, Clay DJ, Poklis A. High-performance liquid chromatography with tandem mass spectrometry for the determination of nine hallucinogenic 25-NBOMe designer drugs in urine specimens. J Anal Toxicol. 2014;38:113\u201321.", "journal-title": "J Anal Toxicol"}, {"key": "526_CR12", "doi-asserted-by": "crossref", "first-page": "764", "DOI": "10.1002/dta.1522", "volume": "6", "author": "JL Poklis", "year": "2014", "unstructured": "Poklis JL, Nanco CR, Troendle MM, Wolf CE, Poklis A. Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication. Drug Test Anal. 2014;6:764\u20139.", "journal-title": "Drug Test Anal"}, {"key": "526_CR13", "doi-asserted-by": "crossref", "first-page": "e14", "DOI": "10.1016/j.forsciint.2013.10.015", "volume": "234", "author": "JL Poklis", "year": "2014", "unstructured": "Poklis JL, Devers KG, Arbefeville EF, Pearson JM, Houston E, Poklis A. Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death. Forensic Sci Int. 2014;234:e14\u201320.", "journal-title": "Forensic Sci Int"}, {"key": "526_CR14", "doi-asserted-by": "crossref", "first-page": "617", "DOI": "10.1093/jat/bkv073", "volume": "39", "author": "JL Poklis", "year": "2015", "unstructured": "Poklis JL, Raso SA, Alford KN, Poklis A, Peace MR. Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and other dimethoxyphenyl-N-[(2-methoxyphenyl) methyl]ethanamine derivatives on blotter paper. J Anal Toxicol. 2015;39:617\u201323.", "journal-title": "J Anal Toxicol"}, {"key": "526_CR15", "doi-asserted-by": "crossref", "first-page": "248", "DOI": "10.1002/dta.1865", "volume": "8", "author": "Y Boumrah", "year": "2016", "unstructured": "Boumrah Y, Humbert L, Phanithavong M, Khimeche K, Dahmani A, Allorge D. In vitro characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high resolution MS. Drug Test Anal. 2016;8:248\u201356.", "journal-title": "Drug Test Anal"}, {"key": "526_CR16", "doi-asserted-by": "crossref", "first-page": "671", "DOI": "10.1002/dta.2031", "volume": "9", "author": "LM Nielsen", "year": "2017", "unstructured": "Nielsen LM, Holm NB, Leth-Petersen S, Kristensen JL, Olsen L, Linnet K. Characterization of the hepatic cytochrome P450 enzymes involved in the metabolism of 25I-NBOMe and 25I-NBOH. Drug Test Anal. 2017;9:671\u20139.", "journal-title": "Drug Test Anal"}, {"key": "526_CR17", "unstructured": "Temporal KH, Scott KS, Mohr ALA, Logan BK. Metabolic profile determination of NBOMe compounds using human liver microsomes and comparison with findings in authentic human blood and urine. J Anal Toxicol DOI. 2017; doi:\n10.1093/jat/bkx029\n\n.", "DOI": "10.1093/jat/bkx029", "doi-asserted-by": "publisher"}, {"key": "526_CR18", "doi-asserted-by": "crossref", "first-page": "487", "DOI": "10.3109/15563650.2013.802795", "volume": "51", "author": "SL Hill", "year": "2013", "unstructured": "Hill SL, Doris T, Gurung S, Katebe S, Lomas A, Dunn M, et al. Severe clinical toxicity associated with analytically confirmed recreational use of 25I-NBOMe: case series. Clin Toxicol (Phila). 2013;51:487\u201392.", "journal-title": "Clin Toxicol (Phila)"}, {"key": "526_CR19", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1007/s13181-013-0314-y", "volume": "10", "author": "SJ Stellpflug", "year": "2014", "unstructured": "Stellpflug SJ, Kealey SE, Hegarty CB, Janis GC. 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing. J Med Toxicol. 2014;10:45\u201350.", "journal-title": "J Med Toxicol"}, {"key": "526_CR20", "doi-asserted-by": "crossref", "first-page": "561", "DOI": "10.3109/15563650.2014.909932", "volume": "52", "author": "MH Tang", "year": "2014", "unstructured": "Tang MH, Ching CK, Tsui MS, Chu FK, Mak TW. Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe. Clin Toxicol (Phila). 2014;52:561\u20135.", "journal-title": "Clin Toxicol (Phila)"}, {"key": "526_CR21", "doi-asserted-by": "crossref", "first-page": "20", "DOI": "10.1097/PAF.0000000000000082", "volume": "35", "author": "JP Walterscheid", "year": "2014", "unstructured": "Walterscheid JP, Phillips GT, Lopez AE, Gonsoulin ML, Chen HH, Sanchez LA. Pathological findings in 2 cases of fatal 25I-NBOMe toxicity. Am J Forensic Med Pathol. 2014;35:20\u20135.", "journal-title": "Am J Forensic Med Pathol"}, {"key": "526_CR22", "doi-asserted-by": "crossref", "first-page": "379", "DOI": "10.1080/02791072.2014.960111", "volume": "46", "author": "J Suzuki", "year": "2014", "unstructured": "Suzuki J, Poklis JL, Poklis A. \"My friend said it was good LSD\": a suicide attempt following analytically confirmed 25I-NBOMe ingestion. J Psychoactive Drugs. 2014;46:379\u201382.", "journal-title": "J Psychoactive Drugs"}, {"key": "526_CR23", "doi-asserted-by": "crossref", "first-page": "602", "DOI": "10.1093/jat/bkv058", "volume": "39", "author": "KG Shanks", "year": "2015", "unstructured": "Shanks KG, Sozio T, Behonick GS. Fatal intoxications with 25B-NBOMe and 25I-NBOMe in Indiana during 2014. J Anal Toxicol. 2015;39:602\u20136.", "journal-title": "J Anal Toxicol"}, {"key": "526_CR24", "doi-asserted-by": "crossref", "first-page": "910", "DOI": "10.1002/dta.1889", "volume": "8", "author": "F Westphal", "year": "2016", "unstructured": "Westphal F, Girreser U, Waldmuller D. Analytical characterization of four new ortho-methoxybenzylated amphetamine-type designer drugs. Drug Test Anal. 2016;8:910\u20139.", "journal-title": "Drug Test Anal"}, {"key": "526_CR25", "doi-asserted-by": "crossref", "first-page": "1956", "DOI": "10.1124/mol.106.028720", "volume": "70", "author": "MR Braden", "year": "2006", "unstructured": "Braden MR, Parrish JC, Naylor JC, Nichols DE. Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists. Mol Pharmacol. 2006;70:1956\u201364.", "journal-title": "Mol Pharmacol"}, {"key": "526_CR26", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1021/cn400216u", "volume": "5", "author": "M Hansen", "year": "2014", "unstructured": "Hansen M, Phonekeo K, Paine JS, Leth-Petersen S, Begtrup M, Brauner-Osborne H, et al. Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists. ACS Chem Neurosci. 2014;5:243\u20139.", "journal-title": "ACS Chem Neurosci"}, {"key": "526_CR27", "doi-asserted-by": "crossref", "first-page": "200", "DOI": "10.1016/j.neuropharm.2013.08.025", "volume": "77", "author": "AL Halberstadt", "year": "2014", "unstructured": "Halberstadt AL, Geyer MA. Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response. Neuropharmacology. 2014;77:200\u20137.", "journal-title": "Neuropharmacology"}, {"key": "526_CR28", "doi-asserted-by": "crossref", "first-page": "1165", "DOI": "10.1021/cn500292d", "volume": "6", "author": "DE Nichols", "year": "2015", "unstructured": "Nichols DE, Sassano MF, Halberstadt AL, Klein LM, Brandt SD, Elliott SP, et al. N-benzyl-5-methoxytryptamines as potent serotonin 5-HT2 receptor family agonists and comparison with a series of phenethylamine analogues. ACS Chem Neurosci. 2015;6:1165\u201375.", "journal-title": "ACS Chem Neurosci"}, {"key": "526_CR29", "doi-asserted-by": "crossref", "first-page": "544", "DOI": "10.1097/FTD.0b013e3181eea318", "volume": "32", "author": "HH Maurer", "year": "2010", "unstructured": "Maurer HH. Chemistry, pharmacology, and metabolism of emerging drugs of abuse [review]. Ther Drug Monit. 2010;32:544\u20139.", "journal-title": "Ther Drug Monit"}, {"key": "526_CR30", "doi-asserted-by": "crossref", "first-page": "780", "DOI": "10.1177/0269881114523866", "volume": "28", "author": "W Lawn", "year": "2014", "unstructured": "Lawn W, Barratt M, Williams M, Horne A, Winstock A. The NBOMe hallucinogenic drug series: patterns of use, characteristics of users and self-reported effects in a large international sample. J Psychopharmacol. 2014;28:780\u20138.", "journal-title": "J Psychopharmacol"}, {"key": "526_CR31", "unstructured": "Bersani FS, Corazza O, Albano G, Valeriani G, Santacroce R, Bolzan Mariotti PF, Cinosi E, Simonato P, Martinotti G, Bersani G, Schifano F (2014) 25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug. Biomed Res Int 734749.", "DOI": "10.1155/2014/734749", "doi-asserted-by": "crossref"}, {"key": "526_CR32", "doi-asserted-by": "crossref", "first-page": "7831", "DOI": "10.1007/s00216-015-8955-0", "volume": "407", "author": "JA Michely", "year": "2015", "unstructured": "Michely JA, Helfer AG, Brandt SD, Meyer MR, Maurer HH. Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS/MS. Anal Bioanal Chem. 2015;407:7831\u201342.", "journal-title": "Anal Bioanal Chem"}, {"key": "526_CR33", "doi-asserted-by": "crossref", "first-page": "3481", "DOI": "10.1007/s00216-011-5032-1", "volume": "400", "author": "DK Wissenbach", "year": "2011", "unstructured": "Wissenbach DK, Meyer MR, Remane D, Philipp AA, Weber AA, Maurer HH. Drugs of abuse screening in urine as part of a metabolite-based LC-MS(n) screening concept. Anal Bioanal Chem. 2011;400:3481\u20139.", "journal-title": "Anal Bioanal Chem"}, {"key": "526_CR34", "doi-asserted-by": "crossref", "first-page": "32", "DOI": "10.1016/j.jpba.2017.05.028", "volume": "143", "author": "LHR Richter", "year": "2017", "unstructured": "Richter LHR, Flockerzi V, Maurer HH, Meyer MR. Pooled human liver preparations, HepaRG, or HepG2 cell lines for metabolism studies of new psychoactive substances? A study using MDMA, MDBD, butylone, MDPPP, MDPV, MDPB, 5-MAPB, and 5-API as examples. J Pharm Biomed Anal. 2017;143:32\u201342.", "journal-title": "J Pharm Biomed Anal"}, {"key": "526_CR35", "doi-asserted-by": "crossref", "first-page": "3125", "DOI": "10.1007/s00216-013-6741-4", "volume": "405", "author": "J Welter", "year": "2013", "unstructured": "Welter J, Meyer MR, Wolf E, Weinmann W, Kavanagh P, Maurer HH. 2-Methiopropamine, a thiophene analogue of methamphetamine: studies on its metabolism and detectability in the rat and human using GC-MS and LC-(HR)-MS techniques. Anal Bioanal Chem. 2013;405:3125\u201335.", "journal-title": "Anal Bioanal Chem"}, {"key": "526_CR36", "doi-asserted-by": "crossref", "first-page": "55", "DOI": "10.1016/j.toxlet.2016.06.013", "volume": "258", "author": "L Wagmann", "year": "2016", "unstructured": "Wagmann L, Meyer MR, Maurer HH. What is the contribution of human FMO3 in the N-oxygenation of selected therapeutic drugs and drugs of abuse? Toxicol Lett. 2016;258:55\u201370.", "journal-title": "Toxicol Lett"}, {"key": "526_CR37", "doi-asserted-by": "crossref", "first-page": "1845", "DOI": "10.1007/s00216-013-7539-0", "volume": "406", "author": "MR Meyer", "year": "2014", "unstructured": "Meyer MR, Lindauer C, Welter J, Maurer HH. Dimethocaine, a synthetic cocaine derivative: studies on its in vivo metabolism and its detectability in urine by LC-HR-MSn and GC-MS using a rat model. Anal Bioanal Chem. 2014;406:1845\u201354.", "journal-title": "Anal Bioanal Chem"}, {"key": "526_CR38", "author": "HH Maurer", "year": "2016", "unstructured": "Maurer HH, Pfleger K, Weber AA. Mass spectral data of drugs, poisons, pesticides, pollutants and their metabolites. Weinheim: Wiley-VCH; 2016.", "volume-title": "Mass spectral data of drugs, poisons, pesticides, pollutants and their metabolites"}, {"key": "526_CR39", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1016/j.aca.2015.08.018", "volume": "891", "author": "AG Helfer", "year": "2015", "unstructured": "Helfer AG, Michely JA, Weber AA, Meyer MR, Maurer HH. Orbitrap technology for comprehensive metabolite-based liquid chromatographic-high resolution-tandem mass spectrometric urine drug screening\u2014exemplified for cardiovascular drugs. Anal Chim Acta. 2015;891:221\u201333.", "journal-title": "Anal Chim Acta"}, {"key": "526_CR40", "author": "HH Maurer", "year": "2014", "unstructured": "Maurer HH, Wissenbach DK, Weber AA. Maurer/Wissenbach/Weber MWW LC-MSn library of drugs, poisons, and their metabolites. Weinheim: Wiley-VCH; 2014.", "volume-title": "Maurer/Wissenbach/Weber MWW LC-MSn library of drugs, poisons, and their metabolites"}, {"key": "526_CR41", "author": "HH Maurer", "year": "2017", "unstructured": "Maurer HH, Meyer MR, Helfer AG, Weber AA. Maurer/Meyer/Helfer/Weber MMHW LC-HR-MS/MS library of drugs, poisons, and their metabolites. Weinheim: Wiley-VCH; 2017.", "volume-title": "Maurer/Meyer/Helfer/Weber MMHW LC-HR-MS/MS library of drugs, poisons, and their metabolites"}, {"key": "526_CR42", "doi-asserted-by": "crossref", "first-page": "355", "DOI": "10.1007/BF00378589", "volume": "54", "author": "K Engstrom", "year": "1984", "unstructured": "Engstrom K, Riihimaki V, Laine A. Urinary disposition of ethylbenzene and m-xylene in man following separate and combined exposure. Int Arch Occup Environ Health. 1984;54:355\u201363.", "journal-title": "Int Arch Occup Environ Health"}, {"key": "526_CR43", "doi-asserted-by": "crossref", "first-page": "281", "DOI": "10.3109/00498258509045362", "volume": "15", "author": "K Engstrom", "year": "1985", "unstructured": "Engstrom K, Elovaara E, Aitio A. Metabolism of ethylbenzene in the rat during long-term intermittent inhalation exposure. Xenobiotica. 1985;15:281\u20136.", "journal-title": "Xenobiotica"}, {"key": "526_CR44", "doi-asserted-by": "crossref", "first-page": "352", "DOI": "10.1093/toxsci/kfn244", "volume": "107", "author": "SA Saghir", "year": "2009", "unstructured": "Saghir SA, Rick DL, McClymont EL, Zhang F, Bartels MJ, Bus JS. Mechanism of ethylbenzene-induced mouse-specific lung tumor: metabolism of ethylbenzene by rat, mouse, and human liver and lung microsomes. Toxicol Sci. 2009;107:352\u201366.", "journal-title": "Toxicol Sci"}, {"key": "526_CR45", "doi-asserted-by": "crossref", "first-page": "96", "DOI": "10.1021/acs.chemrestox.5b00450", "volume": "29", "author": "S Leth-Petersen", "year": "2016", "unstructured": "Leth-Petersen S, Gabel-Jensen C, Gillings N, Lehel S, Hansen HD, Knudsen GM, et al. Metabolic fate of hallucinogenic NBOMes. Chem Res Toxicol. 2016;29:96\u2013100.", "journal-title": "Chem Res Toxicol"}, {"key": "526_CR46", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.1080/00498250600627475", "volume": "36", "author": "N Shima", "year": "2006", "unstructured": "Shima N, Kamata HT, Katagi M, Tsuchihashi H. Urinary excretion of the main metabolites of methamphetamine, including p-hydroxymethamphetamine-sulfate and p-hydroxymethamphetamine-glucuronide, in humans and rats. Xenobiotica. 2006;36:259\u201367.", "journal-title": "Xenobiotica"}, {"key": "526_CR47", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1016/j.toxlet.2015.08.012", "volume": "238", "author": "CSD Wink", "year": "2015", "unstructured": "Wink CSD, Meyer GMJ, Meyer MR, Maurer HH. Toxicokinetics of lefetamine and derived diphenylethylamine designer drugs\u2014contribution of human cytochrome P450 isozymes to their main phase I metabolic steps. Toxicol Lett. 2015;238:39\u201344.", "journal-title": "Toxicol Lett"}], "container-title": ["Analytical and Bioanalytical Chemistry"], "language": "en", "link": [{"URL": "http://link.springer.com/article/10.1007/s00216-017-0526-0/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00216-017-0526-0.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00216-017-0526-0.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 1, 19]], "date-time": "2018-01-19T11:30:33Z", "timestamp": 1516361433000}, "score": 41.256226, "issued": {"date-parts": [[2017, 7, 31]]}, "references-count": 47, "journal-issue": {"published-print": {"date-parts": [[2018, 1]]}, "issue": "3"}, "alternative-id": ["526"], "URL": "http://dx.doi.org/10.1007/s00216-017-0526-0", "relation": {"cites": []}, "ISSN": ["1618-2642", "1618-2650"], "issn-type": [{"value": "1618-2642", "type": "print"}, {"value": "1618-2650", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T02:24:45Z", "timestamp": 1574475885879}, "reference-count": 34, "publisher": "Wiley", "issue": "12", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1762, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Mass Spectrom."], "published-print": {"date-parts": [[2010, 12]]}, "DOI": "10.1002/jms.1859", "type": "journal-article", "created": {"date-parts": [[2010, 11, 7]], "date-time": "2010-11-07T09:47:19Z", "timestamp": 1289123239000}, "page": "1426-1442", "source": "Crossref", "is-referenced-by-count": 132, "title": ["Studies on the metabolism of the \u03b1-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS"], "prefix": "10.1002", "volume": "45", "author": [{"given": "Markus R.", "family": "Meyer", "sequence": "first", "affiliation": []}, {"given": "Peng", "family": "Du", "sequence": "additional", "affiliation": []}, {"given": "Frank", "family": "Schuster", "sequence": "additional", "affiliation": []}, {"given": "Hans H.", "family": "Maurer", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2010, 11, 4]]}, "reference": [{"key": "10.1002/jms.1859-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "60", "DOI": "10.1159/000467975", "article-title": "A controlled evaluation of pyrovalerone in chronically fatigued volunteers", "volume": "8", "author": "Goldberg", "year": "1973", "journal-title": "Int. Pharmacopsychiatr."}, {"key": "10.1002/jms.1859-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1007/BF00404168", "article-title": "Experimental psychological differentiation of the effect of 2 psychostimulants (F-1983 and amphetamine) in humans", "volume": "8", "author": "Heimann", "year": "1965", "journal-title": "Psychopharmacologia"}, {"key": "10.1002/jms.1859-BIB3|cit3", "first-page": "88", "article-title": "The psychotropic effect of the pyrovalerone (F-1983), placebo, the milieu therapy and mental condition of the patients in forensic psychiatry", "volume": "47", "author": "Soderholm", "year": "1976", "journal-title": "Nervenarzt"}, {"key": "10.1002/jms.1859-BIB4|cit4", "first-page": "325", "article-title": "Role of central catecholamines in the psychostimulant activity of pyrovalerone", "volume": "224", "author": "Fauquet", "year": "1976", "journal-title": "Arch. Int. Pharmacodyn. Ther."}, {"key": "10.1002/jms.1859-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "1693", "DOI": "10.1016/0006-2952(78)90180-6", "article-title": "Effects of pyrovalerone on peripheral noradrenergic mechanisms", "volume": "27", "author": "Servin", "year": "1978", "journal-title": "Biochem. Pharmacol."}, {"key": "10.1002/jms.1859-BIB6|cit6", "first-page": "871", "article-title": "Comparative pharmacological study of a new central stimulant, 1-p-tolyl-1-oxo-2-pyrrolidino-n-pentane HCl", "volume": "13", "author": "Stille", "year": "1963", "journal-title": "Arzneim. Forsch."}, {"key": "10.1002/jms.1859-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "1420", "DOI": "10.1021/jm050797a", "article-title": "1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (pyrovalerone) analogues: a promising class of monoamine uptake inhibitors", "volume": "49", "author": "Meltzer", "year": "2006", "journal-title": "J. Med. Chem."}, {"key": "10.1002/jms.1859-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1016/j.jchromb.2003.07.008", "article-title": "Metabolism of the new designer drug alpha-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4\u2032methyl-alpha-pyrrolidinopropiophenone (MPPP) studied in urine using gas chromatography-mass spectrometry", "volume": "796", "author": "Springer", "year": "2003", "journal-title": "J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."}, {"key": "10.1002/jms.1859-BIB9|cit9", "author": "Springer", "first-page": "122", "year": "2002", "volume-title": "Proceedings of the 39th International TIAFT Meeting in Prague, 2001"}, {"key": "10.1002/jms.1859-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "227", "DOI": "10.1080/00498250400028239", "article-title": "Identification of cytochrome P450 enzymes involved in the metabolism of 3\u2032,4\u2032-methylenedioxy-\u03b1-pyrrolidinopropiophenone (MDPPP), a designer drug, in human liver microsomes", "volume": "35", "author": "Springer", "year": "2005", "journal-title": "Xenobiotica"}, {"key": "10.1002/jms.1859-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1016/S1570-0232(01)00578-5", "article-title": "Studies on the metabolism and toxicological detection of the new designer drug 4\u2032-methyl-alpha-pyrrolidinopropiophenone in urine using gas chromatography-mass spectrometry", "volume": "773", "author": "Springer", "year": "2002", "journal-title": "J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."}, {"key": "10.1002/jms.1859-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1016/j.jchromb.2005.07.003", "article-title": "Studies on the metabolism and toxicological detection of the new designer drug 4\u2032-methyl-alpha-pyrrolidinobutyrophenone (MPBP) in urine using gas chromatography-mass spectrometry", "volume": "824", "author": "Peters", "year": "2005", "journal-title": "J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."}, {"key": "10.1002/jms.1859-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "952", "DOI": "10.1002/jms.1571", "article-title": "New designer drug alpha-pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques", "volume": "44", "author": "Sauer", "year": "2009", "journal-title": "J. Mass Spectrom."}, {"key": "10.1002/jms.1859-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "1225", "DOI": "10.1007/s00216-010-3636-5", "article-title": "Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry", "volume": "397", "author": "Meyer", "year": "2010", "journal-title": "Anal. Bioanal. Chem."}, {"key": "10.1002/jms.1859-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/j.forsciint.2009.05.001", "article-title": "Mass and NMR spectroscopic characterization of 3,4-methylenedioxypyrovalerone: a designer drug with alpha-pyrrolidinophenone structure", "volume": "190", "author": "Westphal", "year": "2009", "journal-title": "Forensic Sci. Int."}, {"key": "10.1002/jms.1859-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "1310", "DOI": "10.1515/CCLM.2004.250", "article-title": "Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control [review]", "volume": "42", "author": "Maurer", "year": "2004", "journal-title": "Clin. Chem. Lab. Med."}, {"key": "10.1002/jms.1859-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "1399", "DOI": "10.1002/jms.1112", "article-title": "Hyphenated mass spectrometric techniques-indispensable tools in clinical and forensic toxicology and in doping control [review]", "volume": "41", "author": "Maurer", "year": "2006", "journal-title": "J. Mass Spectrom."}, {"key": "10.1002/jms.1859-BIB18|cit18", "author": "Maurer", "year": "2007", "volume-title": "Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants and Their Metabolites"}, {"key": "10.1002/jms.1859-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "683", "DOI": "10.1139/cjr50b-083", "article-title": "Diazohydrocarbons", "volume": "28", "author": "McKay", "year": "1950", "journal-title": "Can. J. Res."}, {"key": "10.1002/jms.1859-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "1837", "DOI": "10.1007/s00216-008-1917-z", "article-title": "Metabolism and toxicological detection of the designer drug 4-chloro-2,5-dimethoxyamphetamine in rat urine using gas chromatography-mass spectrometry", "volume": "390", "author": "Ewald", "year": "2008", "journal-title": "Anal. Bioanal. Chem."}, {"key": "10.1002/jms.1859-BIB21|cit21", "author": "Maurer", "year": "2011", "volume-title": "Mass Spectral Library of Drugs, Poisons, Pesticides, Pollutants and Their Metabolites"}, {"key": "10.1002/jms.1859-BIB22|cit22", "author": "Maurer", "year": "2007", "volume-title": "Mass Spectral Library of Drugs, Poisons, Pesticides, Pollutants and Their Metabolites"}, {"key": "10.1002/jms.1859-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "575", "DOI": "10.1373/clinchem.2009.135517", "article-title": "Automated mass spectral deconvolution and identification system for GC-MS screening for drugs, poisons, and metabolites in urine", "volume": "56", "author": "Meyer", "year": "2010", "journal-title": "Clin. Chem."}, {"key": "10.1002/jms.1859-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "32", "DOI": "10.1016/j.forsciint.2006.07.024", "article-title": "Mass spectral and NMR spectral data of two new designer drugs with an alpha-aminophenone structure: 4\u2032-methyl-alpha-pyrrolidinohexanophenone and 4\u2032-methyl-alpha-pyrrolidinobutyrophenone", "volume": "169", "author": "Westphal", "year": "2007", "journal-title": "Forensic Sci. Int."}, {"key": "10.1002/jms.1859-BIB25|cit25", "author": "McLafferty", "year": "1993", "volume-title": "Interpretation of Mass Spectra"}, {"key": "10.1002/jms.1859-BIB26|cit26", "author": "Smith", "year": "1999", "volume-title": "Understanding Mass Spectra-A Basic Approach"}, {"key": "10.1002/jms.1859-BIB27|cit27", "author": "de-Zeeuw", "year": "1992", "volume-title": "Gas Chromatographic Retention Indices of Toxicologically Relevant Substances and Their Metabolites (Report of the DFG Commission for Clinical Toxicological Analysis, Special Issue of the TIAFT Bulletin)"}, {"key": "10.1002/jms.1859-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1016/S1570-0232(03)00334-9", "article-title": "Metabolism and toxicological detection of the new designer drug 4\u2032-methoxy-\u03b1-pyrrolidinopropiophenone studied in rat urine using gas chromatography-mass spectrometry", "volume": "793", "author": "Springer", "year": "2003", "journal-title": "J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."}, {"key": "10.1002/jms.1859-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "568", "DOI": "10.1093/jat/20.7.568", "article-title": "Detection and identification of pyrovalerone and its hydroxylated metabolite in the rat", "volume": "20", "author": "Shin", "year": "1996", "journal-title": "J. Anal. Toxicol."}, {"key": "10.1002/jms.1859-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "357", "DOI": "10.2174/1389200003338929", "article-title": "The biotransformation of nitrogen containing xenobiotics to lactams", "volume": "1", "author": "Vickers", "year": "2000", "journal-title": "Curr. Drug Metab."}, {"key": "10.1002/jms.1859-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "1205", "DOI": "10.1021/tx900134e", "article-title": "Enantioselectivity in the methylation of the catecholic phase-I metabolites of methylenedioxy designer drugs and their capability to inhibit COMT catalyzed dopamine 3-methylation", "volume": "22", "author": "Meyer", "year": "2009", "journal-title": "Chem. Res. Toxicol."}, {"key": "10.1002/jms.1859-BIB32|cit32", "author": "Maurer", "year": "2011", "volume-title": "Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants and Their Metabolites"}, {"key": "10.1002/jms.1859-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "1915", "DOI": "10.1002/hlca.19580410703", "article-title": "Gaschromatographische Charakterisierung organischer Verbindungen. Teil 1. Retentionsindices aliphatischer Halogenide, Alkohole, Aldehyde und Ketone", "volume": "41", "author": "Kovats", "year": "1958", "journal-title": "Helv. Chim. Acta"}, {"key": "10.1002/jms.1859-BIB34|cit34", "first-page": "699", "article-title": "Senatskommission f\u00fcr Klinisch-toxikologische Analytik", "volume": "20", "author": "DFG", "year": "1982", "journal-title": "J. Clin. Chem. Clin. Biochem."}], "container-title": ["Journal of Mass Spectrometry"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjms.1859", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 6]], "date-time": "2019-03-06T00:41:04Z", "timestamp": 1551832864000}, "score": 41.060562, "issued": {"date-parts": [[2010, 11, 4]]}, "references-count": 34, "journal-issue": {"published-print": {"date-parts": [[2010, 12]]}, "issue": "12"}, "URL": "http://dx.doi.org/10.1002/jms.1859", "relation": {"cites": []}, "ISSN": ["1076-5174"], "issn-type": [{"value": "1076-5174", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T16:31:27Z", "timestamp": 1574526687360}, "reference-count": 20, "publisher": "Wiley", "issue": "4", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 964, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drug Test Analysis"], "published-print": {"date-parts": [[2013, 4]]}, "DOI": "10.1002/dta.1443", "type": "journal-article", "created": {"date-parts": [[2013, 1, 10]], "date-time": "2013-01-10T07:03:30Z", "timestamp": 1357801410000}, "page": "259-265", "source": "Crossref", "is-referenced-by-count": 17, "title": ["Studies on the metabolism and detectability of the designer drug \u03b2-naphyrone in rat urine using GC-MS and LC-HR-MS/MS"], "prefix": "10.1002", "volume": "5", "author": [{"given": "Markus R.", "family": "Meyer", "sequence": "first", "affiliation": [{"name": "Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical, Pharmacology and Toxicology; Saarland University; D-66421; Homburg; Saar; Germany"}]}, {"given": "Denise", "family": "Prosser", "sequence": "additional", "affiliation": [{"name": "Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical, Pharmacology and Toxicology; Saarland University; D-66421; Homburg; Saar; Germany"}]}, {"given": "Hans H.", "family": "Maurer", "sequence": "additional", "affiliation": [{"name": "Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical, Pharmacology and Toxicology; Saarland University; D-66421; Homburg; Saar; Germany"}]}], "member": "311", "published-online": {"date-parts": [[2013, 1, 10]]}, "reference": [{"key": "10.1002/dta.1443-BIB0001|dta1443-cit-0001", "doi-asserted-by": "crossref", "first-page": "377", "DOI": "10.1002/dta.155", "article-title": "Analyses of second-generation 'legal highs' in the UK: initial findings", "volume": "2", "author": "Brandt", "year": "2010", "journal-title": "Drug Test. Anal."}, {"key": "10.1002/dta.1443-BIB0002|dta1443-cit-0002", "doi-asserted-by": "crossref", "first-page": "569", "DOI": "10.1002/dta.204", "article-title": "Analysis of NRG 'legal highs' in the UK: Identification and formation of novel cathinones", "volume": "3", "author": "Brandt", "year": "2011", "journal-title": "Drug Test. Anal."}, {"key": "10.1002/dta.1443-BIB0003|dta1443-cit-0003", "doi-asserted-by": "crossref", "first-page": "93", "DOI": "10.1016/j.jflm.2010.12.001", "article-title": "Naphyrone: Analytical profile of the new \u201clegal high\u201d substitute for mephedrone", "volume": "18", "author": "De Paoli", "year": "2011", "journal-title": "J. Forensic Legal Med."}, {"key": "10.1002/dta.1443-BIB0004|dta1443-cit-0004", "doi-asserted-by": "crossref", "first-page": "691", "DOI": "10.3109/15563650.2011.592838", "article-title": "Sympathomimetic toxicity in a case of analytically confirmed recreational use of naphyrone (naphthylpyrovalerone)", "volume": "49", "author": "Derungs", "year": "2011", "journal-title": "Clin. Toxicol. (Phila.)"}, {"key": "10.1002/dta.1443-BIB0005|dta1443-cit-0005", "doi-asserted-by": "crossref", "first-page": "496", "DOI": "10.1002/dta.185", "article-title": "The naphyrone story: The alpha or beta-naphthyl isomer?", "volume": "2", "author": "Brandt", "year": "2010", "journal-title": "Drug Test. Anal."}, {"key": "10.1002/dta.1443-BIB0006|dta1443-cit-0006", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1007/s13181-011-0193-z", "article-title": "The toxicology of bath salts: A review of synthetic cathinones", "volume": "8", "author": "Prosser", "year": "2012", "journal-title": "J. Med. Toxicol."}, {"key": "10.1002/dta.1443-BIB0007|dta1443-cit-0007", "author": "Simmler", "year": "2012", "article-title": "Pharmacological characterization of designer cathinones in vitro", "journal-title": "Br. J. Pharmacol."}, {"key": "10.1002/dta.1443-BIB0008|dta1443-cit-0008", "doi-asserted-by": "crossref", "first-page": "1420", "DOI": "10.1021/jm050797a", "article-title": "1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (pyrovalerone) analogues: A promising class of monoamine uptake inhibitors", "volume": "49", "author": "Meltzer", "year": "2006", "journal-title": "J. Med. Chem."}, {"key": "10.1002/dta.1443-BIB0009|dta1443-cit-0009", "doi-asserted-by": "crossref", "first-page": "2141", "DOI": "10.1007/s00216-011-5678-8", "article-title": "Generation of metabolites by an automated online metabolism method using human liver microsomes with subsequent identification by LC-MS(n), and metabolism of 11 cathinones", "volume": "402", "author": "Mueller", "year": "2012", "journal-title": "Anal. Bioanal. Chem."}, {"key": "10.1002/dta.1443-BIB0010|dta1443-cit-0010", "author": "Maurer", "year": "2011", "volume-title": "Mass Spectral Library of Drugs, Poisons, Pesticides, Pollutants and their Metabolites"}, {"key": "10.1002/dta.1443-BIB0011|dta1443-cit-0011", "author": "Maurer", "year": "2011", "volume-title": "Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants and their Metabolites"}, {"key": "10.1002/dta.1443-BIB0012|dta1443-cit-0012", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1002/jms.2960", "article-title": "New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: Studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine", "volume": "47", "author": "Meyer", "year": "2012", "journal-title": "J. Mass Spectrom."}, {"key": "10.1002/dta.1443-BIB0013|dta1443-cit-0013", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1007/s00216-010-4398-9", "article-title": "Development of the first metabolite-based LC-MSn urine drug screening procedure - exemplified for antidepressants", "volume": "400", "author": "Wissenbach", "year": "2011", "journal-title": "Anal. Bioanal. Chem."}, {"key": "10.1002/dta.1443-BIB0014|dta1443-cit-0014", "doi-asserted-by": "crossref", "first-page": "3481", "DOI": "10.1007/s00216-011-5032-1", "article-title": "Drugs of abuse screening in urine as part of a metabolite-based LC-MS(n) screening concept", "volume": "400", "author": "Wissenbach", "year": "2011", "journal-title": "Anal. Bioanal. Chem."}, {"key": "10.1002/dta.1443-BIB0015|dta1443-cit-0015", "doi-asserted-by": "crossref", "first-page": "1837", "DOI": "10.1007/s00216-008-1917-z", "article-title": "Metabolism and toxicological detection of the designer drug 4-chloro-2,5-dimethoxyamphetamine in rat urine using gas chromatography-mass spectrometry", "volume": "390", "author": "Ewald", "year": "2008", "journal-title": "Anal. Bioanal. Chem."}, {"key": "10.1002/dta.1443-BIB0016|dta1443-cit-0016", "doi-asserted-by": "crossref", "first-page": "575", "DOI": "10.1373/clinchem.2009.135517", "article-title": "Automated mass spectral deconvolution and identification system for GC-MS screening for drugs, poisons, and metabolites in urine", "volume": "56", "author": "Meyer", "year": "2010", "journal-title": "Clin. Chem."}, {"key": "10.1002/dta.1443-BIB0017|dta1443-cit-0017", "author": "McLafferty", "year": "1993", "volume-title": "Interpretation of Mass Spectra"}, {"key": "10.1002/dta.1443-BIB0018|dta1443-cit-0018", "author": "Smith", "year": "1999", "volume-title": "Understanding Mass Spectra- A Basic Approach"}, {"key": "10.1002/dta.1443-BIB0019|dta1443-cit-0019", "doi-asserted-by": "crossref", "first-page": "952", "DOI": "10.1002/jms.1571", "article-title": "New designer drug alpha-pyrrolidinovalerophenone (PVP): Studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques", "volume": "44", "author": "Sauer", "year": "2009", "journal-title": "J. Mass Spectrom."}, {"key": "10.1002/dta.1443-BIB0020|dta1443-cit-0020", "doi-asserted-by": "crossref", "first-page": "1426", "DOI": "10.1002/jms.1859", "article-title": "Studies on the metabolism of the alpha-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat urine and human liver microsomes using GC-MS and LC-high-resolution-MS and its detectability in urine by GC-MS", "volume": "45", "author": "Meyer", "year": "2010", "journal-title": "J. Mass Spectrom."}], "container-title": ["Drug Testing and Analysis"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fdta.1443", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 21]], "date-time": "2017-06-21T05:27:01Z", "timestamp": 1498022821000}, "score": 40.867943, "subtitle": ["Metabolism of \u03b2-naphyrone and its toxicological detection"], "issued": {"date-parts": [[2013, 1, 10]]}, "references-count": 20, "journal-issue": {"published-print": {"date-parts": [[2013, 4]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1002/dta.1443", "relation": {"cites": []}, "ISSN": ["1942-7603"], "issn-type": [{"value": "1942-7603", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 6]], "date-time": "2019-12-06T14:20:49Z", "timestamp": 1575642049677}, "reference-count": 20, "publisher": "Wiley", "issue": "2", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 942, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Mass Spectrom."], "published-print": {"date-parts": [[2013, 2]]}, "DOI": "10.1002/jms.3142", "type": "journal-article", "created": {"date-parts": [[2013, 2, 4]], "date-time": "2013-02-04T12:35:05Z", "timestamp": 1359981305000}, "page": "243-249", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Studies on the metabolism and detectability of the emerging drug of abuse diphenyl-2-pyrrolidinemethanol (D2PM) in rat urine using GC-MS and LC-HR-MS/MS"], "prefix": "10.1002", "volume": "48", "author": [{"given": "Markus R.", "family": "Meyer", "sequence": "first", "affiliation": [{"name": "Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology Toxicology; Saarland University; D-66421; Homburg (Saar); Germany"}]}, {"given": "Sara", "family": "Schmitt", "sequence": "additional", "affiliation": [{"name": "Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology Toxicology; Saarland University; D-66421; Homburg (Saar); Germany"}]}, {"given": "Hans H.", "family": "Maurer", "sequence": "additional", "affiliation": [{"name": "Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology Toxicology; Saarland University; D-66421; Homburg (Saar); Germany"}]}], "member": "311", "published-online": {"date-parts": [[2013, 2, 3]]}, "reference": [{"key": "10.1002/jms.3142-BIB0001|jms3142-cit-0001", "doi-asserted-by": "crossref", "first-page": "15", "DOI": "10.3109/15563650.2011.645952", "article-title": "'Legal highs'--novel and emerging psychoactive drugs: a chemical overview for the toxicologist", "volume": "50", "author": "Gibbons", "year": "2012", "journal-title": "Clin. Toxicol. (Phila.)"}, {"key": "10.1002/jms.3142-BIB0002|jms3142-cit-0002", "doi-asserted-by": "crossref", "first-page": "525", "DOI": "10.1002/dta.308", "article-title": "Special issue on illicit drugs", "volume": "3", "author": "Brandt", "year": "2011", "journal-title": "Drug Test. Anal."}, {"key": "10.1002/jms.3142-BIB0003|jms3142-cit-0003", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1016/j.pnpbp.2012.05.021", "article-title": "2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol): A preliminary review", "volume": "39", "author": "Corkery", "year": "2012", "journal-title": "Prog. Neuropsychopharmacol. Biol. Psychiatry"}, {"key": "10.1002/jms.3142-BIB0004|jms3142-cit-0004", "doi-asserted-by": "crossref", "first-page": "727", "DOI": "10.3109/15563650.2012.716158", "article-title": "Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP)", "volume": "50", "author": "Wood", "year": "2012", "journal-title": "Clin. Toxicol. (Phila.)"}, {"key": "10.1002/jms.3142-BIB0005|jms3142-cit-0005", "doi-asserted-by": "crossref", "first-page": "167", "DOI": "10.1007/BF03161195", "article-title": "Cardiovascular toxicity associated with recreational use of diphenylprolinol (diphenyl-2-pyrrolidinemethanol [D2PM])", "volume": "4", "author": "Lidder", "year": "2008", "journal-title": "J. Med. Toxicol."}, {"key": "10.1002/jms.3142-BIB0006|jms3142-cit-0006", "doi-asserted-by": "crossref", "first-page": "349", "DOI": "10.1007/s00228-011-1142-0", "article-title": "A case series of individuals with analytically confirmed acute diphenyl-2-pyrrolidinemethanol (D2PM) toxicity", "volume": "68", "author": "Wood", "year": "2012", "journal-title": "Eur. J. Clin. Pharmacol."}, {"key": "10.1002/jms.3142-BIB0007|jms3142-cit-0007", "doi-asserted-by": "crossref", "first-page": "3771", "DOI": "10.1016/j.jchromb.2011.10.014", "article-title": "Analytical characterization and rapid determination of 2-(diphenylmethyl)pyrrolidine in blood and application to an internet product", "volume": "879", "author": "De", "year": "2011", "journal-title": "J. Chromatogr. B"}, {"key": "10.1002/jms.3142-BIB0008|jms3142-cit-0008", "doi-asserted-by": "crossref", "first-page": "108", "DOI": "10.3109/15563650.2011.647992", "article-title": "'Ivory wave' toxicity in recreational drug users; integration of clinical and poisons information services to manage legal high poisoning", "volume": "50", "author": "Murray", "year": "2012", "journal-title": "Clin. Toxicol. (Phila.)"}, {"key": "10.1002/jms.3142-BIB0009|jms3142-cit-0009", "author": "Maurer", "year": "2011", "volume-title": "Mass Spectral Library of Drugs, Poisons, Pesticides, Pollutants and their Metabolites"}, {"key": "10.1002/jms.3142-BIB0010|jms3142-cit-0010", "author": "Maurer", "year": "2011", "volume-title": "Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants and their Metabolites"}, {"key": "10.1002/jms.3142-BIB0011|jms3142-cit-0011", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1002/jms.2960", "article-title": "New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine", "volume": "47", "author": "Meyer", "year": "2012", "journal-title": "J. Mass Spectrom."}, {"key": "10.1002/jms.3142-BIB0012|jms3142-cit-0012", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1007/s00216-010-4398-9", "article-title": "Development of the first metabolite-based LC-MSn urine drug screening procedure - exemplified for antidepressants", "volume": "400", "author": "Wissenbach", "year": "2011", "journal-title": "Anal. Bioanal. Chem."}, {"key": "10.1002/jms.3142-BIB0013|jms3142-cit-0013", "doi-asserted-by": "crossref", "first-page": "3481", "DOI": "10.1007/s00216-011-5032-1", "article-title": "Drugs of abuse screening in urine as part of a metabolite-based LC-MS(n) screening concept", "volume": "400", "author": "Wissenbach", "year": "2011", "journal-title": "Anal. Bioanal. Chem."}, {"key": "10.1002/jms.3142-BIB0014|jms3142-cit-0014", "doi-asserted-by": "crossref", "first-page": "1837", "DOI": "10.1007/s00216-008-1917-z", "article-title": "Metabolism and toxicological detection of the designer drug 4-chloro-2,5-dimethoxyamphetamine in rat urine using gas chromatography-mass spectrometry", "volume": "390", "author": "Ewald", "year": "2008", "journal-title": "Anal. Bioanal. Chem."}, {"key": "10.1002/jms.3142-BIB0015|jms3142-cit-0015", "doi-asserted-by": "crossref", "first-page": "575", "DOI": "10.1373/clinchem.2009.135517", "article-title": "Automated mass spectral deconvolution and identification system for GC-MS screening for drugs, poisons, and metabolites in urine", "volume": "56", "author": "Meyer", "year": "2010", "journal-title": "Clin. Chem."}, {"key": "10.1002/jms.3142-BIB0016|jms3142-cit-0016", "author": "McLafferty", "year": "1993", "volume-title": "Interpretation of Mass Spectra"}, {"key": "10.1002/jms.3142-BIB0017|jms3142-cit-0017", "author": "Smith", "year": "1999", "volume-title": "Understanding Mass Spectra - A Basic Approach"}, {"key": "10.1002/jms.3142-BIB0018|jms3142-cit-0018", "doi-asserted-by": "crossref", "first-page": "1426", "DOI": "10.1002/jms.1859", "article-title": "Studies on the metabolism of the alpha-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat urine and human liver microsomes using GC-MS and LC-high-resolution-MS and its detectability in urine by GC-MS", "volume": "45", "author": "Meyer", "year": "2010", "journal-title": "J. Mass Spectrom."}, {"key": "10.1002/jms.3142-BIB0019|jms3142-cit-0019", "first-page": "8", "article-title": "European Union Decision 2002/657/EC 17.08.2002: commission decision laying down performance criteria for the analytical methods to be used for certain substances and residues thereof in live animals and animal products", "volume": "221", "author": "European Communities", "year": "2002", "journal-title": "Off. J. Eur. Commun."}, {"key": "10.1002/jms.3142-BIB0020|jms3142-cit-0020", "first-page": "52", "article-title": "MS identification guidelines in forensic toxicology - An Australian approach", "volume": "42", "author": "Gerostamoulos", "year": "2012", "journal-title": "TIAFT Bulletin"}], "container-title": ["Journal of Mass Spectrometry"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjms.3142", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 21]], "date-time": "2017-06-21T06:53:10Z", "timestamp": 1498027990000}, "score": 40.867943, "subtitle": ["Metabolism of D2PM and its toxicological detection"], "issued": {"date-parts": [[2013, 2]]}, "references-count": 20, "journal-issue": {"published-print": {"date-parts": [[2013, 2]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1002/jms.3142", "relation": {"cites": []}, "ISSN": ["1076-5174"], "issn-type": [{"value": "1076-5174", "type": "print"}], "subject": ["Spectroscopy"]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T03:14:51Z", "timestamp": 1575429291439}, "reference-count": 32, "publisher": "Springer Science and Business Media LLC", "issue": "7", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2014, 1, 23]], "date-time": "2014-01-23T00:00:00Z", "timestamp": 1390435200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Anal Bioanal Chem"], "published-print": {"date-parts": [[2014, 3]]}, "DOI": "10.1007/s00216-013-7595-5", "type": "journal-article", "created": {"date-parts": [[2014, 1, 22]], "date-time": "2014-01-22T12:58:27Z", "timestamp": 1390395507000}, "page": "1957-1974", "source": "Crossref", "is-referenced-by-count": 21, "title": ["Studies on the metabolism and the detectability of 4-methyl-amphetamine and its isomers 2-methyl-amphetamine and 3-methyl-amphetamine in rat urine using GC-MS and LC-(high-resolution)-MS n"], "prefix": "10.1007", "volume": "406", "author": [{"given": "Jessica", "family": "Welter", "sequence": "first", "affiliation": []}, {"given": "Markus R.", "family": "Meyer", "sequence": "additional", "affiliation": []}, {"given": "Pierce", "family": "Kavanagh", "sequence": "additional", "affiliation": []}, {"given": "Hans H.", "family": "Maurer", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2014, 1, 23]]}, "reference": [{"key": "7595_CR1", "first-page": "306", "volume": "35", "author": "F Westphal", "year": "2011", "unstructured": "Westphal F, Schaefer T, Zechlin L, Stoll S (2011) Identification of 4-methylamphetamine in a seized amphetamine mixture. Toxichem Krimtech 35:306\u2013315", "journal-title": "Toxichem Krimtech"}, {"key": "7595_CR2", "doi-asserted-by": "crossref", "first-page": "848", "DOI": "10.1124/jpet.104.080101", "volume": "313", "author": "S Wee", "year": "2005", "unstructured": "Wee S, Anderson KG, Baumann MH, Rothman RB, Blough BE, Woolverton WL (2005) Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs. J Pharmacol Exp Ther 313:848\u2013854", "journal-title": "J Pharmacol Exp Ther"}, {"key": "7595_CR3", "doi-asserted-by": "crossref", "first-page": "245", "DOI": "10.1196/annals.1369.064", "volume": "1074", "author": "RB Rothman", "year": "2006", "unstructured": "Rothman RB, Baumann MH (2006) Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs. Ann N Y Acad Sci 1074:245\u2013260", "journal-title": "Ann N Y Acad Sci"}, {"key": "7595_CR4", "doi-asserted-by": "crossref", "first-page": "218", "DOI": "10.1124/jpet.110.176271", "volume": "337", "author": "MH Baumann", "year": "2011", "unstructured": "Baumann MH, Clark RD, Woolverton WL, Wee S, Blough BE, Rothman RB (2011) In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the rat. J Pharmacol Exp Ther 337:218\u2013225", "journal-title": "J Pharmacol Exp Ther"}, {"key": "7595_CR5", "doi-asserted-by": "crossref", "first-page": "278", "DOI": "10.1016/j.pbb.2009.09.007", "volume": "94", "author": "HL Kimmel", "year": "2009", "unstructured": "Kimmel HL, Manvich DF, Blough BE, Negus SS, Howell LL (2009) Behavioral and neurochemical effects of amphetamine analogs that release monoamines in the squirrel monkey. Pharmacol Biochem Behav 94:278\u2013284", "journal-title": "Pharmacol Biochem Behav"}, {"key": "7595_CR6", "doi-asserted-by": "crossref", "first-page": "234", "DOI": "10.1016/j.drugalcdep.2008.10.005", "volume": "100", "author": "PJ Wellman", "year": "2009", "unstructured": "Wellman PJ, Davis KW, Clifford PS, Rothman RB, Blough BE (2009) Changes in feeding and locomotion induced by amphetamine analogs in rats. Drug Alcohol Depend 100:234\u2013239", "journal-title": "Drug Alcohol Depend"}, {"key": "7595_CR7", "doi-asserted-by": "crossref", "first-page": "627", "DOI": "10.1124/jpet.106.107383", "volume": "320", "author": "SS Negus", "year": "2007", "unstructured": "Negus SS, Mello NK, Blough BE, Baumann MH, Rothman RB (2007) Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate \u201cagonist\u201d medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys. J Pharmacol Exp Ther 320:627\u2013636", "journal-title": "J Pharmacol Exp Ther"}, {"key": "7595_CR8", "first-page": "298", "volume": "100", "author": "DF Marsh", "year": "1950", "unstructured": "Marsh DF, Herring DA (1950) The pharmacological activity of the ring methyl substituted phenisopropylamines. J Pharmacol Exp Ther 100:298\u2013308", "journal-title": "J Pharmacol Exp Ther"}, {"key": "7595_CR9", "doi-asserted-by": "crossref", "first-page": "835", "DOI": "10.1016/0091-3057(90)90571-X", "volume": "37", "author": "RA Higgs", "year": "1990", "unstructured": "Higgs RA, Glennon RA (1990) Stimulus properties of ring-methyl amphetamine analogs. Pharmacol Biochem Behav 37:835\u2013837", "journal-title": "Pharmacol Biochem Behav"}, {"key": "7595_CR10", "unstructured": "European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2012) Europol Joint Report on a new psychoactive substance: 4-methylamphetamine. http://www.emcdda.europa.eu/attachements.cfm/att_191982_EN_TDAS12001ENN.PDF Accessed December 2013"}, {"key": "7595_CR11", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1016/j.forsciint.2012.01.028", "volume": "220", "author": "S Davis", "year": "2012", "unstructured": "Davis S, Blakey K, Rands-Trevor K (2012) GC-MS and GC-IRD analysis of 2-, 3- and 4-methylmethamphetamine and 2-, 3- and 4-methylamphetamine. Forensic Sci Int 220:67\u201373", "journal-title": "Forensic Sci Int"}, {"key": "7595_CR12", "doi-asserted-by": "crossref", "first-page": "2081", "DOI": "10.1002/jssc.201200921", "volume": "36", "author": "AJ Pedersen", "year": "2013", "unstructured": "Pedersen AJ, Dalsgaard PW, Rode AJ, Rasmussen BS, Muller IB, Johansen SS, Linnet K (2013) Screening for illicit and medicinal drugs in whole blood using fully automated SPE and ultra-high-performance liquid chromatography with TOF-MS with data-independent acquisition. J Sep Sci 36:2081\u20132089", "journal-title": "J Sep Sci"}, {"key": "7595_CR13", "doi-asserted-by": "crossref", "first-page": "37", "DOI": "10.1016/j.chroma.2012.07.098", "volume": "1258", "author": "S Strano-Rossi", "year": "2012", "unstructured": "Strano-Rossi S, Anzillotti L, Castrignano E, Romolo FS, Chiarotti M (2012) Ultra high performance liquid chromatography-electrospray ionization-tandem mass spectrometry screening method for direct analysis of designer drugs, \u201cspice\u201d and stimulants in oral fluid. J Chromatogr A 1258:37\u201342", "journal-title": "J Chromatogr A"}, {"key": "7595_CR14", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1007/s00216-010-4398-9", "volume": "400", "author": "DK Wissenbach", "year": "2011", "unstructured": "Wissenbach DK, Meyer MR, Remane D, Weber AA, Maurer HH (2011) Development of the first metabolite-based LC-MSn urine drug screening procedure\u2014exemplified for antidepressants. Anal Bioanal Chem 400:79\u201388", "journal-title": "Anal Bioanal Chem"}, {"key": "7595_CR15", "doi-asserted-by": "crossref", "first-page": "3481", "DOI": "10.1007/s00216-011-5032-1", "volume": "400", "author": "DK Wissenbach", "year": "2011", "unstructured": "Wissenbach DK, Meyer MR, Remane D, Philipp AA, Weber AA, Maurer HH (2011) Drugs of abuse screening in urine as part of a metabolite-based LC-MS(n) screening concept. Anal Bioanal Chem 400:3481\u20133489", "journal-title": "Anal Bioanal Chem"}, {"key": "7595_CR16", "doi-asserted-by": "crossref", "first-page": "115", "DOI": "10.1016/j.forsciint.2013.02.039", "volume": "228", "author": "JD Power", "year": "2013", "unstructured": "Power JD, Clarke K, McDermott SD, McGlynn P, Barry M, White C, O\u2019Brien J, Kavanagh P (2013) The identification of 4-methylamphetamine and its synthesis by-products in forensic samples. Forensic Sci Int 228:115\u2013131", "journal-title": "Forensic Sci Int"}, {"key": "7595_CR17", "doi-asserted-by": "crossref", "first-page": "3125", "DOI": "10.1007/s00216-013-6741-4", "volume": "405", "author": "J Welter", "year": "2013", "unstructured": "Welter J, Meyer MR, Wolf E, Weinmann W, Kavanagh P, Maurer HH (2013) 2-Methiopropamine, a thiophene analogue of methamphetamine: studies on its metabolism and detectability in the rat and human using GC-MS and LC-(HR)-MS techniques. Anal Bioanal Chem 405:3125\u20133135", "journal-title": "Anal Bioanal Chem"}, {"key": "7595_CR18", "author": "HH Maurer", "year": "2011", "unstructured": "Maurer HH, Pfleger K, Weber AA (2011) Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites. Wiley-VCH, Weinheim", "volume-title": "Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites"}, {"key": "7595_CR19", "doi-asserted-by": "crossref", "first-page": "1837", "DOI": "10.1007/s00216-008-1917-z", "volume": "390", "author": "AH Ewald", "year": "2008", "unstructured": "Ewald AH, Ehlers D, Maurer HH (2008) Metabolism and toxicological detection of the designer drug 4-chloro-2,5-dimethoxyamphetamine in rat urine using gas chromatography\u2013mass spectrometry. Anal Bioanal Chem 390:1837\u20131842", "journal-title": "Anal Bioanal Chem"}, {"key": "7595_CR20", "doi-asserted-by": "crossref", "first-page": "575", "DOI": "10.1373/clinchem.2009.135517", "volume": "56", "author": "MR Meyer", "year": "2010", "unstructured": "Meyer MR, Peters FT, Maurer HH (2010) Automated mass spectral deconvolution and identification system for GC-MS screening for drugs, poisons, and metabolites in urine. Clin Chem 56:575\u2013584", "journal-title": "Clin Chem"}, {"key": "7595_CR21", "doi-asserted-by": "crossref", "first-page": "659", "DOI": "10.1002/jms.483", "volume": "38", "author": "FT Peters", "year": "2003", "unstructured": "Peters FT, Schaefer S, Staack RF, Kraemer T, Maurer HH (2003) Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. J Mass Spectrom 38:659\u2013676", "journal-title": "J Mass Spectrom"}, {"key": "7595_CR22", "doi-asserted-by": "crossref", "first-page": "1225", "DOI": "10.1007/s00216-010-3636-5", "volume": "397", "author": "MR Meyer", "year": "2010", "unstructured": "Meyer MR, Wilhelm J, Peters FT, Maurer HH (2010) Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography\u2013mass spectrometry. Anal Bioanal Chem 397:1225\u20131233", "journal-title": "Anal Bioanal Chem"}, {"key": "7595_CR23", "author": "FW McLafferty", "year": "1993", "unstructured": "McLafferty FW, Turecek F (1993) Interpretation of mass spectra. University Science, Mill Valley", "volume-title": "Interpretation of mass spectra"}, {"key": "7595_CR24", "author": "RM Smith", "year": "1999", "unstructured": "Smith RM, Busch KL (1999) Understanding mass spectra\u2014a basic approach. Wiley, New York", "volume-title": "Understanding mass spectra\u2014a basic approach"}, {"key": "7595_CR25", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1042/bj1290011", "volume": "129", "author": "J Caldwell", "year": "1972", "unstructured": "Caldwell J, Dring LG, Williams RT (1972) Metabolism of [C-14]methamphetamine in man, guinea-pig and rat. Biochemical Journal 129:11\u201312", "journal-title": "Biochemical Journal"}, {"key": "7595_CR26", "doi-asserted-by": "crossref", "first-page": "425", "DOI": "10.1042/bj1160425", "volume": "116", "author": "LG Dring", "year": "1970", "unstructured": "Dring LG, Smith RL, Williams RT (1970) The metabolic fate of amphetamine in man and other species. Biochem J 116:425\u2013435", "journal-title": "Biochem J"}, {"key": "7595_CR27", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1007/BF00316321", "volume": "59", "author": "K Shimosato", "year": "1986", "unstructured": "Shimosato K, Tomita M, Ijiri I (1986) Urinary excretion of p-hydroxylated methamphetamine metabolites in man. I. A method for determination by high-performance liquid chromatography-electrochemistry. Arch Toxicol 59:135\u2013140", "journal-title": "Arch Toxicol"}, {"key": "7595_CR28", "doi-asserted-by": "crossref", "first-page": "430", "DOI": "10.1002/dta.1369", "volume": "5", "author": "AJ Pedersen", "year": "2013", "unstructured": "Pedersen AJ, Reitzel LA, Johansen SS, Linnet K (2013) In vitro metabolism studies on mephedrone and analysis of forensic cases. Drug Test Anal 5:430\u2013438", "journal-title": "Drug Test Anal"}, {"key": "7595_CR29", "doi-asserted-by": "crossref", "first-page": "314", "DOI": "10.1080/00498250701802506", "volume": "38", "author": "N Shima", "year": "2008", "unstructured": "Shima N, Katagi M, Kamata H, Zaitsu K, Kamata T, Nishikawa M, Miki A, Tsuchihashi H, Sakuma T, Nemoto N (2008) Urinary excretion of the main metabolites of 3,4-methylenedioxymethamphetamine (MDMA), including the sulfate and glucuronide of 4-hydroxy-3-methoxymethamphetamine (HMMA), in humans and rats. Xenobiotica 38:314\u2013324", "journal-title": "Xenobiotica"}, {"key": "7595_CR30", "doi-asserted-by": "crossref", "first-page": "6307", "DOI": "10.1007/s00216-013-7051-6", "volume": "405", "author": "MR Meyer", "year": "2013", "unstructured": "Meyer MR, Bach M, Welter J, Bovens M, Turcant A, Maurer HH (2013) Ketamine-derived designer drug methoxetamine: metabolism including isoenzyme kinetics and toxicological detectability using GC-MS and LC-(HR-)MSn. Anal Bioanal Chem 405:6307\u20136321", "journal-title": "Anal Bioanal Chem"}, {"key": "7595_CR31", "first-page": "348", "volume": "28", "author": "MY Law", "year": "2000", "unstructured": "Law MY, Slawson MH, Moody DE (2000) Selective involvement of cytochrome P450 2D subfamily in in vivo 4-hydroxylation of amphetamine in rat. Drug Metab Dispos 28:348\u2013353", "journal-title": "Drug Metab Dispos"}, {"key": "7595_CR32", "doi-asserted-by": "crossref", "first-page": "907", "DOI": "10.1111/j.1476-5381.2009.00267.x", "volume": "157", "author": "V Sharma", "year": "2009", "unstructured": "Sharma V, McNeill JH (2009) To scale or not to scale: the principles of dose extrapolation. Br J Pharmacol 157:907\u2013921", "journal-title": "Br J Pharmacol"}], "container-title": ["Analytical and Bioanalytical Chemistry"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00216-013-7595-5.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00216-013-7595-5/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00216-013-7595-5", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 23]], "date-time": "2019-05-23T17:18:27Z", "timestamp": 1558631907000}, "score": 39.49084, "issued": {"date-parts": [[2014, 1, 23]]}, "references-count": 32, "journal-issue": {"published-print": {"date-parts": [[2014, 3]]}, "issue": "7"}, "alternative-id": ["7595"], "URL": "http://dx.doi.org/10.1007/s00216-013-7595-5", "relation": {"cites": []}, "ISSN": ["1618-2642", "1618-2650"], "issn-type": [{"value": "1618-2642", "type": "print"}, {"value": "1618-2650", "type": "electronic"}], "subject": ["Analytical Chemistry", "Biochemistry"]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T18:25:09Z", "timestamp": 1574706309493}, "reference-count": 32, "publisher": "Springer Science and Business Media LLC", "issue": "22", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2015, 6, 25]], "date-time": "2015-06-25T00:00:00Z", "timestamp": 1435190400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Anal Bioanal Chem"], "published-print": {"date-parts": [[2015, 9]]}, "DOI": "10.1007/s00216-015-8828-6", "type": "journal-article", "created": {"date-parts": [[2015, 6, 24]], "date-time": "2015-06-24T09:11:45Z", "timestamp": 1435137105000}, "page": "6697-6719", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 52, "title": ["Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MSn, and LC-HR-MS/MS"], "prefix": "10.1007", "volume": "407", "author": [{"given": "Achim T.", "family": "Caspar", "sequence": "first", "affiliation": []}, {"given": "Andreas G.", "family": "Helfer", "sequence": "additional", "affiliation": []}, {"given": "Julian A.", "family": "Michely", "sequence": "additional", "affiliation": []}, {"given": "Volker", "family": "Auw\u00e4rter", "sequence": "additional", "affiliation": []}, {"given": "Simon D.", "family": "Brandt", "sequence": "additional", "affiliation": []}, {"given": "Markus R.", "family": "Meyer", "sequence": "additional", "affiliation": []}, {"given": "Hans H.", "family": "Maurer", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2015, 6, 25]]}, "reference": [{"key": "8828_CR1", "doi-asserted-by": "crossref", "first-page": "544", "DOI": "10.1097/FTD.0b013e3181eea318", "volume": "32", "author": "HH Maurer", "year": "2010", "unstructured": "Maurer HH (2010) Chemistry, pharmacology, and metabolism of emerging drugs of abuse [review]. Ther Drug Monit 32:544\u2013549", "journal-title": "Ther Drug Monit"}, {"key": "8828_CR2", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1021/cn400216u", "volume": "5", "author": "M Hansen", "year": "2014", "unstructured": "Hansen M, Phonekeo K, Paine JS, Leth-Petersen S, Begtrup M, Brauner-Osborne H, Kristensen JL (2014) Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists. ACS Chem Neurosci 5:243\u2013249", "journal-title": "ACS Chem Neurosci"}, {"key": "8828_CR3", "doi-asserted-by": "crossref", "first-page": "1956", "DOI": "10.1124/mol.106.028720", "volume": "70", "author": "MR Braden", "year": "2006", "unstructured": "Braden MR, Parrish JC, Naylor JC, Nichols DE (2006) Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists. Mol Pharmacol 70:1956\u20131964", "journal-title": "Mol Pharmacol"}, {"key": "8828_CR4", "doi-asserted-by": "crossref", "first-page": "764", "DOI": "10.1002/dta.1522", "volume": "6", "author": "JL Poklis", "year": "2014", "unstructured": "Poklis JL, Nanco CR, Troendle MM, Wolf CE, Poklis A (2014) Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication. Drug Test Anal 6:764\u2013769", "journal-title": "Drug Test Anal"}, {"key": "8828_CR5", "doi-asserted-by": "crossref", "first-page": "e14", "DOI": "10.1016/j.forsciint.2013.10.015", "volume": "234", "author": "JL Poklis", "year": "2014", "unstructured": "Poklis JL, Devers KG, Arbefeville EF, Pearson JM, Houston E, Poklis A (2014) Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death. Forensic Sci Int 234:e14\u2013e20", "journal-title": "Forensic Sci Int"}, {"key": "8828_CR6", "doi-asserted-by": "crossref", "first-page": "174", "DOI": "10.3109/15563650.2013.772191", "volume": "51", "author": "SR Rose", "year": "2013", "unstructured": "Rose SR, Poklis JL, Poklis A (2013) A case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug. Clin Toxicol (Phila) 51:174\u2013177", "journal-title": "Clin Toxicol (Phila)"}, {"key": "8828_CR7", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1007/s13181-013-0314-y", "volume": "10", "author": "SJ Stellpflug", "year": "2014", "unstructured": "Stellpflug SJ, Kealey SE, Hegarty CB, Janis GC (2014) 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing. J Med Toxicol 10:45\u201350", "journal-title": "J Med Toxicol"}, {"key": "8828_CR8", "doi-asserted-by": "crossref", "first-page": "20", "DOI": "10.1097/PAF.0000000000000082", "volume": "35", "author": "JP Walterscheid", "year": "2014", "unstructured": "Walterscheid JP, Phillips GT, Lopez AE, Gonsoulin ML, Chen HH, Sanchez LA (2014) Pathological findings in 2 cases of fatal 25I-NBOMe toxicity. Am J Forensic Med Pathol 35:20\u201325", "journal-title": "Am J Forensic Med Pathol"}, {"key": "8828_CR9", "doi-asserted-by": "crossref", "first-page": "561", "DOI": "10.3109/15563650.2014.909932", "volume": "52", "author": "MH Tang", "year": "2014", "unstructured": "Tang MH, Ching CK, Tsui MS, Chu FK, Mak TW (2014) Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe. Clin Toxicol (Phila) 52:561\u2013565", "journal-title": "Clin Toxicol (Phila)"}, {"key": "8828_CR10", "doi-asserted-by": "crossref", "first-page": "1794", "DOI": "10.1002/bmc.2999", "volume": "27", "author": "JL Poklis", "year": "2013", "unstructured": "Poklis JL, Charles J, Wolf CE, Poklis A (2013) High-performance liquid chromatography tandem mass spectrometry method for the determination of 2CC-NBOMe and 25I-NBOMe in human serum. Biomed Chromatogr 27:1794\u20131800", "journal-title": "Biomed Chromatogr"}, {"key": "8828_CR11", "first-page": "317", "volume": "100", "author": "HH Maurer", "year": "2010", "unstructured": "Maurer HH (2010) Analytical toxicology [review]. Experientia 100:317\u2013337", "journal-title": "Experientia"}, {"key": "8828_CR12", "doi-asserted-by": "crossref", "first-page": "561", "DOI": "10.1097/FTD.0b013e31826a622d.", "volume": "34", "author": "HH Maurer", "year": "2012", "unstructured": "Maurer HH (2012) How can analytical diagnostics in clinical toxicology be successfully performed today? Ther Drug Monit 34:561\u2013564", "journal-title": "Ther Drug Monit"}, {"key": "8828_CR13", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.1016/j.chroma.2012.08.069", "volume": "1292", "author": "HH Maurer", "year": "2013", "unstructured": "Maurer HH (2013) What is the future of (ultra)high performance liquid chromatography coupled to low and high resolution mass spectrometry for toxicological drug screening? [review]. J Chromatogr A 1292:19\u201324", "journal-title": "J Chromatogr A"}, {"key": "8828_CR14", "doi-asserted-by": "crossref", "first-page": "831", "DOI": "10.1007/s00216-014-8083-2", "volume": "407", "author": "CSD Wink", "year": "2015", "unstructured": "Wink CSD, Meyer MR, Braun T, Turcant A, Maurer HH (2015) Biotransformation and detectability of the designer drug 2,5-dimethoxy-4-propylphenethylamine (2C-P) studied in urine by GC-MS, LC-MSn and LC-high resolution-MSn. Anal Bioanal Chem 407:831\u2013843", "journal-title": "Anal Bioanal Chem"}, {"key": "8828_CR15", "doi-asserted-by": "crossref", "first-page": "374", "DOI": "10.1016/j.jchromb.2006.08.049", "volume": "846", "author": "DS Theobald", "year": "2007", "unstructured": "Theobald DS, Fritschi G, Maurer HH (2007) Studies on the toxicological detection of the designer drug 4-bromo-2,5-dimethoxy-beta-phenethylamine (2C-B) in rat urine using gas chromatography-mass spectrometry. J Chromatogr B 846:374\u2013377", "journal-title": "J Chromatogr B"}, {"key": "8828_CR16", "doi-asserted-by": "crossref", "first-page": "287", "DOI": "10.1016/j.bcp.2006.09.022", "volume": "73", "author": "DS Theobald", "year": "2007", "unstructured": "Theobald DS, Maurer HH (2007) Identification of monoamine oxidase and cytochrome P450 isoenzymes involved in the deamination of phenethylamine-derived designer drugs (2C-series). Biochem Pharmacol 73:287\u2013297", "journal-title": "Biochem Pharmacol"}, {"key": "8828_CR17", "doi-asserted-by": "crossref", "first-page": "872", "DOI": "10.1002/jms.1045", "volume": "41", "author": "DS Theobald", "year": "2006", "unstructured": "Theobald DS, Putz M, Schneider E, Maurer HH (2006) New designer drug 4-iodo-2,5-dimethoxy-beta-phenethylamine (2C-I): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric and capillary electrophoretic/mass spectrometric techniques. J Mass Spectrom 41:872\u2013886", "journal-title": "J Mass Spectrom"}, {"key": "8828_CR18", "doi-asserted-by": "crossref", "first-page": "76", "DOI": "10.1016/j.jchromb.2006.03.001", "volume": "842", "author": "DS Theobald", "year": "2006", "unstructured": "Theobald DS, Maurer HH (2006) Studies on the metabolism and toxicological detection of the designer drug 4-ethyl-2,5-dimethoxy-beta-phenethylamine (2C-E) in rat urine using gas chromatographic-mass spectrometric techniques. J Chromatogr B 842:76\u201390", "journal-title": "J Chromatogr B"}, {"key": "8828_CR19", "doi-asserted-by": "crossref", "first-page": "1509", "DOI": "10.1002/jms.1128", "volume": "41", "author": "DS Theobald", "year": "2006", "unstructured": "Theobald DS, Maurer HH (2006) Studies on the metabolism and toxicological detection of the designer drug 2,5-dimethoxy-4-methyl-beta-phenethylamine (2C-D) in rat urine using gas chromatographic-mass spectrometric techniques. J Mass Spectrom 41:1509\u20131519", "journal-title": "J Mass Spectrom"}, {"key": "8828_CR20", "doi-asserted-by": "crossref", "first-page": "1157", "DOI": "10.1002/jms.890", "volume": "40", "author": "DS Theobald", "year": "2005", "unstructured": "Theobald DS, Staack RF, Puetz M, Maurer HH (2005) New designer drug 2,5-dimethoxy-4-ethylthio-beta-phenethylamine (2C-T-2): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry. J Mass Spectrom 40:1157\u20131172", "journal-title": "J Mass Spectrom"}, {"key": "8828_CR21", "doi-asserted-by": "crossref", "first-page": "105", "DOI": "10.1002/jms.784", "volume": "40", "author": "DS Theobald", "year": "2005", "unstructured": "Theobald DS, Fehn S, Maurer HH (2005) New designer drug 2,5-dimethoxy-4-propylthiophenethylamine (2C-T-7): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry. J Mass Spectrom 40:105\u2013116", "journal-title": "J Mass Spectrom"}, {"key": "8828_CR22", "doi-asserted-by": "crossref", "first-page": "1845", "DOI": "10.1007/s00216-013-7539-0", "volume": "406", "author": "MR Meyer", "year": "2014", "unstructured": "Meyer MR, Lindauer C, Welter J, Maurer HH (2014) Dimethocaine, a synthetic cocaine derivative: studies on its in vivo metabolism and its detectability in urine by LC-HR-MSn and GC-MS using a rat model. Anal Bioanal Chem 406:1845\u20131854", "journal-title": "Anal Bioanal Chem"}, {"key": "8828_CR23", "doi-asserted-by": "crossref", "first-page": "3481", "DOI": "10.1007/s00216-011-5032-1", "volume": "400", "author": "DK Wissenbach", "year": "2011", "unstructured": "Wissenbach DK, Meyer MR, Remane D, Philipp AA, Weber AA, Maurer HH (2011) Drugs of abuse screening in urine as part of a metabolite-based LC-MS(n) screening concept. Anal Bioanal Chem 400:3481\u20133489", "journal-title": "Anal Bioanal Chem"}, {"key": "8828_CR24", "doi-asserted-by": "crossref", "first-page": "1371", "DOI": "10.1007/s00216-014-8360-0", "volume": "407", "author": "J Welter", "year": "2015", "unstructured": "Welter J, Kavanagh P, Meyer MR, Maurer HH (2015) Benzofuran analogues of amphetamine and methamphetamine: studies on the metabolism and toxicological analysis of 5-APB and 5-MAPB in urine and plasma using GC-MS and LC-(HR)-MSn techniques. Anal Bioanal Chem 407:1371\u20131388", "journal-title": "Anal Bioanal Chem"}, {"key": "8828_CR25", "doi-asserted-by": "crossref", "first-page": "3125", "DOI": "10.1007/s00216-013-6741-4", "volume": "405", "author": "J Welter", "year": "2013", "unstructured": "Welter J, Meyer MR, Wolf E, Weinmann W, Kavanagh P, Maurer HH (2013) 2-Methiopropamine, a thiophene analogue of methamphetamine: studies on its metabolism and detectability in the rat and human using GC-MS and LC-(HR)-MS techniques. Anal Bioanal Chem 405:3125\u20133135", "journal-title": "Anal Bioanal Chem"}, {"key": "8828_CR26", "author": "AG Helfer", "year": "2015", "unstructured": "Helfer AG, Turcant A, Boels D, Ferec S, Lelievre B, Welter J, Meyer MR, Maurer HH (2015) Elucidation of the metabolites of the novel psychoactive substance 4-methyl-N-ethyl-cathinone (4-MEC) in human urine and pooled liver microsomes by GC-MS and LC-HR-MS/MS techniques and of its detectability by GC-MS or LC-MSn standard screening approaches. Drug Test Anal. doi: 10.1002/dta.1682", "journal-title": "Drug Test Anal"}, {"key": "8828_CR27", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1007/s00216-010-4398-9", "volume": "400", "author": "DK Wissenbach", "year": "2011", "unstructured": "Wissenbach DK, Meyer MR, Remane D, Weber AA, Maurer HH (2011) Development of the first metabolite-based LC-MSn urine drug screening procedure\u2014exemplified for antidepressants. Anal Bioanal Chem 400:79\u201388", "journal-title": "Anal Bioanal Chem"}, {"key": "8828_CR28", "author": "HH Maurer", "year": "2014", "unstructured": "Maurer HH, Wissenbach DK, Weber AA (2014) Maurer/wissenbach/weber MWW LC-MSn library of drugs, poisons, and their metabolites. Wiley-VCH, Weinheim", "volume-title": "Maurer/wissenbach/weber MWW LC-MSn library of drugs, poisons, and their metabolites"}, {"key": "8828_CR29", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1007/s00216-010-4450-9", "volume": "400", "author": "S Broecker", "year": "2011", "unstructured": "Broecker S, Herre S, Wust B, Zweigenbaum J, Pragst F (2011) Development and practical application of a library of CID accurate mass spectra of more than 2,500 toxic compounds for systematic toxicological analysis by LC-QTOF-MS with data-dependent acquisition. Anal Bioanal Chem 400:101\u2013117", "journal-title": "Anal Bioanal Chem"}, {"key": "8828_CR30", "doi-asserted-by": "crossref", "first-page": "124", "DOI": "10.1016/j.toxlet.2014.03.010", "volume": "227", "author": "MR Meyer", "year": "2014", "unstructured": "Meyer MR, Robert A, Maurer HH (2014) Toxicokinetics of novel psychoactive substances: characterization of N-acetyltransferase (NAT) isoenzymes involved in the phase II metabolism of 2C designer drugs. Toxicol Lett 227:124\u2013128", "journal-title": "Toxicol Lett"}, {"key": "8828_CR31", "doi-asserted-by": "crossref", "first-page": "37", "DOI": "10.1016/j.aca.2014.03.017", "volume": "822", "author": "MR Meyer", "year": "2014", "unstructured": "Meyer MR, Richter LHR, Maurer HH (2014) Methylenedioxy designer drugs: mass spectrometric characterization of their glutathione conjugates by means of liquid chromatography-high-resolution mass spectrometry/mass spectrometry and studies on their glutathionyl transferase inhibition potency. Anal Chim Acta 822:37\u201350", "journal-title": "Anal Chim Acta"}, {"key": "8828_CR32", "doi-asserted-by": "crossref", "first-page": "907", "DOI": "10.1111/j.1476-5381.2009.00267.x", "volume": "157", "author": "V Sharma", "year": "2009", "unstructured": "Sharma V, McNeill JH (2009) To scale or not to scale: the principles of dose extrapolation. Br J Pharmacol 157:907\u2013921", "journal-title": "Br J Pharmacol"}], "container-title": ["Analytical and Bioanalytical Chemistry"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00216-015-8828-6.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00216-015-8828-6/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00216-015-8828-6", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 23]], "date-time": "2019-05-23T17:17:43Z", "timestamp": 1558631863000}, "score": 39.080822, "issued": {"date-parts": [[2015, 6, 25]]}, "references-count": 32, "journal-issue": {"published-print": {"date-parts": [[2015, 9]]}, "issue": "22"}, "alternative-id": ["8828"], "URL": "http://dx.doi.org/10.1007/s00216-015-8828-6", "relation": {"cites": []}, "ISSN": ["1618-2642", "1618-2650"], "issn-type": [{"value": "1618-2642", "type": "print"}, {"value": "1618-2650", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T19:56:45Z", "timestamp": 1574452605525}, "reference-count": 65, "publisher": "Springer Science and Business Media LLC", "issue": "5", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2012, 2, 16]], "date-time": "2012-02-16T00:00:00Z", "timestamp": 1329350400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Anal Bioanal Chem"], "published-print": {"date-parts": [[2012, 5]]}, "DOI": "10.1007/s00216-012-5807-z", "type": "journal-article", "created": {"date-parts": [[2012, 2, 15]], "date-time": "2012-02-15T03:49:09Z", "timestamp": 1329277749000}, "page": "1221-1231", "source": "Crossref", "is-referenced-by-count": 57, "title": ["Current applications of high-resolution mass spectrometry in drug metabolism studies"], "prefix": "10.1007", "volume": "403", "author": [{"given": "Markus R.", "family": "Meyer", "sequence": "first", "affiliation": []}, {"given": "Hans H.", "family": "Maurer", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2012, 2, 16]]}, "reference": [{"key": "5807_CR1", "doi-asserted-by": "crossref", "first-page": "405", "DOI": "10.1007/s00216-011-4859-9", "volume": "401", "author": "M Thevis", "year": "2011", "unstructured": "Thevis M, Thomas A, Schanzer W (2011) Anal Bioanal Chem 401:405\u2013420", "journal-title": "Anal Bioanal Chem"}, {"key": "5807_CR2", "doi-asserted-by": "crossref", "first-page": "329", "DOI": "10.2174/138920011795202910", "volume": "12", "author": "Y Liang", "year": "2011", "unstructured": "Liang Y, Wang G, Xie L, Sheng L (2011) Curr Drug Metab 12:329\u2013344", "journal-title": "Curr Drug Metab"}, {"key": "5807_CR3", "doi-asserted-by": "crossref", "first-page": "1249", "DOI": "10.1002/jms.1607", "volume": "44", "author": "AA Philipp", "year": "2009", "unstructured": "Philipp AA, Wissenbach DK, Zoerntlein SW, Klein ON, Kanogsunthornrat J, Maurer HH (2009) J Mass Spectrom 44:1249\u20131261", "journal-title": "J Mass Spectrom"}, {"key": "5807_CR4", "doi-asserted-by": "crossref", "first-page": "2379", "DOI": "10.1007/s00216-009-3239-1", "volume": "396", "author": "AA Philipp", "year": "2010", "unstructured": "Philipp AA, Wissenbach DK, Weber AA, Zapp J, Zoerntlein SW, Klein ON, Kanogsunthornrat J, Maurer HH (2010) Anal Bioanal Chem 396:2379\u20132391", "journal-title": "Anal Bioanal Chem"}, {"key": "5807_CR5", "doi-asserted-by": "crossref", "first-page": "1344", "DOI": "10.1002/jms.1848", "volume": "45", "author": "AA Philipp", "year": "2010", "unstructured": "Philipp AA, Wissenbach DK, Weber AA, Zapp J, Maurer HH (2010) J Mass Spectrom 45:1344\u20131357", "journal-title": "J Mass Spectrom"}, {"key": "5807_CR6", "doi-asserted-by": "crossref", "first-page": "34", "DOI": "10.1093/jat/29.1.34", "volume": "29", "author": "I Ojanpera", "year": "2005", "unstructured": "Ojanpera I, Pelander A, Laks S, Gergov M, Vuori E, Witt M (2005) J Anal Toxicol 29:34\u201340", "journal-title": "J Anal Toxicol"}, {"key": "5807_CR7", "doi-asserted-by": "crossref", "first-page": "423", "DOI": "10.1002/(SICI)1096-9888(200003)35:3<423::AID-JMS953>3.0.CO;2-7", "volume": "35", "author": "H Zhang", "year": "2000", "unstructured": "Zhang H, Heinig K, Henion J (2000) J Mass Spectrom 35:423\u2013431", "journal-title": "J Mass Spectrom"}, {"key": "5807_CR8", "doi-asserted-by": "crossref", "first-page": "979", "DOI": "10.1002/rcm.4952", "volume": "25", "author": "A Kaufmann", "year": "2011", "unstructured": "Kaufmann A, Butcher P, Maden K, Walker S, Widmer M (2011) Rapid Commun Mass Spectrom 25:979\u2013992", "journal-title": "Rapid Commun Mass Spectrom"}, {"key": "5807_CR9", "doi-asserted-by": "crossref", "first-page": "591", "DOI": "10.1002/cbdv.200900022", "volume": "6", "author": "B Testa", "year": "2009", "unstructured": "Testa B, Kramer SD (2009) Chem Biodivers 6:591\u2013684", "journal-title": "Chem Biodivers"}, {"key": "5807_CR10", "doi-asserted-by": "crossref", "first-page": "2645", "DOI": "10.1007/s00216-010-4370-8", "volume": "399", "author": "DM Drexler", "year": "2011", "unstructured": "Drexler DM, Reily MD, Shipkova PA (2011) Anal Bioanal Chem 399:2645\u20132653", "journal-title": "Anal Bioanal Chem"}, {"key": "5807_CR11", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1016/j.clinbiochem.2010.08.016", "volume": "44", "author": "A Roux", "year": "2011", "unstructured": "Roux A, Lison D, Junot C, Heilier JF (2011) Clin Biochem 44:119\u2013135", "journal-title": "Clin Biochem"}, {"key": "5807_CR12", "doi-asserted-by": "crossref", "first-page": "387", "DOI": "10.1039/B906712B", "volume": "40", "author": "WB Dunn", "year": "2011", "unstructured": "Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL (2011) Chem Soc Rev 40:387\u2013426", "journal-title": "Chem Soc Rev"}, {"key": "5807_CR13", "doi-asserted-by": "crossref", "first-page": "112", "DOI": "10.1002/jms.1878", "volume": "46", "author": "S Beuck", "year": "2011", "unstructured": "Beuck S, Schanzer W, Thevis M (2011) J Mass Spectrom 46:112\u2013130", "journal-title": "J Mass Spectrom"}, {"key": "5807_CR14", "doi-asserted-by": "crossref", "first-page": "329", "DOI": "10.1021/tx200008f", "volume": "24", "author": "A LeBlanc", "year": "2011", "unstructured": "LeBlanc A, Sleno L (2011) Chem Res Toxicol 24:329\u2013339", "journal-title": "Chem Res Toxicol"}, {"key": "5807_CR15", "doi-asserted-by": "crossref", "first-page": "1426", "DOI": "10.1002/jms.1859", "volume": "45", "author": "MR Meyer", "year": "2010", "unstructured": "Meyer MR, Du P, Schuster F, Maurer HH (2010) J Mass Spectrom 45:1426\u20131442", "journal-title": "J Mass Spectrom"}, {"key": "5807_CR16", "doi-asserted-by": "crossref", "first-page": "725", "DOI": "10.1002/jms.1943", "volume": "46", "author": "T Liu", "year": "2011", "unstructured": "Liu T, Du F, Wan Y, Zhu F, Xing J (2011) J Mass Spectrom 46:725\u2013733", "journal-title": "J Mass Spectrom"}, {"key": "5807_CR17", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1016/j.toxlet.2011.04.015", "volume": "204", "author": "L Ye", "year": "2011", "unstructured": "Ye L, Wang T, Yang C, Tang L, Zhou J, Lv C, Gong Y, Jiang Z, Liu Z (2011) Toxicol Lett 204:81\u201391", "journal-title": "Toxicol Lett"}, {"key": "5807_CR18", "doi-asserted-by": "crossref", "first-page": "1009", "DOI": "10.1002/rcm.3422", "volume": "22", "author": "Z Liu", "year": "2008", "unstructured": "Liu Z, Huang L, Dai M, Chen D, Wang Y, Tao Y, Yuan Z (2008) Rapid Commun Mass Spectrom 22:1009\u20131016", "journal-title": "Rapid Commun Mass Spectrom"}, {"key": "5807_CR19", "doi-asserted-by": "crossref", "first-page": "203", "DOI": "10.1002/jms.1498", "volume": "44", "author": "G Chen", "year": "2009", "unstructured": "Chen G, Daaro I, Pramanik BN, Piwinski JJ (2009) J Mass Spectrom 44:203\u2013213", "journal-title": "J Mass Spectrom"}, {"key": "5807_CR20", "first-page": "1", "volume": "2", "author": "JP Scarth", "year": "2010", "unstructured": "Scarth JP, Spencer HA, Timbers SE, Hudson SC, Hillyer LL (2010) Drug Test Anal 2:1\u201310", "journal-title": "Drug Test Anal"}, {"key": "5807_CR21", "doi-asserted-by": "crossref", "first-page": "173", "DOI": "10.1016/j.ejps.2010.06.006", "volume": "41", "author": "B Prasad", "year": "2010", "unstructured": "Prasad B, Singh S (2010) Eur J Pharm Sci 41:173\u2013188", "journal-title": "Eur J Pharm Sci"}, {"key": "5807_CR22", "doi-asserted-by": "crossref", "first-page": "196", "DOI": "10.1016/j.chroma.2007.01.024", "volume": "1156", "author": "E Nagele", "year": "2007", "unstructured": "Nagele E, Fandino AS (2007) J Chromatogr A 1156:196\u2013200", "journal-title": "J Chromatogr A"}, {"key": "5807_CR23", "doi-asserted-by": "crossref", "first-page": "57", "DOI": "10.1016/j.chroma.2008.10.111", "volume": "1215", "author": "T Kosjek", "year": "2008", "unstructured": "Kosjek T, Zigon D, Kralj B, Heath E (2008) J Chromatogr A 1215:57\u201363", "journal-title": "J Chromatogr A"}, {"key": "5807_CR24", "doi-asserted-by": "crossref", "first-page": "1883", "DOI": "10.1124/dmd.111.040980", "volume": "39", "author": "J Guo", "year": "2011", "unstructured": "Guo J, Gu C, Zhou D, Elmore CS, Bui KH, Grimm SW (2011) Drug Metab Dispos 39:1883\u20131894", "journal-title": "Drug Metab Dispos"}, {"key": "5807_CR25", "doi-asserted-by": "crossref", "first-page": "385", "DOI": "10.3109/00498254.2010.545453", "volume": "41", "author": "J Guo", "year": "2011", "unstructured": "Guo J, Davis PC, Gu C, Grimm SW (2011) Xenobiotica 41:385\u2013399", "journal-title": "Xenobiotica"}, {"key": "5807_CR26", "doi-asserted-by": "crossref", "first-page": "475", "DOI": "10.1016/j.jpba.2009.05.009", "volume": "50", "author": "B Prasad", "year": "2009", "unstructured": "Prasad B, Singh S (2009) J Pharm Biomed Anal 50:475\u2013490", "journal-title": "J Pharm Biomed Anal"}, {"key": "5807_CR27", "doi-asserted-by": "crossref", "first-page": "3907", "DOI": "10.1002/rcm.4329", "volume": "23", "author": "A Xiong", "year": "2009", "unstructured": "Xiong A, Yang L, He Y, Zhang F, Wang J, Han H, Wang C, Bligh SW, Wang Z (2009) Rapid Commun Mass Spectrom 23:3907\u20133916", "journal-title": "Rapid Commun Mass Spectrom"}, {"key": "5807_CR28", "doi-asserted-by": "crossref", "first-page": "1423", "DOI": "10.1002/jms.1624", "volume": "44", "author": "J Jung", "year": "2009", "unstructured": "Jung J, Meyer MR, Maurer HH, Neus\u00fc\u00df C, Weinmann W, Auwaerter V (2009) J Mass Spectrom 44:1423\u20131433", "journal-title": "J Mass Spectrom"}, {"key": "5807_CR29", "doi-asserted-by": "crossref", "first-page": "1003", "DOI": "10.1039/C0AN00632G", "volume": "136", "author": "A Thomas", "year": "2011", "unstructured": "Thomas A, Kohler M, Schanzer W, Delahaut P, Thevis M (2011) Analyst 136:1003\u20131012", "journal-title": "Analyst"}, {"key": "5807_CR30", "unstructured": "de Albuquerque CG, Carius GB, Dias LF, Costa PM, Mazzarino M, de la Torre, X, Botre F, Radler de Aquino NF (2011) J Steroid Biochem Mol Biol 127:248\u2013254", "DOI": "10.1016/j.jsbmb.2011.08.014", "doi-asserted-by": "crossref"}, {"key": "5807_CR31", "doi-asserted-by": "crossref", "first-page": "2187", "DOI": "10.1002/rcm.5100", "volume": "25", "author": "M Thevis", "year": "2011", "unstructured": "Thevis M, Thomas A, Moller I, Geyer H, Dalton JT, Schanzer W (2011) Rapid Commun Mass Spectrom 25:2187\u20132195", "journal-title": "Rapid Commun Mass Spectrom"}, {"key": "5807_CR32", "doi-asserted-by": "crossref", "first-page": "2245", "DOI": "10.1002/rcm.4637", "volume": "24", "author": "M Thevis", "year": "2010", "unstructured": "Thevis M, Thomas A, Fussholler G, Beuck S, Geyer H, Schanzer W (2010) Rapid Commun Mass Spectrom 24:2245\u20132254", "journal-title": "Rapid Commun Mass Spectrom"}, {"key": "5807_CR33", "doi-asserted-by": "crossref", "first-page": "371", "DOI": "10.1016/j.jpba.2008.01.024", "volume": "47", "author": "D Stulten", "year": "2008", "unstructured": "Stulten D, Lamshoft M, Zuhlke S, Spiteller M (2008) J Pharm Biomed Anal 47:371\u2013376", "journal-title": "J Pharm Biomed Anal"}, {"key": "5807_CR34", "doi-asserted-by": "crossref", "first-page": "4079", "DOI": "10.1002/rcm.3313", "volume": "21", "author": "RS Plumb", "year": "2007", "unstructured": "Plumb RS, Rainville PD, Potts WB III, Castro-Perez JM, Johnson KA, Wilson ID (2007) Rapid Commun Mass Spectrom 21:4079\u20134085", "journal-title": "Rapid Commun Mass Spectrom"}, {"key": "5807_CR35", "doi-asserted-by": "crossref", "first-page": "178", "DOI": "10.1016/j.aca.2008.10.015", "volume": "637", "author": "B Destrez", "year": "2009", "unstructured": "Destrez B, Pinel G, Monteau F, Lafont R, Le Bizec B (2009) Anal Chim Acta 637:178\u2013184", "journal-title": "Anal Chim Acta"}, {"key": "5807_CR36", "doi-asserted-by": "crossref", "first-page": "2748", "DOI": "10.1002/elps.200600820", "volume": "28", "author": "R Theurillat", "year": "2007", "unstructured": "Theurillat R, Knobloch M, Schmitz A, Lassahn PG, Mevissen M, Thormann W (2007) Electrophoresis 28:2748\u20132757", "journal-title": "Electrophoresis"}, {"key": "5807_CR37", "doi-asserted-by": "crossref", "first-page": "468", "DOI": "10.2174/138920010791526042", "volume": "11", "author": "MR Meyer", "year": "2010", "unstructured": "Meyer MR, Maurer HH (2010) Curr Drug Metab 11:468\u2013482", "journal-title": "Curr Drug Metab"}, {"key": "5807_CR38", "doi-asserted-by": "crossref", "first-page": "2747", "DOI": "10.1007/s00216-011-4660-9", "volume": "399", "author": "AA Philipp", "year": "2011", "unstructured": "Philipp AA, Wissenbach DK, Weber AA, Zapp J, Maurer HH (2011) Anal Bioanal Chem 399:2747\u20132753", "journal-title": "Anal Bioanal Chem"}, {"key": "5807_CR39", "doi-asserted-by": "crossref", "first-page": "1049", "DOI": "10.1016/j.jchromb.2011.03.005", "volume": "879", "author": "AA Philipp", "year": "2011", "unstructured": "Philipp AA, Wissenbach DK, Weber AA, Zapp J, Maurer HH (2011) J Chromatogr B 879:1049\u20131055", "journal-title": "J Chromatogr B"}, {"key": "5807_CR40", "doi-asserted-by": "crossref", "first-page": "485", "DOI": "10.1002/jms.1545", "volume": "44", "author": "H Oberacher", "year": "2009", "unstructured": "Oberacher H, Pavlic M, Libiseller K, Schubert B, Sulyok M, Schuhmacher R, Csaszar E, Kofeler HC (2009) J Mass Spectrom 44:485\u2013493", "journal-title": "J Mass Spectrom"}, {"key": "5807_CR41", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.2174/1389200054021825", "volume": "6", "author": "RF Staack", "year": "2005", "unstructured": "Staack RF, Maurer HH (2005) Curr Drug Metab 6:259\u2013274", "journal-title": "Curr Drug Metab"}, {"key": "5807_CR42", "doi-asserted-by": "crossref", "first-page": "1351", "DOI": "10.1007/s00216-007-1131-4", "volume": "388", "author": "M Thevis", "year": "2007", "unstructured": "Thevis M, Schanzer W (2007) Anal Bioanal Chem 388:1351\u20131358", "journal-title": "Anal Bioanal Chem"}, {"key": "5807_CR43", "doi-asserted-by": "crossref", "first-page": "483", "DOI": "10.1002/dta.295", "volume": "3", "author": "FT Peters", "year": "2011", "unstructured": "Peters FT, Meyer MR (2011) Drug Test Anal 3:483\u2013495", "journal-title": "Drug Test Anal"}, {"key": "5807_CR44", "doi-asserted-by": "crossref", "first-page": "2162", "DOI": "10.1002/rcm.4615", "volume": "24", "author": "A Kaufmann", "year": "2010", "unstructured": "Kaufmann A, Widmer M, Maden K (2010) Rapid Commun Mass Spectrom 24:2162\u20132170", "journal-title": "Rapid Commun Mass Spectrom"}, {"key": "5807_CR45", "doi-asserted-by": "crossref", "first-page": "561", "DOI": "10.2174/138920010792927343", "volume": "11", "author": "RA Ketola", "year": "2010", "unstructured": "Ketola RA, Hakala KS (2010) Curr Drug Metab 11:561\u2013582", "journal-title": "Curr Drug Metab"}, {"key": "5807_CR46", "doi-asserted-by": "crossref", "first-page": "3015", "DOI": "10.1002/rcm.3702", "volume": "22", "author": "JC Erve", "year": "2008", "unstructured": "Erve JC, Demaio W, Talaat RE (2008) Rapid Commun Mass Spectrom 22:3015\u20133026", "journal-title": "Rapid Commun Mass Spectrom"}, {"key": "5807_CR47", "unstructured": "Soderholm SL, Damm M, Kappe CO (2010) Mol Divers 14:869\u2013888", "DOI": "10.1007/s11030-010-9242-9", "doi-asserted-by": "crossref"}, {"key": "5807_CR48", "doi-asserted-by": "crossref", "first-page": "1234", "DOI": "10.1373/clinchem.2009.138602", "volume": "56", "author": "M Vogeser", "year": "2010", "unstructured": "Vogeser M, Seger C (2010) Clin Chem 56:1234\u20131244", "journal-title": "Clin Chem"}, {"key": "5807_CR49", "doi-asserted-by": "crossref", "first-page": "491", "DOI": "10.1002/mas.20298", "volume": "30", "author": "H Trufelli", "year": "2011", "unstructured": "Trufelli H, Palma P, Famiglini G, Cappiello A (2011) Mass Spectrom Rev 30:491\u2013509", "journal-title": "Mass Spectrom Rev"}, {"key": "5807_CR50", "doi-asserted-by": "crossref", "first-page": "1051", "DOI": "10.4155/bio.10.60", "volume": "2", "author": "DE Mulvana", "year": "2010", "unstructured": "Mulvana DE (2010) Bioanalysis 2:1051\u20131072", "journal-title": "Bioanalysis"}, {"key": "5807_CR51", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1002/jms.551", "volume": "39", "author": "M Holcapek", "year": "2004", "unstructured": "Holcapek M, Volna K, Jandera P, Kolarova L, Lemr K, Exner M, Cirkva A (2004) J Mass Spectrom 39:43\u201350", "journal-title": "J Mass Spectrom"}, {"key": "5807_CR52", "doi-asserted-by": "crossref", "first-page": "8618", "DOI": "10.1021/ac101757m", "volume": "82", "author": "AC Peterson", "year": "2010", "unstructured": "Peterson AC, McAlister GC, Quarmby ST, Griep-Raming J, Coon JJ (2010) Anal Chem 82:8618\u20138628", "journal-title": "Anal Chem"}, {"key": "5807_CR53", "doi-asserted-by": "crossref", "first-page": "1356", "DOI": "10.1002/rcm.4996", "volume": "25", "author": "JL Bushee", "year": "2011", "unstructured": "Bushee JL, Argikar UA (2011) Rapid Commun Mass Spectrom 25:1356\u20131362", "journal-title": "Rapid Commun Mass Spectrom"}, {"key": "5807_CR54", "doi-asserted-by": "crossref", "first-page": "9329", "DOI": "10.1021/ac101864u", "volume": "82", "author": "K Kittler", "year": "2010", "unstructured": "Kittler K, Preiss-Weigert A, These A (2010) Anal Chem 82:9329\u20139335", "journal-title": "Anal Chem"}, {"key": "5807_CR55", "doi-asserted-by": "crossref", "first-page": "3374", "DOI": "10.1021/es103489x", "volume": "45", "author": "A Wick", "year": "2011", "unstructured": "Wick A, Wagner M, Ternes TA (2011) Environ Sci Technol 45:3374\u20133385", "journal-title": "Environ Sci Technol"}, {"key": "5807_CR56", "doi-asserted-by": "crossref", "first-page": "7039", "DOI": "10.1021/es901979h", "volume": "43", "author": "S Kern", "year": "2009", "unstructured": "Kern S, Fenner K, Singer HP, Schwarzenbach RP, Hollender J (2009) Environ Sci Technol 43:7039\u20137046", "journal-title": "Environ Sci Technol"}, {"key": "5807_CR57", "doi-asserted-by": "crossref", "first-page": "3003", "DOI": "10.1002/rcm.4207", "volume": "23", "author": "AC Li", "year": "2009", "unstructured": "Li AC, Ding J, Jiang X, Denissen J (2009) Rapid Commun Mass Spectrom 23:3003\u20133012", "journal-title": "Rapid Commun Mass Spectrom"}, {"key": "5807_CR58", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1016/j.cbi.2008.09.014", "volume": "179", "author": "S Ma", "year": "2009", "unstructured": "Ma S, Zhu M (2009) Chem Biol Interact 179:25\u201337", "journal-title": "Chem Biol Interact"}, {"key": "5807_CR59", "doi-asserted-by": "crossref", "first-page": "25419", "DOI": "10.1074/jbc.R110.200055", "volume": "286", "author": "M Zhu", "year": "2011", "unstructured": "Zhu M, Zhang H, Humphreys WG (2011) J Biol Chem 286:25419\u201325425", "journal-title": "J Biol Chem"}, {"key": "5807_CR60", "doi-asserted-by": "crossref", "first-page": "1172", "DOI": "10.1002/rcm.4482", "volume": "24", "author": "S Abate", "year": "2010", "unstructured": "Abate S, Ahn YG, Kind T, Cataldi TR, Fiehn O (2010) Rapid Commun Mass Spectrom 24:1172\u20131180", "journal-title": "Rapid Commun Mass Spectrom"}, {"key": "5807_CR61", "doi-asserted-by": "crossref", "first-page": "8703", "DOI": "10.1021/ac2021823", "volume": "83", "author": "DJ Creek", "year": "2011", "unstructured": "Creek DJ, Jankevics A, Breitling R, Watson DG, Barrett MP, Burgess KE (2011) Anal Chem 83:8703\u20138710", "journal-title": "Anal Chem"}, {"key": "5807_CR62", "doi-asserted-by": "crossref", "first-page": "958", "DOI": "10.1002/jms.1462", "volume": "43", "author": "P Gartner", "year": "2008", "unstructured": "Gartner P, Hofbauer K, Reichel C, Geisendorfer T, Gmeiner G (2008) J Mass Spectrom 43:958\u2013964", "journal-title": "J Mass Spectrom"}, {"key": "5807_CR63", "doi-asserted-by": "crossref", "first-page": "643", "DOI": "10.1016/j.steroids.2010.03.010", "volume": "75", "author": "JP Scarth", "year": "2010", "unstructured": "Scarth JP, Clarke AD, Teale P, Pearce CM (2010) Steroids 75:643\u2013652", "journal-title": "Steroids"}, {"key": "5807_CR64", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1007/s00216-008-1882-6", "volume": "391", "author": "M Thevis", "year": "2008", "unstructured": "Thevis M, Kohler M, Thomas A, Maurer J, Schlorer N, Kamber M, Schanzer W (2008) Anal Bioanal Chem 391:251\u2013261", "journal-title": "Anal Bioanal Chem"}, {"key": "5807_CR65", "doi-asserted-by": "crossref", "first-page": "543", "DOI": "10.1007/s00216-010-4455-4", "volume": "401", "author": "M Thevis", "year": "2011", "unstructured": "Thevis M, Sigmund G, Gougoulidis V, Beuck S, Schlorer N, Thomas A, Kwiatkowska D, Pokrywka A, Schanzer W (2011) Anal Bioanal Chem 401:543\u2013551", "journal-title": "Anal Bioanal Chem"}], "container-title": ["Analytical and Bioanalytical Chemistry"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00216-012-5807-z.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00216-012-5807-z/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00216-012-5807-z", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 23]], "date-time": "2019-06-23T18:32:07Z", "timestamp": 1561314727000}, "score": 38.985172, "issued": {"date-parts": [[2012, 2, 16]]}, "references-count": 65, "journal-issue": {"published-print": {"date-parts": [[2012, 5]]}, "issue": "5"}, "alternative-id": ["5807"], "URL": "http://dx.doi.org/10.1007/s00216-012-5807-z", "relation": {"cites": []}, "ISSN": ["1618-2642", "1618-2650"], "issn-type": [{"value": "1618-2642", "type": "print"}, {"value": "1618-2650", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T22:17:00Z", "timestamp": 1574547420637}, "reference-count": 25, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2014, 9, 21]], "date-time": "2014-09-21T00:00:00Z", "timestamp": 1411257600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Anal Bioanal Chem"], "published-print": {"date-parts": [[2015, 1]]}, "DOI": "10.1007/s00216-014-8109-9", "type": "journal-article", "created": {"date-parts": [[2014, 9, 20]], "date-time": "2014-09-20T08:07:37Z", "timestamp": 1411200457000}, "page": "761-778", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 11, "title": ["GC-MS, LC-MSn, LC-high resolution-MSn, and NMR studies on the metabolism and toxicological detection of mesembrine and mesembrenone, the main alkaloids of the legal high \u201cKanna\u201d isolated from Sceletium tortuosum"], "prefix": "10.1007", "volume": "407", "author": [{"given": "Golo M. J.", "family": "Meyer", "sequence": "first", "affiliation": []}, {"given": "Carina S. D.", "family": "Wink", "sequence": "additional", "affiliation": []}, {"given": "Josef", "family": "Zapp", "sequence": "additional", "affiliation": []}, {"given": "Hans H.", "family": "Maurer", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2014, 9, 21]]}, "reference": [{"key": "8109_CR1", "doi-asserted-by": "crossref", "first-page": "1567", "DOI": "10.1002/elps.201100683", "volume": "33", "author": "J Roscher", "year": "2012", "unstructured": "Roscher J, Posch TN, Putz M, Huhn C (2012) Forensic analysis of mesembrine alkaloids in Sceletium tortuosum by nonaqueous capillary electrophoresis mass spectrometry. Electrophoresis 33:1567\u20131570", "journal-title": "Electrophoresis"}, {"key": "8109_CR2", "doi-asserted-by": "crossref", "first-page": "173", "DOI": "10.1076/phbi.36.3.173.6350", "volume": "36", "author": "MT Smith", "year": "1998", "unstructured": "Smith MT, Field CR, Crounch NR, Hirst M (1998) The distribution of mesembrine alkaloids in selected taxa of Kanna and their modification in the sceletium-derived Kougoed. Pharmacol Biol 36:173\u2013179", "journal-title": "Pharmacol Biol"}, {"key": "8109_CR3", "unstructured": "Martin NH, Rosenthal D, Jeffs PW (1976) Mass spectra of Sceletiumalkaloids. Org Mass Spectrom 11:1\u201319", "DOI": "10.1002/oms.1210110103", "doi-asserted-by": "crossref"}, {"key": "8109_CR4", "doi-asserted-by": "crossref", "first-page": "86", "DOI": "10.1016/j.jep.2008.10.008", "volume": "121", "author": "S Patnala", "year": "2009", "unstructured": "Patnala S, Kanfer I (2009) Investigations of the phytochemical content of Sceletium tortuosum following the preparation of Kougoed by fermentation of plant material. J Ethnopharmacol 121:86\u201391", "journal-title": "J Ethnopharmacol"}, {"key": "8109_CR5", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1016/0378-8741(95)01342-3", "volume": "50", "author": "MT Smith", "year": "1996", "unstructured": "Smith MT, Crouch NR, Gericke N, Hirst M (1996) Psychoactive constituents of the genus Sceletium N.E.Br. and other Mesembryanthemaceae: a review. J Ethnopharmacol 50:119\u2013130", "journal-title": "J Ethnopharmacol"}, {"key": "8109_CR6", "doi-asserted-by": "crossref", "first-page": "1124", "DOI": "10.1016/j.jep.2011.07.035", "volume": "137", "author": "AL Harvey", "year": "2011", "unstructured": "Harvey AL, Young LC, Viljoen AM, Gericke NP (2011) Pharmacological actions of the South African medicinal and functional food plant Sceletium tortuosum and its principal alkaloids. J Ethnopharmacol 137:1124\u20131129", "journal-title": "J Ethnopharmacol"}, {"key": "8109_CR7", "doi-asserted-by": "crossref", "first-page": "898", "DOI": "10.1089/acm.2012.0185", "volume": "19", "author": "H Nell", "year": "2013", "unstructured": "Nell H, Siebert M, Chellan P, Gericke N (2013) A randomized, double-blind, parallel-group, placebo-controlled trial of extract Sceletium tortuosum (Zembrin) in healthy adults. J Altern Complement Med 19:898\u2013904", "journal-title": "J Altern Complement Med"}, {"key": "8109_CR8", "doi-asserted-by": "crossref", "first-page": "2708", "DOI": "10.1038/npp.2013.183", "volume": "38", "author": "D Terburg", "year": "2013", "unstructured": "Terburg D, Syal S, Rosenberger LA, Heany S, Phillips N, Gericke N, Stein DJ, van Honk J (2013) Acute effects of Sceletium tortuosum (Zembrin), a dual 5-HT reuptake and PDE4 inhibitor, in the human amygdala and its connection to the hypothalamus. Neuropsychopharmacology 38:2708\u20132716", "journal-title": "Neuropsychopharmacology"}, {"key": "8109_CR9", "doi-asserted-by": "crossref", "first-page": "15", "DOI": "10.3109/15563650.2011.645952", "volume": "50", "author": "S Gibbons", "year": "2012", "unstructured": "Gibbons S (2012) \u201cLegal highs\u201d\u2014novel and emerging psychoactive drugs: a chemical overview for the toxicologist. Clin Toxicol (Phila) 50:15\u201324", "journal-title": "Clin Toxicol (Phila)"}, {"key": "8109_CR10", "doi-asserted-by": "crossref", "first-page": "24", "DOI": "10.1002/jms.3112", "volume": "48", "author": "GMJ Meyer", "year": "2013", "unstructured": "Meyer GMJ, Meyer MR, Wissenbach DK, Maurer HH (2013) Studies on the metabolism and toxicological detection of glaucine, an isoquinoline alkaloid from Glaucium flavum (Papaveraceae), in rat urine using GC-MS, LC-MSn, and LC-high-resolution MSn. J Mass Spectrom 48:24\u201341", "journal-title": "J Mass Spectrom"}, {"key": "8109_CR11", "author": "CSD Wink", "year": "2014", "unstructured": "Wink CSD, Meyer GMJ, Wissenbach DK, Jacobsen-Bauer A, Meyer MR, Maurer HH (2014) Lefetamine-derived designer drugs N-ethyl-1,2-diphenylethylamine (NEDPA) and N-iso-propyl-1,2-diphenylethylamine (NPDPA): metabolism and detectability in rat urine using GC-MS, LC-MSn and LC-high resolution (HR)-MS/MS. Drug Test Anal. doi: 10.1002/dta.1621", "journal-title": "Drug Test Anal"}, {"key": "8109_CR12", "author": "HH Maurer", "year": "2011", "unstructured": "Maurer HH, Pfleger K, Weber AA (2011) Mass spectral and GC data of drugs, poisons, pesticides, pollutants, and their metabolites. Wiley-VCH, Weinheim", "volume-title": "Mass spectral and GC data of drugs, poisons, pesticides, pollutants, and their metabolites"}, {"key": "8109_CR13", "doi-asserted-by": "crossref", "first-page": "3481", "DOI": "10.1007/s00216-011-5032-1", "volume": "400", "author": "DK Wissenbach", "year": "2011", "unstructured": "Wissenbach DK, Meyer MR, Remane D, Philipp AA, Weber AA, Maurer HH (2011) Drugs of abuse screening in urine as part of a metabolite-based LC-MS(n) screening concept. Anal Bioanal Chem 400:3481\u20133489", "journal-title": "Anal Bioanal Chem"}, {"key": "8109_CR14", "author": "HH Maurer", "year": "2014", "unstructured": "Maurer HH, Wissenbach DK, Weber AA (2014) Maurer/Wissenbach/Weber MWW LC-MSn Library of Drugs, Poisons, and their Metabolites. Wiley-VCH, Weinheim", "volume-title": "Maurer/Wissenbach/Weber MWW LC-MSn Library of Drugs, Poisons, and their Metabolites"}, {"key": "8109_CR15", "unstructured": "Malz F (2003) Quantitative NMR-[Specktroskopie als Referenzverfahren in der alaytischen Chemie (PhD thesis)], Humboldt-Universit\u00e4t Berlin, Germany"}, {"key": "8109_CR16", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1002/jms.2960", "volume": "47", "author": "MR Meyer", "year": "2012", "unstructured": "Meyer MR, Vollmar C, Schwaninger AE, Maurer HH (2012) New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine. J Mass Spectrom 47:253\u2013262", "journal-title": "J Mass Spectrom"}, {"key": "8109_CR17", "doi-asserted-by": "crossref", "first-page": "3125", "DOI": "10.1007/s00216-013-6741-4", "volume": "405", "author": "J Welter", "year": "2013", "unstructured": "Welter J, Meyer MR, Wolf E, Weinmann W, Kavanagh P, Maurer HH (2013) 2-Methiopropamine, a thiophene analogue of methamphetamine: studies on its metabolism and detectability in the rat and human using GC-MS and LC-(HR)-MS techniques. Anal Bioanal Chem 405:3125\u20133135", "journal-title": "Anal Bioanal Chem"}, {"key": "8109_CR18", "doi-asserted-by": "crossref", "first-page": "9779", "DOI": "10.1007/s00216-013-7419-7", "volume": "405", "author": "GMJ Meyer", "year": "2013", "unstructured": "Meyer GMJ, Maurer HH (2013) Qualitative metabolism assessment and toxicological detection of xylazine, a veterinary tranquilizer and drug of abuse, in rat and human urine using GC-MS, LC-MSn, and LC-HR-MSn. Anal Bioanal Chem 405:9779\u20139789", "journal-title": "Anal Bioanal Chem"}, {"key": "8109_CR19", "doi-asserted-by": "crossref", "first-page": "575", "DOI": "10.1373/clinchem.2009.135517", "volume": "56", "author": "MR Meyer", "year": "2010", "unstructured": "Meyer MR, Peters FT, Maurer HH (2010) Automated mass spectral deconvolution and identification system for GC-MS screening for drugs, poisons, and metabolites in urine. Clin Chem 56:575\u2013584", "journal-title": "Clin Chem"}, {"key": "8109_CR20", "doi-asserted-by": "crossref", "first-page": "190", "DOI": "10.1016/j.phytol.2011.03.003", "volume": "4", "author": "EA Shikanga", "year": "2011", "unstructured": "Shikanga EA, Viljoen A, Combrinck S, Marston A (2011) Isolation of Sceletium alkaloids by high-speed countercurrent chromatography. Phytochem Lett 4:190\u2013193", "journal-title": "Phytochem Lett"}, {"key": "8109_CR21", "doi-asserted-by": "crossref", "first-page": "5263", "DOI": "10.1016/j.tetlet.2004.05.021", "volume": "45", "author": "SP Chavan", "year": "2004", "unstructured": "Chavan SP, Khobragade DA, Pathak AB, Kalkote UR (2004) A simple and efficient synthesis of (\u00b1)-mesembrine. Tetrahedron Lett 45:5263\u20135265", "journal-title": "Tetrahedron Lett"}, {"key": "8109_CR22", "author": "PW Jeffs", "first-page": "1", "year": "1981", "unstructured": "Jeffs PW (1981) Sceletium Alkaloids. In: Manske RHF, Rodrigo RGA (eds) The Alkalods. Academic Press, London, pp 1\u201380", "volume-title": "The Alkalods"}, {"key": "8109_CR23", "doi-asserted-by": "crossref", "first-page": "478", "DOI": "10.1021/np50063a003", "volume": "52", "author": "J Batista", "year": "1989", "unstructured": "Batista J, Viladomat F, Liabres JM, Ramirez G, Codina C, Rubiralta M (1989) Narcissus alkaloids. VIII. Mesembrenone: an unexpected alkaloid from Narcissus pallidulus. J Nat Prod 52:478\u2013480", "journal-title": "J Nat Prod"}, {"key": "8109_CR24", "doi-asserted-by": "crossref", "first-page": "2703", "DOI": "10.1021/jo00932a008", "volume": "39", "author": "PW Jeffs", "year": "1974", "unstructured": "Jeffs PW, Capps T, Johnson DB, Karle JM, Martin NH, Rauckman B (1974) Sceletium alkaloids. VI. Minor alkaloids of S. namaquense and S. strictum. J Org Chem 39:2703\u20132710", "journal-title": "J Org Chem"}, {"key": "8109_CR25", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1146/annurev.pharmtox.47.120505.105337", "volume": "47", "author": "Y Jin", "year": "2007", "unstructured": "Jin Y, Penning TM (2007) Aldo-keto reductases and bioactivation/detoxication. Annu Rev Pharmacol Toxicol 47:263\u2013292", "journal-title": "Annu Rev Pharmacol Toxicol"}], "container-title": ["Analytical and Bioanalytical Chemistry"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00216-014-8109-9.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00216-014-8109-9/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00216-014-8109-9", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 23]], "date-time": "2019-05-23T17:18:50Z", "timestamp": 1558631930000}, "score": 38.514748, "issued": {"date-parts": [[2014, 9, 21]]}, "references-count": 25, "journal-issue": {"published-print": {"date-parts": [[2015, 1]]}, "issue": "3"}, "alternative-id": ["8109"], "URL": "http://dx.doi.org/10.1007/s00216-014-8109-9", "relation": {"cites": []}, "ISSN": ["1618-2642", "1618-2650"], "issn-type": [{"value": "1618-2642", "type": "print"}, {"value": "1618-2650", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T19:12:30Z", "timestamp": 1576782750972}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Therapeutic Drug Monitoring"], "published-print": {"date-parts": [[2019, 8]]}, "DOI": "10.1097/ftd.0000000000000694", "type": "journal-article", "created": {"date-parts": [[2019, 8, 17]], "date-time": "2019-08-17T07:46:49Z", "timestamp": 1566028009000}, "page": "1", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Current Situation of the Metabolomics Techniques Used for the Metabolism Studies of New Psychoactive Substances"], "prefix": "10.1097", "author": [{"given": "Sascha K.", "family": "Manier", "sequence": "first", "affiliation": []}, {"given": "Markus R.", "family": "Meyer", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Therapeutic Drug Monitoring"], "language": "en", "link": [{"URL": "http://journals.lww.com/drug-monitoring/Fulltext/10.1097/FTD.0000000000000694", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T17:36:51Z", "timestamp": 1576777011000}, "score": 36.425793, "subtitle": [""], "issued": {"date-parts": [[2019, 8]]}, "references-count": 0, "URL": "http://dx.doi.org/10.1097/ftd.0000000000000694", "ISSN": ["0163-4356"], "issn-type": [{"value": "0163-4356", "type": "print"}], "subject": ["Pharmacology (medical)", "Pharmacology"]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T20:18:14Z", "timestamp": 1575404294717}, "reference-count": 160, "publisher": "Elsevier", "isbn-type": [{"value": "9780124158160", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2013]]}, "DOI": "10.1016/b978-0-12-415816-0.00006-7", "type": "book-chapter", "created": {"date-parts": [[2013, 11, 25]], "date-time": "2013-11-25T16:09:16Z", "timestamp": 1385395756000}, "page": "131-157", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Analytical Techniques for the Detection of Novel Psychoactive Substances and Their Metabolites"], "prefix": "10.1016", "author": [{"given": "Frank T.", "family": "Peters", "sequence": "first", "affiliation": []}, {"given": "Markus R.", "family": "Meyer", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Novel Psychoactive Substances"], "deposited": {"date-parts": [[2018, 10, 8]], "date-time": "2018-10-08T19:22:41Z", "timestamp": 1539026561000}, "score": 35.221252, "issued": {"date-parts": [[2013]]}, "ISBN": ["9780124158160"], "references-count": 160, "URL": "http://dx.doi.org/10.1016/b978-0-12-415816-0.00006-7"}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T21:39:51Z", "timestamp": 1575409191925}, "reference-count": 34, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://creativecommons.org/licenses/by/4.0", "start": {"date-parts": [[2019, 2, 26]], "date-time": "2019-02-26T00:00:00Z", "timestamp": 1551139200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Sci Rep"], "published-print": {"date-parts": [[2019, 12]]}, "DOI": "10.1038/s41598-019-39235-w", "type": "journal-article", "created": {"date-parts": [[2019, 2, 26]], "date-time": "2019-02-26T11:49:58Z", "timestamp": 1551181798000}, "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Untargeted metabolomics by high resolution mass spectrometry coupled to normal and reversed phase liquid chromatography as a tool to study the in vitro biotransformation of new psychoactive substances"], "prefix": "10.1038", "volume": "9", "author": [{"ORCID": "http://orcid.org/0000-0002-7126-5263", "authenticated-orcid": false, "given": "Sascha K.", "family": "Manier", "sequence": "first", "affiliation": []}, {"ORCID": "http://orcid.org/0000-0002-5361-0895", "authenticated-orcid": false, "given": "Andreas", "family": "Keller", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Sch\u00e4per", "sequence": "additional", "affiliation": []}, {"given": "Markus R.", "family": "Meyer", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2019, 2, 26]]}, "reference": [{"key": "39235_CR1", "unstructured": "Maurer, H. H., Pfleger, K. & Weber, A. A. Mass spectral data of drugs, poisons, pesticides, pollutants and their metabolites. (Wiley-VCH, 2016)."}, {"key": "39235_CR2", "doi-asserted-by": "publisher", "first-page": "897", "DOI": "10.1007/s00216-017-0526-0", "volume": "410", "author": "AT Caspar", "year": "2018", "unstructured": "Caspar, A. T., Westphal, F., Meyer, M. R. & Maurer, H. H. LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening power with further MS techniques. Anal Bioanal Chem 410, 897\u2013912 (2018).", "journal-title": "Anal Bioanal Chem"}, {"key": "39235_CR3", "unstructured": "UNODC. (World Drug Report 2018)."}, {"key": "39235_CR4", "unstructured": "UNODC. World Drug Report 2018. Booklet 3. Analysis of drug markets - opioids, cocaine, cannabis, synthetic drugs."}, {"key": "39235_CR5", "doi-asserted-by": "publisher", "first-page": "483", "DOI": "10.1002/dta.295", "volume": "3", "author": "FT Peters", "year": "2011", "unstructured": "Peters, F. T. & Meyer, M. R. In vitro approaches to studying the metabolism of new psychoactive compounds. Drug Test Anal 3, 483\u2013495 (2011).", "journal-title": "Drug Test Anal"}, {"key": "39235_CR6", "unstructured": "Sinz, M. A. & Lyubimov, A. V. In Encyclopedia of Drug Metabolism and Interactions. (John Wiley & Sons, Inc., 2011)."}, {"key": "39235_CR7", "doi-asserted-by": "publisher", "first-page": "692", "DOI": "10.2174/1570159X14666161018151716", "volume": "15", "author": "JA Michely", "year": "2017", "unstructured": "Michely, J. A. et al. New Psychoactive Substances 3-Methoxyphencyclidine (3-MeO-PCP) and 3-Methoxyrolicyclidine (3-MeO-PCPy): Metabolic Fate Elucidated with Rat Urine and Human Liver Preparations and their Detectability in Urine by GC-MS, \u201cLC-(High Resolution)-MSn\u201d and \u201cLC-(High Resolution)-MS/MS\u201d. Curr Neuropharmacol 15, 692\u2013712 (2017).", "journal-title": "Curr Neuropharmacol"}, {"key": "39235_CR8", "doi-asserted-by": "publisher", "first-page": "7831", "DOI": "10.1007/s00216-015-8955-0", "volume": "407", "author": "JA Michely", "year": "2015", "unstructured": "Michely, J. A. et al. Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MS. Anal Bioanal Chem 407, 7831\u20137842 (2015).", "journal-title": "Anal Bioanal Chem"}, {"key": "39235_CR9", "doi-asserted-by": "publisher", "first-page": "184", "DOI": "10.1002/dta.2197", "volume": "10", "author": "AT Caspar", "year": "2018", "unstructured": "Caspar, A. T. et al. Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MS(n), and LC-HR-MS/MS. Drug Test Anal 10, 184\u2013195 (2018).", "journal-title": "Drug Test Anal"}, {"key": "39235_CR10", "first-page": "ii", "volume": "51", "author": "S Barnes", "year": "2016", "unstructured": "Barnes, S. et al. Training in metabolomics research. I. Designing the experiment, collecting and extracting samples and generating metabolomics data. J. Mass Spectrom. 51, ii\u2013iii (2016).", "journal-title": "J. Mass Spectrom."}, {"key": "39235_CR11", "first-page": "92", "volume": "1", "author": "B Worley", "year": "2013", "unstructured": "Worley, B. & Powers, R. Multivariate Analysis in Metabolomics. Curr Metabolomics 1, 92\u2013107 (2013).", "journal-title": "Curr Metabolomics"}, {"key": "39235_CR12", "doi-asserted-by": "publisher", "first-page": "181", "DOI": "10.1016/j.forsciint.2015.02.004", "volume": "249", "author": "S Matsuta", "year": "2015", "unstructured": "Matsuta, S. et al. Metabolism of the designer drug alpha-pyrrolidinobutiophenone (alpha-PBP) in humans: identification and quantification of the phase I metabolites in urine. Forensic Sci Int 249, 181\u2013188 (2015).", "journal-title": "Forensic Sci Int"}, {"key": "39235_CR13", "doi-asserted-by": "publisher", "first-page": "4845", "DOI": "10.1007/s00216-016-9599-4", "volume": "408", "author": "MJ Swortwood", "year": "2016", "unstructured": "Swortwood, M. J. et al. First metabolic profile of PV8, a novel synthetic cathinone, in human hepatocytes and urine by high-resolution mass spectrometry. Anal Bioanal Chem 408, 4845\u20134856 (2016).", "journal-title": "Anal Bioanal Chem"}, {"key": "39235_CR14", "unstructured": "Manier, S. K. et al. Different In vitro and In vivo tools for elucidating the human metabolism of alpha-cathinone-derived drugs of abuse. Drug Test Anal, \n                    https://doi.org/10.1002/dta.2355\n                    \n                   (2018).", "DOI": "10.1002/dta.2355", "doi-asserted-by": "publisher"}, {"key": "39235_CR15", "doi-asserted-by": "publisher", "first-page": "3125", "DOI": "10.1007/s00216-013-6741-4", "volume": "405", "author": "J Welter", "year": "2013", "unstructured": "Welter, J. et al. 2-methiopropamine, a thiophene analogue of methamphetamine: studies on its metabolism and detectability in the rat and human using GC-MS and LC-(HR)-MS techniques. Anal Bioanal Chem 405, 3125\u20133135 (2013).", "journal-title": "Anal Bioanal Chem"}, {"key": "39235_CR16", "unstructured": "Maurer, H. H., Meyer, M. R., Helfer, A. G. & Weber, A. A. Maurer/Meyer/Helfer/Weber MMHW LC-HR-MS/MS library of drugs, poisons, and their metabolites. (Wiley-VCH, 2018)."}, {"key": "39235_CR17", "doi-asserted-by": "publisher", "first-page": "221", "DOI": "10.1016/j.aca.2015.08.018", "volume": "891", "author": "AG Helfer", "year": "2015", "unstructured": "Helfer, A. G. et al. Orbitrap technology for comprehensive metabolite-based liquid chromatographic-high resolution-tandem mass spectrometric urine drug screening - exemplified for cardiovascular drugs. Anal. Chim. Acta 891, 221\u2013233 (2015).", "journal-title": "Anal. Chim. Acta"}, {"key": "39235_CR18", "doi-asserted-by": "publisher", "first-page": "123", "DOI": "10.1016/j.chroma.2017.09.034", "volume": "1521", "author": "L Wagmann", "year": "2017", "unstructured": "Wagmann, L., Maurer, H. H. & Meyer, M. R. An easy and fast adenosine 5\u2032-diphosphate quantification procedure based on hydrophilic interaction liquid chromatography-high resolution tandem mass spectrometry for determination of the In vitro adenosine 5\u2032-triphosphatase activity of the human breast cancer resistance protein ABCG2. J. Chromatogr. A 1521, 123\u2013130 (2017).", "journal-title": "J. Chromatogr. A"}, {"key": "39235_CR19", "unstructured": "Manier, S. K., Keller, A. & Meyer, M. R. Automated optimization of XCMS parameters for improved peak picking of liquid chromatography-mass spectrometry data using the coefficient of variation and parameter sweeping for untargeted metabolomics. Drug Test Anal, \n                    https://doi.org/10.1002/dta.2552\n                    \n                   (2018).", "DOI": "10.1002/dta.2552", "doi-asserted-by": "publisher"}, {"key": "39235_CR20", "author": "R Wehrens", "volume": "12", "year": "2016", "unstructured": "Wehrens, R. et al. Improved batch correction in untargeted MS-based metabolomics. Metabolomics 12, 88 (2016).", "journal-title": "Metabolomics", "DOI": "10.1007/s11306-016-1015-8", "doi-asserted-by": "publisher"}, {"key": "39235_CR21", "doi-asserted-by": "publisher", "first-page": "339", "DOI": "10.1007/978-1-4939-6747-6_23", "volume": "1550", "author": "R Adusumilli", "year": "2017", "unstructured": "Adusumilli, R. & Mallick, P. Data Conversion with ProteoWizard msConvert. Methods Mol Biol 1550, 339\u2013368 (2017).", "journal-title": "Methods Mol Biol"}, {"key": "39235_CR22", "doi-asserted-by": "publisher", "first-page": "779", "DOI": "10.1021/ac051437y", "volume": "78", "author": "CA Smith", "year": "2006", "unstructured": "Smith, C. A. et al. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal. Chem. 78, 779\u2013787 (2006).", "journal-title": "Anal. Chem."}, {"key": "39235_CR23", "unstructured": "R: A Language and Environment for Statistical Computing v. 3.4.1 (R Foundation for Statistical Computing, R Core Team)."}, {"key": "39235_CR24", "doi-asserted-by": "publisher", "first-page": "283", "DOI": "10.1021/ac202450g", "volume": "84", "author": "C Kuhl", "year": "2012", "unstructured": "Kuhl, C. et al. CAMERA: an integrated strategy for compound spectra extraction and annotation of liquid chromatography/mass spectrometry data sets. Anal. Chem. 84, 283\u2013289 (2012).", "journal-title": "Anal. Chem."}, {"key": "39235_CR25", "first-page": "3221", "volume": "15", "author": "L Maaten van der", "year": "2014", "unstructured": "van der Maaten, L. Accelerating t-SNE using Tree-Based Algorithms. J Mach Learn Res 15, 3221\u20133245 (2014).", "journal-title": "J Mach Learn Res"}, {"key": "39235_CR26", "first-page": "2579", "volume": "9", "author": "L Maaten van der", "year": "2008", "unstructured": "van der Maaten, L. & Hinton, G. Visualizing Data using t-SNE. J Mach Learn Res 9, 2579\u20132605 (2008).", "journal-title": "J Mach Learn Res"}, {"key": "39235_CR27", "doi-asserted-by": "publisher", "first-page": "819", "DOI": "10.1351/pac199365040819", "volume": "65", "author": "LS Ettre", "year": "1993", "unstructured": "Ettre, L. S. Nomenclature for Chromatography. Pure Appl Chem 65, 819\u2013872 (1993).", "journal-title": "Pure Appl Chem"}, {"key": "39235_CR28", "doi-asserted-by": "publisher", "first-page": "211", "DOI": "10.1007/s11306-007-0082-2", "volume": "3", "author": "LW Sumner", "year": "2007", "unstructured": "Sumner, L. W. et al. Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics 3, 211\u2013221 (2007).", "journal-title": "Metabolomics"}, {"key": "39235_CR29", "doi-asserted-by": "publisher", "first-page": "D521", "DOI": "10.1093/nar/gkl923", "volume": "35", "author": "DS Wishart", "year": "2007", "unstructured": "Wishart, D. S. et al. HMDB: the Human Metabolome Database. Nucleic Acids Res 35, D521\u2013526 (2007).", "journal-title": "Nucleic Acids Res"}, {"key": "39235_CR30", "doi-asserted-by": "publisher", "first-page": "411", "DOI": "10.1079/BJN2002689", "volume": "88", "author": "GC Burdge", "year": "2002", "unstructured": "Burdge, G. C. & Wootton, S. A. Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr 88, 411\u2013420 (2002).", "journal-title": "Br J Nutr"}, {"key": "39235_CR31", "doi-asserted-by": "publisher", "first-page": "357", "DOI": "10.2174/1389200003338929", "volume": "1", "author": "S Vickers", "year": "2000", "unstructured": "Vickers, S. & Polsky, S. L. The biotransformation of nitrogen containing xenobiotics to lactams. Curr Drug Metab 1, 357\u2013389 (2000).", "journal-title": "Curr Drug Metab"}, {"key": "39235_CR32", "doi-asserted-by": "publisher", "first-page": "1305", "DOI": "10.1002/jms.3642", "volume": "50", "author": "M Paul", "year": "2015", "unstructured": "Paul, M. et al. Identification of phase I and II metabolites of the new designer drug alpha-pyrrolidinohexiophenone (alpha-PHP) in human urine by liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS). J. Mass Spectrom. 50, 1305\u20131317 (2015).", "journal-title": "J. Mass Spectrom."}, {"key": "39235_CR33", "doi-asserted-by": "publisher", "first-page": "279", "DOI": "10.1007/s11419-015-0274-9", "volume": "33", "author": "N Shima", "year": "2015", "unstructured": "Shima, N. et al. Urinary excretion and metabolism of the \u03b1-pyrrolidinophenone designer drug 1-phenyl-2-(pyrrolidin-1-yl)octan-1-one (PV9) in humans. Forensic Toxicology 33, 279\u2013294 (2015).", "journal-title": "Forensic Toxicology"}, {"key": "39235_CR34", "doi-asserted-by": "publisher", "first-page": "65", "DOI": "10.4155/bio.15.237", "volume": "8", "author": "MJ Swortwood", "year": "2016", "unstructured": "Swortwood, M. J. et al. In vitro, in vivo and in silico metabolic profiling of alpha-pyrrolidinopentiothiophenone, a novel thiophene stimulant. Bioanalysis 8, 65\u201382 (2016).", "journal-title": "Bioanalysis"}], "container-title": ["Scientific Reports"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/s41598-019-39235-w.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/s41598-019-39235-w", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/s41598-019-39235-w.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 26]], "date-time": "2019-02-26T11:56:05Z", "timestamp": 1551182165000}, "score": 34.69219, "issued": {"date-parts": [[2019, 2, 26]]}, "references-count": 34, "journal-issue": {"published-print": {"date-parts": [[2019, 12]]}, "issue": "1"}, "alternative-id": ["39235"], "URL": "http://dx.doi.org/10.1038/s41598-019-39235-w", "relation": {"cites": []}, "ISSN": ["2045-2322"], "issn-type": [{"value": "2045-2322", "type": "electronic"}], "subject": ["Multidisciplinary"], "assertion": [{"value": "10 October 2018", "order": 1, "name": "received", "label": "Received", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "21 January 2019", "order": 2, "name": "accepted", "label": "Accepted", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "26 February 2019", "order": 3, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "The authors declare no competing interests.", "order": 1, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Competing Interests"}}], "article-number": "2741"}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T01:32:23Z", "timestamp": 1574559143150}, "reference-count": 40, "publisher": "Future Science Ltd", "issue": "17", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Bioanalysis"], "published-print": {"date-parts": [[2014, 8]]}, "DOI": "10.4155/bio.14.164", "type": "journal-article", "created": {"date-parts": [[2014, 11, 10]], "date-time": "2014-11-10T17:40:02Z", "timestamp": 1415641202000}, "page": "2275-2284", "source": "Crossref", "is-referenced-by-count": 29, "title": ["Current position of high-resolution MS for drug quantification in clinical & forensic toxicology"], "prefix": "10.4155", "volume": "6", "author": [{"given": "Markus R", "family": "Meyer", "sequence": "first", "affiliation": []}, {"given": "Andreas G", "family": "Helfer", "sequence": "additional", "affiliation": []}, {"given": "Hans H", "family": "Maurer", "sequence": "additional", "affiliation": []}], "member": "2641", "reference": [{"key": "B1", "DOI": "10.1016/j.forsciint.2006.05.019", "doi-asserted-by": "publisher"}, {"key": "B2", "DOI": "10.1016/j.chroma.2012.08.069", "doi-asserted-by": "publisher"}, {"key": "B3", "DOI": "10.2174/138920011795202910", "doi-asserted-by": "publisher"}, {"key": "B4", "DOI": "10.1007/s00216-011-4859-9", "doi-asserted-by": "publisher"}, {"key": "B5", "DOI": "10.1007/s00216-012-5807-z", "doi-asserted-by": "publisher"}, {"key": "B6", "DOI": "10.1007/s00216-012-5726-z", "doi-asserted-by": "publisher"}, {"key": "B7", "DOI": "10.1002/rcm.4952", "doi-asserted-by": "publisher"}, {"key": "B8", "DOI": "10.1021/ac4001223", "doi-asserted-by": "publisher"}, {"key": "B9", "DOI": "10.1074/mcp.O111.013698", "doi-asserted-by": "publisher"}, {"key": "B10", "DOI": "10.1002/rcm.6121", "doi-asserted-by": "publisher"}, {"key": "B11", "DOI": "10.1016/j.aca.2010.05.020", "doi-asserted-by": "publisher"}, {"key": "B12", "DOI": "10.1002/rcm.3207", "doi-asserted-by": "publisher"}, {"key": "B13", "DOI": "10.1002/jms.1921", "doi-asserted-by": "publisher"}, {"key": "B14", "DOI": "10.4155/bio.12.3", "doi-asserted-by": "publisher"}, {"key": "B15", "DOI": "10.4155/bio.13.87", "doi-asserted-by": "publisher"}, {"key": "B16", "DOI": "10.1093/jat/bks071", "doi-asserted-by": "publisher"}, {"key": "B17", "DOI": "10.1002/rcm.6439", "doi-asserted-by": "publisher"}, {"key": "B18", "DOI": "10.1007/s00216-011-5641-8", "doi-asserted-by": "publisher"}, {"key": "B19", "DOI": "10.1016/j.jpba.2011.03.045", "doi-asserted-by": "publisher"}, {"key": "B20", "DOI": "10.1002/rcm.6628", "doi-asserted-by": "publisher"}, {"key": "B21", "DOI": "10.4155/bio.13.100", "doi-asserted-by": "publisher"}, {"key": "B22", "DOI": "10.1016/j.clinbiochem.2010.08.008", "doi-asserted-by": "publisher"}, {"key": "B23", "author": "European Communities", "volume": "221", "first-page": "8", "year": "2002", "journal-title": "Off. J. Eur. Commun."}, {"key": "B24", "DOI": "10.5740/jaoacint.11-074", "doi-asserted-by": "publisher"}, {"key": "B25", "DOI": "10.4155/bio.13.70", "doi-asserted-by": "publisher"}, {"key": "B26", "DOI": "10.1016/j.chroma.2013.11.054", "doi-asserted-by": "publisher"}, {"key": "B27", "DOI": "10.1021/ac403672u", "doi-asserted-by": "publisher"}, {"key": "B28", "DOI": "10.1002/jms.2958", "doi-asserted-by": "publisher"}, {"key": "B29", "DOI": "10.1016/j.jchromb.2012.04.013", "doi-asserted-by": "publisher"}, {"key": "B30", "DOI": "10.1016/j.jpba.2013.11.010", "doi-asserted-by": "publisher"}, {"key": "B31", "DOI": "10.1007/s00216-011-4742-8", "doi-asserted-by": "publisher"}, {"key": "B32", "DOI": "10.1007/s00216-013-7386-z", "doi-asserted-by": "publisher"}, {"key": "B33", "DOI": "10.1039/c0an00850h", "doi-asserted-by": "publisher"}, {"key": "B34", "DOI": "10.1016/j.chroma.2011.07.050", "doi-asserted-by": "publisher"}, {"key": "B35", "DOI": "10.1016/j.chroma.2013.06.028", "doi-asserted-by": "publisher"}, {"key": "B36", "DOI": "10.1002/rcm.5178", "doi-asserted-by": "publisher"}, {"key": "B37", "DOI": "10.1016/j.forsciint.2012.12.013", "doi-asserted-by": "publisher"}, {"key": "B38", "DOI": "10.1002/jms.1929", "doi-asserted-by": "publisher"}, {"key": "B39", "DOI": "10.1016/j.jchromb.2011.08.025", "doi-asserted-by": "publisher"}, {"key": "B40", "DOI": "10.1002/rcm.6461", "doi-asserted-by": "publisher"}], "container-title": ["Bioanalysis"], "language": "en", "link": [{"URL": "http://www.future-science.com/doi/pdf/10.4155/bio.14.164", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T09:53:31Z", "timestamp": 1574243611000}, "score": 34.607834, "issued": {"date-parts": [[2014, 8]]}, "references-count": 40, "journal-issue": {"published-print": {"date-parts": [[2014, 8]]}, "issue": "17"}, "alternative-id": ["10.4155/bio.14.164"], "URL": "http://dx.doi.org/10.4155/bio.14.164", "relation": {"cites": []}, "ISSN": ["1757-6180", "1757-6199"], "issn-type": [{"value": "1757-6180", "type": "print"}, {"value": "1757-6199", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T22:42:45Z", "timestamp": 1574721765896}, "reference-count": 36, "publisher": "Springer Science and Business Media LLC", "issue": "25", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2015, 8, 22]], "date-time": "2015-08-22T00:00:00Z", "timestamp": 1440201600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Anal Bioanal Chem"], "published-print": {"date-parts": [[2015, 10]]}, "DOI": "10.1007/s00216-015-8955-0", "type": "journal-article", "created": {"date-parts": [[2015, 8, 21]], "date-time": "2015-08-21T07:55:39Z", "timestamp": 1440143739000}, "page": "7831-7842", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 25, "title": ["Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC\u2013MS, LC\u2013MS n , and LC\u2013HR\u2013MS\u2013MS"], "prefix": "10.1007", "volume": "407", "author": [{"given": "Julian A.", "family": "Michely", "sequence": "first", "affiliation": []}, {"given": "Andreas G.", "family": "Helfer", "sequence": "additional", "affiliation": []}, {"given": "Simon D.", "family": "Brandt", "sequence": "additional", "affiliation": []}, {"given": "Markus R.", "family": "Meyer", "sequence": "additional", "affiliation": []}, {"given": "Hans H.", "family": "Maurer", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2015, 8, 22]]}, "reference": [{"key": "8955_CR1", "unstructured": "United Nations Office on Drugs and Crime (UNODC) (2014) World Drug Report 2014. http://www.unodc.org/documents/data-and-analysis/WDR2014/World_Drug_Report_2014_web.pdf"}, {"key": "8955_CR2", "doi-asserted-by": "crossref", "first-page": "587", "DOI": "10.1002/dta.1686", "volume": "6", "author": "SD Brandt", "year": "2014", "unstructured": "Brandt SD, King LA, Evans-Brown M (2014) The new drug phenomenon. Drug Test Anal 6:587\u2013597", "journal-title": "Drug Test Anal"}, {"key": "8955_CR3", "doi-asserted-by": "crossref", "first-page": "225", "DOI": "10.1007/s00216-013-7425-9", "volume": "406", "author": "MR Meyer", "year": "2014", "unstructured": "Meyer MR, Caspar A, Brandt SD, Maurer HH (2014) A qualitative/quantitative approach for the detection of 37 tryptamine-derived designer drugs, 5 beta-carbolines, ibogaine, and yohimbine in human urine and plasma using standard urine screening and multi-analyte approaches. Anal Bioanal Chem 406:225\u2013237", "journal-title": "Anal Bioanal Chem"}, {"key": "8955_CR4", "doi-asserted-by": "crossref", "first-page": "4135", "DOI": "10.1007/s00213-014-3557-7", "volume": "231", "author": "BE Blough", "year": "2014", "unstructured": "Blough BE, Landavazo A, Decker AM, Partilla JS, Baumann MH, Rothman RB (2014) Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes. Psychopharmacology (Berl) 231:4135\u20134144", "journal-title": "Psychopharmacology (Berl)"}, {"key": "8955_CR5", "doi-asserted-by": "crossref", "first-page": "1591", "DOI": "10.1007/s00702-009-0308-8", "volume": "116", "author": "NV Cozzi", "year": "2009", "unstructured": "Cozzi NV, Gopalakrishnan A, Anderson LL, Feih JT, Shulgin AT, Daley PF, Ruoho AE (2009) Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter. J Neural Transm 116:1591\u20131599", "journal-title": "J Neural Transm"}, {"key": "8955_CR6", "doi-asserted-by": "crossref", "first-page": "364", "DOI": "10.1016/j.neuropharm.2011.01.017", "volume": "61", "author": "AL Halberstadt", "year": "2011", "unstructured": "Halberstadt AL, Geyer MA (2011) Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. Neuropharmacology 61:364\u2013381", "journal-title": "Neuropharmacology"}, {"key": "8955_CR7", "doi-asserted-by": "crossref", "first-page": "1548", "DOI": "10.1177/0269881110388326", "volume": "25", "author": "AL Halberstadt", "year": "2011", "unstructured": "Halberstadt AL, Koedood L, Powell SB, Geyer MA (2011) Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice. J Psychopharmacol 25:1548\u20131561", "journal-title": "J Psychopharmacol"}, {"key": "8955_CR8", "doi-asserted-by": "crossref", "first-page": "559", "DOI": "10.1002/wmts.42", "volume": "1", "author": "DE Nichols", "year": "2012", "unstructured": "Nichols DE (2012) Structure-activity relationships of serotonin 5-HT2A agonists. WIREs Membr Transport Signaling 1:559\u2013579", "journal-title": "WIREs Membr Transport Signaling"}, {"key": "8955_CR9", "unstructured": "Shulgin AT (2003) Basic pharmacology and effects. In: Laing R R, Halluinogens A Forensic drug handbook. Elsevier Science, London, 67\u2013137"}, {"key": "8955_CR10", "unstructured": "Shulgin AT, Shulgin A (2004) 5-MeO-DALT. http://isomerdesign.com/PiHKAL/read.php?domain=tk&id=56"}, {"key": "8955_CR11", "unstructured": "Shulgin AT, Shulgin A (2004) DALT. http://isomerdesign.com/PiHKAL/read.php?domain=tk&id=57"}, {"key": "8955_CR12", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.1016/j.pnpbp.2012.05.022", "volume": "39", "author": "JM Corkery", "year": "2012", "unstructured": "Corkery JM, Durkin E, Elliott S, Schifano F, Ghodse AH (2012) The recreational tryptamine 5-MeO-DALT (N, N-diallyl-5-methoxytryptamine): a brief review. Prog Neuropsychopharmacol Biol Psychiatry 39:259\u2013262", "journal-title": "Prog Neuropsychopharmacol Biol Psychiatry"}, {"key": "8955_CR13", "doi-asserted-by": "crossref", "first-page": "844", "DOI": "10.1111/1556-4029.12367", "volume": "59", "author": "A Jovel", "year": "2014", "unstructured": "Jovel A, Felthous A, Bhattacharyya A (2014) Delirium due to intoxication from the novel synthetic tryptamine 5-MeO-DALT. J Forensic Sci 59:844\u2013846", "journal-title": "J Forensic Sci"}, {"key": "8955_CR14", "doi-asserted-by": "crossref", "first-page": "858", "DOI": "10.1016/j.trac.2010.04.008", "volume": "29", "author": "SD Brandt", "year": "2010", "unstructured": "Brandt SD, Martins CPB (2010) Analytical methods for psychoactive N, N-dialkylated tryptamines. Trends Anal Chem 29:858\u2013869", "journal-title": "Trends Anal Chem"}, {"key": "8955_CR15", "doi-asserted-by": "crossref", "first-page": "636", "DOI": "10.1002/dta.1343", "volume": "4", "author": "A Gaujac", "year": "2012", "unstructured": "Gaujac A, Navickiene S, Collins MI, Brandt SD, de Andrade JB (2012) Analytical techniques for the determination of tryptamines and beta-carbolines in plant matrices and in psychoactive beverages consumed during religious ceremonies and neo-shamanic urban practices. Drug Test Anal 4:636\u2013648", "journal-title": "Drug Test Anal"}, {"key": "8955_CR16", "doi-asserted-by": "crossref", "first-page": "328", "DOI": "10.1097/FTD.0b013e3181dcb40c", "volume": "32", "author": "M Katagi", "year": "2010", "unstructured": "Katagi M, Kamata T, Zaitsu K, Shima N, Kamata H, Nakanishi K, Nishioka H, Miki A, Tsuchihashi H (2010) Metabolism and toxicologic analysis of tryptamine-derived drugs of abuse. Ther Drug Monit 32:328\u2013331", "journal-title": "Ther Drug Monit"}, {"key": "8955_CR17", "doi-asserted-by": "crossref", "first-page": "423", "DOI": "10.1002/jlcr.1557", "volume": "51", "author": "SD Brandt", "year": "2008", "unstructured": "Brandt SD, Tirunarayanapuram SS, Freeman S, Dempster N, Barker SA, Daley PF, Cozzi NV, Martins CPB (2008) Microwave-accelerated synthesis of psychoactive deuterated N, N-dialkylated-[alpha, alpha, beta, beta-d(4)]-tryptamines. J Label Compd Radiopharm 51:423\u2013429", "journal-title": "J Label Compd Radiopharm"}, {"key": "8955_CR18", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1007/s00216-010-4398-9", "volume": "400", "author": "DK Wissenbach", "year": "2011", "unstructured": "Wissenbach DK, Meyer MR, Remane D, Weber AA, Maurer HH (2011) Development of the first metabolite-based LC\u2013MSn urine drug screening procedure - exemplified for antidepressants. Anal Bioanal Chem 400:79\u201388", "journal-title": "Anal Bioanal Chem"}, {"key": "8955_CR19", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1002/jms.2960", "volume": "47", "author": "MR Meyer", "year": "2012", "unstructured": "Meyer MR, Vollmar C, Schwaninger AE, Maurer HH (2012) New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC\u2013MS and LC-high-resolution MS and their detectability in urine. J Mass Spectrom 47:253\u2013262", "journal-title": "J Mass Spectrom"}, {"key": "8955_CR20", "doi-asserted-by": "crossref", "first-page": "368", "DOI": "10.1002/dta.1682", "volume": "7", "author": "AG Helfer", "year": "2015", "unstructured": "Helfer AG, Turcant A, Boels D, Ferec S, Lelievre B, Welter J, Meyer MR, Maurer HH (2015) Elucidation of the metabolites of the novel psychoactive substance 4-methyl-N-ethyl-cathinone (4-MEC) in human urine and pooled liver microsomes by GC\u2013MS and LC\u2013HR\u2013MS\u2013MS techniques and of its detectability by GC\u2013MS or LC\u2013MS n standard screening approaches. Drug Test Anal 7:368\u2013375", "journal-title": "Drug Test Anal"}, {"key": "8955_CR21", "author": "HH Maurer", "year": "2011", "unstructured": "Maurer HH, Pfleger K, Weber AA (2011) Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites. Wiley-VCH, Weinheim (Germany)", "volume-title": "Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites"}, {"key": "8955_CR22", "doi-asserted-by": "crossref", "first-page": "3815", "DOI": "10.1007/s00216-014-7796-6", "volume": "406", "author": "J Welter", "year": "2014", "unstructured": "Welter J, Kavanagh P, Maurer HH (2014) GC\u2013MS and LC-(high-resolution)-MS n studies on the metabolic fate and detectability of camfetamine in rat urine. Anal Bioanal Chem 406:3815\u20133829", "journal-title": "Anal Bioanal Chem"}, {"key": "8955_CR23", "author": "HH Maurer", "year": "2015", "unstructured": "Maurer HH, Pfleger K, Weber AA (2015) Mass spectral library of drugs, poisons, pesticides, pollutants and their metabolites. Wiley-VCH, Weinheim", "volume-title": "Mass spectral library of drugs, poisons, pesticides, pollutants and their metabolites"}, {"key": "8955_CR24", "doi-asserted-by": "crossref", "first-page": "575", "DOI": "10.1373/clinchem.2009.135517", "volume": "56", "author": "MR Meyer", "year": "2010", "unstructured": "Meyer MR, Peters FT, Maurer HH (2010) Automated mass spectral deconvolution and identification system for GC\u2013MS screening for drugs, poisons, and metabolites in urine. Clin Chem 56:575\u2013584", "journal-title": "Clin Chem"}, {"key": "8955_CR25", "author": "HH Maurer", "year": "2014", "unstructured": "Maurer HH, Wissenbach DK, Weber AA (2014) Maurer/Wissenbach/Weber MWW LC\u2013MSn Library of drugs, poisons, and their metabolites. Wiley-VCH, Weinheim", "volume-title": "Maurer/Wissenbach/Weber MWW LC\u2013MSn Library of drugs, poisons, and their metabolites"}, {"key": "8955_CR26", "doi-asserted-by": "crossref", "first-page": "626", "DOI": "10.1002/mas.20332", "volume": "30", "author": "WMA Niessen", "year": "2011", "unstructured": "Niessen WMA (2011) Fragmentation of toxicologically relevant drugs in positive-ion liquid chromatography-tandem mass spectrometry. Mass Spectrom Rev 30:626\u2013663", "journal-title": "Mass Spectrom Rev"}, {"key": "8955_CR27", "author": "AT Caspar", "year": "2015", "unstructured": "Caspar AT, Helfer AG, Michely JA, Auwaerter V, Brandt SD, Meyer MR, Maurer HH (2015) Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC\u2013MS, LC\u2013MSn, and LC\u2013HR\u2013MS\u2013MS. Anal Bioanal Chem. doi: 10.1007/s00216-015-8828-6", "journal-title": "Anal Bioanal Chem"}, {"key": "8955_CR28", "doi-asserted-by": "crossref", "first-page": "1371", "DOI": "10.1007/s00216-014-8360-0", "volume": "407", "author": "J Welter", "year": "2015", "unstructured": "Welter J, Kavanagh P, Meyer MR, Maurer HH (2015) Benzofuran analogues of amphetamine and methamphetamine: studies on the metabolism and toxicological analysis of 5-APB and 5-MAPB in urine and plasma using GC\u2013MS and LC-(HR)-MS n techniques. Anal Bioanal Chem 407:1371\u20131388", "journal-title": "Anal Bioanal Chem"}, {"key": "8955_CR29", "doi-asserted-by": "crossref", "first-page": "831", "DOI": "10.1007/s00216-014-8083-2", "volume": "407", "author": "CSD Wink", "year": "2015", "unstructured": "Wink CSD, Meyer MR, Braun T, Turcant A, Maurer HH (2015) Biotransformation and detectability of the designer drug 2,5-dimethoxy-4-propylphenethylamine (2C-P) studied in urine by GC\u2013MS, LC\u2013MS n and LC-high resolution-MS n . Anal Bioanal Chem 407:831\u2013843", "journal-title": "Anal Bioanal Chem"}, {"key": "8955_CR30", "doi-asserted-by": "crossref", "first-page": "746", "DOI": "10.1002/dta.1559", "volume": "6", "author": "MR Meyer", "year": "2014", "unstructured": "Meyer MR, Mauer S, Meyer GMJ, Dinger J, Klein B, Westphal F, Maurer HH (2014) The in vivo and in vitro metabolism and the detectability in urine of 3',4'-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC\u2013MS and LC\u2013MSn. Drug Test Anal 6:746\u2013756", "journal-title": "Drug Test Anal"}, {"key": "8955_CR31", "doi-asserted-by": "crossref", "first-page": "3125", "DOI": "10.1007/s00216-013-6741-4", "volume": "405", "author": "J Welter", "year": "2013", "unstructured": "Welter J, Meyer MR, Wolf E, Weinmann W, Kavanagh P, Maurer HH (2013) 2-Methiopropamine, a thiophene analogue of methamphetamine: studies on its metabolism and detectability in the rat and human using GC\u2013MS and LC-(HR)-MS techniques. Anal Bioanal Chem 405:3125\u20133135", "journal-title": "Anal Bioanal Chem"}, {"key": "8955_CR32", "doi-asserted-by": "crossref", "first-page": "1225", "DOI": "10.1007/s00216-010-3636-5", "volume": "397", "author": "MR Meyer", "year": "2010", "unstructured": "Meyer MR, Wilhelm J, Peters FT, Maurer HH (2010) Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry. Anal Bioanal Chem 397:1225\u20131233", "journal-title": "Anal Bioanal Chem"}, {"key": "8955_CR33", "doi-asserted-by": "crossref", "first-page": "2379", "DOI": "10.1007/s00216-009-3239-1", "volume": "396", "author": "AA Philipp", "year": "2010", "unstructured": "Philipp AA, Wissenbach DK, Weber AA, Zapp J, Zoerntlein SW, Klein ON, Kanogsunthornrat J, Maurer HH (2010) Use of liquid chromatography coupled to low- and high-resolution linear ion trap mass spectrometry for studying the metabolism of paynantheine, an alkaloid of the herbal drug Kratom in rat and human urine. Anal Bioanal Chem 396:2379\u20132391", "journal-title": "Anal Bioanal Chem"}, {"key": "8955_CR34", "doi-asserted-by": "crossref", "first-page": "1344", "DOI": "10.1002/jms.1848", "volume": "45", "author": "AA Philipp", "year": "2010", "unstructured": "Philipp AA, Wissenbach DK, Weber AA, Zapp J, Maurer HH (2010) Phase I and II metabolites of speciogynine, a diastereomer of the main Kratom alkaloid mitragynine, identified in rat and human urine by liquid chromatography coupled to low and high resolution linear ion trap mass spectrometry. J Mass Spectrom 45:1344\u20131357", "journal-title": "J Mass Spectrom"}, {"key": "8955_CR35", "doi-asserted-by": "crossref", "first-page": "907", "DOI": "10.1111/j.1476-5381.2009.00267.x", "volume": "157", "author": "V Sharma", "year": "2009", "unstructured": "Sharma V, McNeill JH (2009) To scale or not to scale: the principles of dose extrapolation. Br J Pharmacol 157:907\u2013921", "journal-title": "Br J Pharmacol"}, {"key": "8955_CR36", "doi-asserted-by": "crossref", "first-page": "1915", "DOI": "10.1002/hlca.19580410703", "volume": "41", "author": "E Kovats", "year": "1958", "unstructured": "Kovats E (1958) Gaschromatographische Charakterisierung organischer Verbindungen. Teil 1. Retentionsindices aliphatischer Halogenide, Alkohole, Aldehyde und Ketone. Helv Chim Acta 41:1915\u20131932", "journal-title": "Helv Chim Acta"}], "container-title": ["Analytical and Bioanalytical Chemistry"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00216-015-8955-0.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00216-015-8955-0/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00216-015-8955-0", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 23]], "date-time": "2019-05-23T17:17:46Z", "timestamp": 1558631866000}, "score": 34.536896, "issued": {"date-parts": [[2015, 8, 22]]}, "references-count": 36, "journal-issue": {"published-print": {"date-parts": [[2015, 10]]}, "issue": "25"}, "alternative-id": ["8955"], "URL": "http://dx.doi.org/10.1007/s00216-015-8955-0", "relation": {"cites": []}, "ISSN": ["1618-2642", "1618-2650"], "issn-type": [{"value": "1618-2642", "type": "print"}, {"value": "1618-2650", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T01:03:51Z", "timestamp": 1574816631584}, "reference-count": 34, "publisher": "Wiley", "issue": "1", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2017, 8, 31]], "date-time": "2017-08-31T00:00:00Z", "timestamp": 1504137600000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://onlinelibrary.wiley.com/termsAndConditions#vor", "start": {"date-parts": [[2017, 8, 31]], "date-time": "2017-08-31T00:00:00Z", "timestamp": 1504137600000}, "delay-in-days": 0, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drug Test. Analysis"], "published-print": {"date-parts": [[2018, 1]]}, "DOI": "10.1002/dta.2255", "type": "journal-article", "created": {"date-parts": [[2017, 7, 29]], "date-time": "2017-07-29T13:06:38Z", "timestamp": 1501333598000}, "page": "158-163", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Power of Orbitrap-based LC-high resolution-MS/MS for comprehensive drug testing in urine with or without conjugate cleavage or using dried urine spots after on-spot cleavage in comparison to established LC-MSn\n or GC-MS procedures"], "prefix": "10.1002", "volume": "10", "author": [{"given": "Julian A.", "family": "Michely", "sequence": "first", "affiliation": [{"name": "Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical, Pharmacology and Toxicology; Saarland University; Homburg Saar Germany"}]}, {"ORCID": "http://orcid.org/0000-0003-4377-6784", "authenticated-orcid": false, "given": "Markus R.", "family": "Meyer", "sequence": "additional", "affiliation": [{"name": "Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical, Pharmacology and Toxicology; Saarland University; Homburg Saar Germany"}]}, {"ORCID": "http://orcid.org/0000-0003-4579-4660", "authenticated-orcid": false, "given": "Hans H.", "family": "Maurer", "sequence": "additional", "affiliation": [{"name": "Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical, Pharmacology and Toxicology; Saarland University; Homburg Saar Germany"}]}], "member": "311", "published-online": {"date-parts": [[2017, 8, 31]]}, "reference": [{"issue": "1", "key": "10.1002/dta.2255-BIB0001|dta2255-cit-0002", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1007/s00216-010-4398-9", "article-title": "Development of the first metabolite-based LC-MS(n) urine drug screening procedure-exemplified for antidepressants", "volume": "400", "author": "Wissenbach", "year": "2011", "journal-title": "Anal Bioanal Chem"}, {"issue": "1", "key": "10.1002/dta.2255-BIB0002|dta2255-cit-0003", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1007/s00216-010-4450-9", "article-title": "Development and practical application of a library of CID accurate mass spectra of more than 2,500 toxic compounds for systematic toxicological analysis by LC-QTOF-MS with data-dependent acquisition", "volume": "400", "author": "Broecker", "year": "2011", "journal-title": "Anal Bioanal Chem"}, {"issue": "7", "key": "10.1002/dta.2255-BIB0003|dta2255-cit-0004", "doi-asserted-by": "crossref", "first-page": "477", "DOI": "10.1093/jat/bks061", "article-title": "Rapid screening for 67 drugs and metabolites in serum or plasma by accurate-mass LC-TOF-MS", "volume": "36", "author": "Marin", "year": "2012", "journal-title": "J Anal Toxicol"}, {"issue": "13", "key": "10.1002/dta.2255-BIB0004|dta2255-cit-0005", "doi-asserted-by": "crossref", "first-page": "2081", "DOI": "10.1002/jssc.201200921", "article-title": "Screening for illicit and medicinal drugs in whole blood using fully automated SPE and ultra-high-performance liquid chromatography with TOF-MS with data-independent acquisition", "volume": "36", "author": "Pedersen", "year": "2013", "journal-title": "J Sep Sci"}, {"key": "10.1002/dta.2255-BIB0005|dta2255-cit-0006", "doi-asserted-by": "crossref", "first-page": "46", "DOI": "10.1016/j.cca.2016.01.017", "article-title": "Fully automated semi-quantitative toxicological screening in three biological matrices using turbulent flow chromatography/high resolution mass spectrometry", "volume": "455", "author": "Roche", "year": "2016", "journal-title": "Clin Chim Acta"}, {"key": "10.1002/dta.2255-BIB0006|dta2255-cit-0007", "doi-asserted-by": "crossref", "first-page": "84", "DOI": "10.1016/j.forsciint.2014.04.035", "article-title": "'Psychotropics caught in a trap' - adopting a screening approach to specific needs", "volume": "243", "author": "Kempf", "year": "2014", "journal-title": "Forensic Sci Int"}, {"issue": "6", "key": "10.1002/dta.2255-BIB0007|dta2255-cit-0008", "doi-asserted-by": "crossref", "first-page": "467", "DOI": "10.2174/1386207003331355", "article-title": "Screening procedures for simultaneous detection of several drug classes used for high throughput toxicological analyses and doping control. A review", "volume": "3", "author": "Maurer", "year": "2000", "journal-title": "Comb Chem High Throughput Screen"}, {"key": "10.1002/dta.2255-BIB0008|dta2255-cit-0009", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.1016/j.aca.2016.04.046", "article-title": "Review: LC coupled to low- and high-resolution mass spectrometry for new psychoactive substance screening in biological matrices - where do we stand today?", "volume": "927", "author": "Meyer", "year": "2016", "journal-title": "Anal Chim Acta"}, {"key": "10.1002/dta.2255-BIB0009|dta2255-cit-0010", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.1016/j.chroma.2012.08.069", "article-title": "What is the future of (ultra) high performance liquid chromatography coupled to low and high resolution mass spectrometry for toxicological drug screening?", "volume": "1292", "author": "Maurer", "year": "2013", "journal-title": "J Chromatogr A"}, {"key": "10.1002/dta.2255-BIB0010|dta2255-cit-0011", "doi-asserted-by": "crossref", "first-page": "92", "DOI": "10.1016/j.chroma.2013.11.054", "article-title": "Direct analysis of the mushroom poisons alpha- and beta-amanitin in human urine using a novel on-line turbulent flow chromatography mode coupled to liquid chromatography-high resolution-mass spectrometry/mass spectrometry", "volume": "1325", "author": "Helfer", "year": "2014", "journal-title": "J Chromatogr A"}, {"key": "10.1002/dta.2255-BIB0011|dta2255-cit-0012", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1016/j.aca.2015.08.018", "article-title": "Orbitrap technology for comprehensive metabolite-based liquid chromatographic-high resolution-tandem mass spectrometric urine drug screening - exemplified for cardiovascular drugs", "volume": "891", "author": "Helfer", "year": "2015", "journal-title": "Anal Chim Acta"}, {"issue": "2", "key": "10.1002/dta.2255-BIB0012|dta2255-cit-0013", "doi-asserted-by": "crossref", "first-page": "117", "DOI": "10.1002/jms.3328", "article-title": "A comprehensive library-based, automated screening procedure for 46 synthetic cannabinoids in serum employing liquid chromatography-quadrupole ion trap mass spectrometry with high-temperature electrospray ionization", "volume": "49", "author": "Huppertz", "year": "2014", "journal-title": "J Mass Spectrom"}, {"key": "10.1002/dta.2255-BIB0013|dta2255-cit-0014", "doi-asserted-by": "crossref", "first-page": "138", "DOI": "10.1016/j.jchromb.2016.06.036", "article-title": "LC-HR-MS/MS standard urine screening approach: Pros and cons of automated on-line extraction by turbulent flow chromatography versus dilute-and-shoot and comparison with established urine precipitation", "volume": "1043", "author": "Helfer", "year": "2017", "journal-title": "J Chromatogr B Analyt Technol Biomed Life Sci"}, {"issue": "9", "key": "10.1002/dta.2255-BIB0014|dta2255-cit-0015", "doi-asserted-by": "crossref", "first-page": "2161", "DOI": "10.1007/s00204-016-1764-1", "article-title": "High-resolution mass spectrometry in toxicology: Current status and future perspectives", "volume": "90", "author": "Maurer", "year": "2016", "journal-title": "Arch Toxicol"}, {"issue": "2", "key": "10.1002/dta.2255-BIB0015|dta2255-cit-0016", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1002/cpt.534", "article-title": "Approaches, challenges, and advances in metabolism of new synthetic cannabinoids and identification of optimal urinary marker metabolites", "volume": "101", "author": "Diao", "year": "2017", "journal-title": "Clin Pharmacol Ther"}, {"issue": "13-14", "key": "10.1002/dta.2255-BIB0016|dta2255-cit-0017", "doi-asserted-by": "crossref", "first-page": "1078", "DOI": "10.1016/j.clinbiochem.2016.05.007", "article-title": "Alternative sampling strategies for the assessment of alcohol intake of living persons", "volume": "49", "author": "Kummer", "year": "2016", "journal-title": "Clin Biochem"}, {"issue": "16", "key": "10.1002/dta.2255-BIB0017|dta2255-cit-0018", "doi-asserted-by": "crossref", "first-page": "1961", "DOI": "10.4155/bio.15.139", "article-title": "DBS and beyond", "volume": "7", "author": "Stove", "year": "2015", "journal-title": "Bioanalysis"}, {"issue": "5", "key": "10.1002/dta.2255-BIB0018|dta2255-cit-0019", "first-page": "399", "article-title": "Dried blood spots: Concepts, present status, and future perspectives in bioanalysis", "volume": "6", "author": "Sharma", "year": "2014", "journal-title": "Drug Test Anal"}, {"key": "10.1002/dta.2255-BIB0019|dta2255-cit-0020", "doi-asserted-by": "crossref", "first-page": "44", "DOI": "10.1016/j.aca.2015.07.012", "article-title": "Direct ionization methods in mass spectrometry: An overview", "volume": "890", "author": "Klampfl", "year": "2015", "journal-title": "Anal Chim Acta"}, {"issue": "17", "key": "10.1002/dta.2255-BIB0020|dta2255-cit-0021", "doi-asserted-by": "crossref", "first-page": "2211", "DOI": "10.4155/bio.14.156", "article-title": "Spot them in the spot: Analysis of abused substances using dried blood spots", "volume": "6", "author": "Sadones", "year": "2014", "journal-title": "Bioanalysis"}, {"issue": "20", "key": "10.1002/dta.2255-BIB0021|dta2255-cit-0022", "doi-asserted-by": "crossref", "first-page": "2581", "DOI": "10.4155/bio.13.214", "article-title": "Recent advances in the bioanalytical applications of dried matrix spotting for the analysis of drugs and their metabolites", "volume": "5", "author": "Zimmer", "year": "2013", "journal-title": "Bioanalysis"}, {"issue": "4", "key": "10.1002/dta.2255-BIB0022|dta2255-cit-0023", "doi-asserted-by": "crossref", "first-page": "367", "DOI": "10.1002/dta.1505", "article-title": "Rapid and simple LC-MS/MS screening of 64 novel psychoactive substances using dried blood spots", "volume": "6", "author": "Ambach", "year": "2014", "journal-title": "Drug Test Anal"}, {"issue": "1", "key": "10.1002/dta.2255-BIB0023|dta2255-cit-0024", "doi-asserted-by": "crossref", "first-page": "30", "DOI": "10.1002/dta.1927", "article-title": "Quantitative determination of opioids in whole blood using fully automated dried blood spot desorption coupled to on-line SPE-LC-MS/MS", "volume": "8", "author": "Verplaetse", "year": "2016", "journal-title": "Drug Test Anal"}, {"key": "10.1002/dta.2255-BIB0024|dta2255-cit-0025", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1016/j.aca.2013.04.061", "article-title": "Direct tandem mass spectrometry for the simultaneous assay of opioids, cocaine and metabolites in dried urine spots", "volume": "784", "author": "Otero-Fernandez", "year": "2013", "journal-title": "Anal Chim Acta"}, {"issue": "12", "key": "10.1002/dta.2255-BIB0025|dta2255-cit-0026", "doi-asserted-by": "crossref", "first-page": "1118", "DOI": "10.1016/j.clinbiochem.2013.03.027", "article-title": "Simultaneous detection of 19 drugs of abuse on dried urine spot by liquid chromatography-tandem mass spectrometry", "volume": "46", "author": "Lee", "year": "2013", "journal-title": "Clin Biochem"}, {"key": "10.1002/dta.2255-BIB0026|dta2255-cit-0027", "doi-asserted-by": "crossref", "first-page": "112", "DOI": "10.1016/j.aca.2017.05.033", "article-title": "Dried urine spots - a novel sampling technique for comprehensive LC-MS n drug screening", "volume": "982", "author": "Michely", "year": "2017", "journal-title": "Anal Chim Acta"}, {"key": "10.1002/dta.2255-BIB0027|dta2255-cit-0028", "author": "Maurer", "year": "2016", "volume-title": "Mass spectral data of drugs, poisons, pesticides, pollutants and their metabolites"}, {"key": "10.1002/dta.2255-BIB0028|dta2255-cit-0029", "author": "Maurer", "year": "2017", "volume-title": "Maurer/Meyer/Helfer/Weber MMHW LC-HR-MS/MS Library of Drugs, Poisons, and their Metabolites"}, {"key": "10.1002/dta.2255-BIB0029|dta2255-cit-0030", "author": "Maurer", "year": "2017", "volume-title": "Maurer/Wissenbach/Weber MWW LC-MSn Library of Drugs, Poisons, and their Metabolites, 2nd rev"}, {"key": "10.1002/dta.2255-BIB0030|dta2255-cit-0031", "author": "Maurer", "year": "2016", "volume-title": "Mass spectral Library of Drugs, Poisons, Pesticides, Pollutants and their Metabolites"}, {"issue": "4", "key": "10.1002/dta.2255-BIB0031|dta2255-cit-0032", "doi-asserted-by": "crossref", "first-page": "575", "DOI": "10.1373/clinchem.2009.135517", "article-title": "Automated mass spectral deconvolution and identification system for GC-MS screening for drugs, poisons, and metabolites in urine", "volume": "56", "author": "Meyer", "year": "2010", "journal-title": "Clin Chem"}, {"issue": "10", "key": "10.1002/dta.2255-BIB0032|dta2255-cit-0033", "doi-asserted-by": "crossref", "first-page": "3481", "DOI": "10.1007/s00216-011-5032-1", "article-title": "Drugs of abuse screening in urine as part of a metabolite-based LC-MSn screening concept", "volume": "400", "author": "Wissenbach", "year": "2011", "journal-title": "Anal Bioanal Chem"}, {"issue": "1", "key": "10.1002/dta.2255-BIB0033|dta2255-cit-0034", "doi-asserted-by": "crossref", "first-page": "225", "DOI": "10.1007/s00216-013-7425-9", "article-title": "A qualitative/quantitative approach for the detection of 37 tryptamine-derived designer drugs, 5 beta-carbolines, ibogaine, and yohimbine in human urine and plasma using standard urine screening and multi-analyte approaches", "volume": "406", "author": "Meyer", "year": "2014", "journal-title": "Anal Bioanal Chem"}, {"key": "10.1002/dta.2255-BIB0034|dta2255-cit-0035", "author": "Baselt", "year": "2011", "volume-title": "Disposition of Toxic Drugs and Chemicals in Man"}], "container-title": ["Drug Testing and Analysis"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fdta.2255", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/dta.2255", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 7]], "date-time": "2018-08-07T01:49:00Z", "timestamp": 1533606540000}, "score": 34.380875, "issued": {"date-parts": [[2017, 8, 31]]}, "references-count": 34, "journal-issue": {"published-print": {"date-parts": [[2018, 1]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1002/dta.2255", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["1942-7603"], "issn-type": [{"value": "1942-7603", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}